{
    "url": "https://www.amgenpipeline.com/",
    "statusCode": 200,
    "browserHtml": "<!DOCTYPE html><!--[if lt IE 7]>      <html class=\"no-js lt-ie9 lt-ie8 lt-ie7\"> <![endif]--><!--[if IE 7]>         <html class=\"no-js lt-ie9 lt-ie8\"> <![endif]--><!--[if IE 8]>         <html class=\"no-js lt-ie9\"> <![endif]--><!--[if gt IE 8]><!--><html class=\"js no-applicationcache audio audio-ogg audio-mp3 audio-opus audio-wav audio-m4a canvas canvastext geolocation hashchange history inputtypes-search inputtypes-tel inputtypes-url inputtypes-email no-inputtypes-datetime inputtypes-date inputtypes-month inputtypes-week inputtypes-time inputtypes-datetime-local inputtypes-number inputtypes-range inputtypes-color postmessage postmessage-structuredclones svg video no-video-ogg video-h264 no-video-h265 video-webm video-vp9 no-video-hls no-video-av1 webgl websockets cssanimations backgroundsize borderimage borderradius boxshadow csscolumns csscolumns-width csscolumns-span csscolumns-fill csscolumns-gap csscolumns-rule csscolumns-rulecolor csscolumns-rulestyle csscolumns-rulewidth csscolumns-breakbefore csscolumns-breakafter csscolumns-breakinside flexbox fontface generatedcontent cssgradients hsla multiplebgs opacity cssreflections rgba textshadow csstransforms supports csstransforms3d csstransitions localstorage sessionstorage no-websqldatabase svgclippaths inlinesvg smil webworkers indexeddb indexeddb-deletedatabase\" lang=\"en\" page-id=\"{D0FF2E16-CAFE-4EAA-AC7F-B7A45E7A8D7A}\"><!--<![endif]--><head prefix=\"\">\n        <meta http-equiv=\"Content-Security-Policy\" content=\"upgrade-insecure-requests\">\n    \n<link rel=\"preconnect\" src=\"https://consent.cookiebot.com/\" crossorigin=\"\">\n<link rel=\"dns-prefetch\" src=\"https://consent.cookiebot.com/\">\n<link rel=\"preconnect\" src=\"https://connect.facebook.net/\" crossorigin=\"\">\n<link rel=\"dns-prefetch\" src=\"https://connect.facebook.net/\">\n<link rel=\"preconnect\" src=\"https://www.google-analytics.com/\" crossorigin=\"\">\n<link rel=\"dns-prefetch\" src=\"https://www.google-analytics.com/\">\n<link rel=\"preconnect\" src=\"https://www.googletagmanager.com/\" crossorigin=\"\">\n<link rel=\"dns-prefetch\" src=\"https://www.googletagmanager.com/\">\n<link rel=\"preconnect\" src=\"https://players.brightcove.net/\" crossorigin=\"\">\n<link rel=\"dns-prefetch\" src=\"https://players.brightcove.net/\">\n<link rel=\"preconnect\" src=\"https://vjs.zencdn.net/\" crossorigin=\"\">\n<link rel=\"dns-prefetch\" src=\"https://vjs.zencdn.net/\">\n    \n\n\n\n    \n\n    \n\n\n\n\n<script async=\"\" src=\"https://www.googletagmanager.com/gtm.js?id=GTM-M4CP89H\"></script><script type=\"text/javascript\" charset=\"UTF-8\" async=\"\" src=\"https://consent.cookiebot.com/3c04f870-41c9-42bc-965e-776f1eef473a/cc.js?renew=false&amp;referer=www.amgenpipeline.com&amp;dnt=false&amp;init=false&amp;georegions=%5B%7B%22r%22%3A%22GB%2CDE%2CFR%2CNL%2CIN%22%2C%22i%22%3A%227ca522be-0c36-4abe-b5be-20129dbf1b64%22%7D%5D\"></script><script>let setgeotarge = false; setgeofencing = false</script>\n\n        <script>setgeotarge = true;</script>\n    <script id=\"Cookiebot\" src=\"https://consent.cookiebot.com/uc.js\" data-cbid=\"3c04f870-41c9-42bc-965e-776f1eef473a\" data-culture=\"\" type=\"text/javascript\" data-consentmode=\"disabled\" data-georegions=\"{'region':'GB,DE,FR,NL,IN','cbid':'7ca522be-0c36-4abe-b5be-20129dbf1b64'}\" async=\"\"></script>\n\n\n\n\n    <script>setgeofencing = true;</script>\n    <style>\n        .disable-abtn {\n            color: gray !important;\n            pointer-events: none !important;\n        }\n    </style>\n\n<script type=\"text/javascript\">\n\n    function getcountrycode() {\n\n        if (document.getElementById(\"CybotCookiebotDialog\")) {\n            var countryCode = Cookiebot.userCountry.toUpperCase();\n            var countryListEU = [\"GB\", \"AT\", \"BE\", \"BG\", \"CY\", \"CZ\", \"DE\", \"DK\", \"ES\", \"EE\", \"FI\", \"FR\", \"GR\", \"HR\", \"HU\", \"IE\", \"IT\", \"LT\", \"LU\", \"LV\", \"MT\", \"NL\", \"PL\", \"PT\", \"RO\", \"SK\", \"SI\", \"SE\"];\n            if (countryListEU.includes(countryCode)) {\n                countryCode = \"EU\"\n            }\n            var usRegionList = [\"US-01\", \"US-02\", \"US-04\", \"US-05\", \"US-06\", \"US-08\", \"US-09\", \"US-10\", \"US-11\", \"US-12\", \"US-13\", \"US-15\", \"US-16\", \"US-17\", \"US-18\", \"US-19\", \"US-20\", \"US-21\", \"US-22\", \"US-23\", \"US-24\", \"US-25\", \"US-26\", \"US-27\", \"US-28\", \"US-29\", \"US-30\", \"US-31\", \"US-32\", \"US-33\", \"US-34\", \"US-35\", \"US-36\", \"US-37\", \"US-38\", \"US-39\", \"US-40\", \"US-41\", \"US-42\", \"US-44\", \"US-45\", \"US-46\", \"US-47\", \"US-48\", \"US-49\", \"US-50\", \"US-51\", \"US-53\", \"US-54\", \"US-55\", \"US-56\"];\n            if (usRegionList.includes(countryCode)) {\n                countryCode = \"US\";\n            }\n            if (countryCode != \"US\" && countryCode != \"EU\" && countryCode != \"CA\") {\n                countryCode = \"ccpa_default\";\n            }\n            document.getElementById(\"CybotCookiebotDialog\").classList.add(countryCode);\n            //console.log(\"country code class \" + countryCode);\n        }\n    }\n\n\n    function ReshowPopup() {\n        if (document.cookie.indexOf('cbrenew') > -1) {\n            if (document.getElementById(\"CybotCookiebotDialogBodyButtonAccept\")) {\n                CheckELMAndApplyCSS(\"CybotCookiebotDialogBodyButtonAccept\", \"disable-abtn\", \"add\");\n                document.getElementById(\"CybotCookiebotDialogBodyButtonAccept\").setAttribute('style', 'border:1px solid gray !important;color:gray !important');\n                if (document.getElementById(\"nvtext\")) {\n                    document.getElementById(\"nvtext\").setAttribute('style', 'display:block !important');\n                }\n            }\n        }\n        if (setgeotarge) { getcountrycode(); }\n    }\n\n    function CalllSetTimeOut() {setTimeout(function () {console.log(\".\"); ReshowPopup(); CalllSetTimeOutTwice(); },1500)}\n    function CalllSetTimeOutTwice() { setTimeout(function () {console.log(\"..\"); ReshowPopup(); CalllSetTimeOutThrice(); }, 3000) }\n    function CalllSetTimeOutThrice() { setTimeout(function () {console.log(\"...\"); ReshowPopup();  }, 4500) }\n\n\n    function CookiebotRenewClick() {\n        if (document.getElementsByClassName(\"cb-renew\").length > 0) {\n            let renewCBBtn = document.getElementsByClassName(\"cb-renew\")[0];\n            renewCBBtn.removeAttribute(\"onclick\");\n            renewCBBtn.href = \"#\";\n\n            renewCBBtn.addEventListener('click', function () {\n               // document.cookie = \"CookieConsent\" + '=; Path=/; Expires=Thu, 01 Jan 1970 00:00:01 GMT;';\n                Cookiebot.renew();\n                ReshowPopup();\n                setTimeout(function () { ReshowPopup(); CalllSetTimeOut(); }, 900);\n            });\n        }\n    }\n\n    window.addEventListener('DOMContentLoaded', function () {\n        CookiebotRenewClick();\n    });\n\n\n\n        function setCookieForCountryCode(name, value, days) {\n            var expires = \"\";\n            if (days) {\n                var date = new Date();\n                date.setTime(date.getTime() + (days * 24 * 60 * 60 * 1000));\n                expires = \"; expires=\" + date.toUTCString();\n            } document.cookie = name + \"=\" + (value || \"\") + expires + \"; path=/\";\n        }\n\n        function CheckELMAndApplyCSS(ele, cssname, addorremove) {\n\n            var domELE = document.getElementById(ele);\n            if (domELE && addorremove == \"add\") {\n                domELE.classList.add(cssname);\n            }\n            if (domELE && addorremove == \"rm\") {\n                domELE.classList.remove(cssname);\n            }\n\n        }\n\n        async function checkElementExists(element, timeout = Infinity) {\n            let startTime = Date.now();\n            return new Promise((resolve) => {\n                const intervalId = setInterval(() => {\n                    if (document.querySelector(element)) {\n                        clearInterval(intervalId);\n                        resolve(true);\n                    } else if (Date.now() - startTime >= timeout * 1000) {\n                        clearInterval(intervalId);\n                        resolve(false);\n                    }\n                }, 100, (1));\n            });\n        }\n\n\n        function blockPopup()\n        {\n\n            var regionArray = [];\n            var disableCountryCode = Cookiebot.userCountry.toUpperCase();\n            setCookieForCountryCode(\"RegionCode\", disableCountryCode, 365);\n            CheckELMAndApplyCSS(\"CybotCookiebotDialogBodyButtonAccept\", \"disable-abtn\", \"add\");\n\n                   regionArray.push(\"US-53\");\n                   regionArray.push(\"US-32\");\n                   regionArray.push(\"US-24\");\n\n                if (regionArray.includes(disableCountryCode))\n                {\n                    if (document.getElementById(\"CybotCookiebotDialogBodyButtonAccept\"))\n                        document.getElementById(\"CybotCookiebotDialogBodyButtonAccept\").setAttribute('style', 'border:1px solid gray !important;color:gray !important');\n\n                    if (document.getElementById(\"nvtext\"))\n                        document.getElementById(\"nvtext\").setAttribute('style', 'display:block !important');\n\n                    setCookieForCountryCode(\"cbrenew\", \"1\", 365);\n\n                }\n                else\n                    CheckELMAndApplyCSS(\"CybotCookiebotDialogBodyButtonAccept\", \"disable-abtn\", \"rm\");\n            }\n\n        checkElementExists(\"#CybotCookiebotDialog\", 120).then((result) => {\n            if (result)\n            {\n                if (setgeofencing) {\n                    blockPopup();\n                }\n                if (setgeotarge) {\n                    getcountrycode();\n                }\n\n            }\n            else\n            {\n                console.log(\"ncb\");\n            }\n        });\n\n\n</script>\n\n\n\n\n\n\n    \n    <meta name=\"viewport\" content=\"width=device-width, initial-scale=1\">\n    <meta http-equiv=\"X-UA-Compatible\" content=\"IE=edge\">\n<link href=\"/-/media/Feature/Experience-Accelerator/Bootstrap-4/Bootstrap-4/Styles/bootstrap-grid.css\" rel=\"stylesheet\"><link href=\"/-/media/Base-Themes/GeoTarget-Footer-CSS/Styles/Geotarget_Footer.css\" rel=\"stylesheet\"><link href=\"/-/media/Base-Themes/Core-Libraries/styles/mediaelementplayer.css\" rel=\"stylesheet\"><link href=\"/-/media/Base-Themes/Core-Libraries/styles/mediaelementplayer-legacy.css\" rel=\"stylesheet\"><link href=\"/-/media/Base-Themes/Core-Libraries/styles/font-awesomemin.css\" rel=\"stylesheet\"><link href=\"/-/media/Base-Themes/Core-Libraries/styles/fullcalendar.css\" rel=\"stylesheet\"><link href=\"/-/media/Base-Themes/Core-Libraries/styles/jquery-ui.css\" rel=\"stylesheet\"><link href=\"/-/media/Base-Themes/Core-Libraries/styles/jquery-ui-1133.css\" rel=\"stylesheet\"><link href=\"/-/media/Base-Themes/Main-Theme/styles/author.css\" rel=\"stylesheet\"><link href=\"/-/media/Base-Themes/Main-Theme/styles/core.css\" rel=\"stylesheet\"><link href=\"/-/media/Base-Themes/Main-Theme/styles/file-type-icons.css\" rel=\"stylesheet\"><link href=\"/-/media/Base-Themes/Main-Theme/styles/grayscale-mode.css\" rel=\"stylesheet\"><link href=\"/-/media/Base-Themes/Main-Theme/styles/reset.css\" rel=\"stylesheet\"><link href=\"/-/media/Themes/GlobalWithoutCCPA/GlobalWithoutCCPA/GlobalWithoutCCPA/styles/global-styles.css\" rel=\"stylesheet\"><link href=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/styles/google-font.css\" rel=\"stylesheet\"><link href=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/styles/comboTreePlugin.css\" rel=\"stylesheet\"><link href=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/styles/component-column-splitter.css\" rel=\"stylesheet\"><link href=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/styles/component-container.css\" rel=\"stylesheet\"><link href=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/styles/component-divider.css\" rel=\"stylesheet\"><link href=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/styles/component-field-editor.css\" rel=\"stylesheet\"><link href=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/styles/component-flash.css\" rel=\"stylesheet\"><link href=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/styles/component-flip.css\" rel=\"stylesheet\"><link href=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/styles/component-forms.css\" rel=\"stylesheet\"><link href=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/styles/component-fullcalendar.css\" rel=\"stylesheet\"><link href=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/styles/component-iframe.css\" rel=\"stylesheet\"><link href=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/styles/component-image.css\" rel=\"stylesheet\"><link href=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/styles/component-language-selector.css\" rel=\"stylesheet\"><link href=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/styles/component-link.css\" rel=\"stylesheet\"><link href=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/styles/component-link-list.css\" rel=\"stylesheet\"><link href=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/styles/component-media-link.css\" rel=\"stylesheet\"><link href=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/styles/component-navigation.css\" rel=\"stylesheet\"><link href=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/styles/component-page-list.css\" rel=\"stylesheet\"><link href=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/styles/component-promo.css\" rel=\"stylesheet\"><link href=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/styles/component-richtext-content.css\" rel=\"stylesheet\"><link href=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/styles/component-site-selector.css\" rel=\"stylesheet\"><link href=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/styles/component-tabs.css\" rel=\"stylesheet\"><link href=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/styles/component-title.css\" rel=\"stylesheet\"><link href=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/styles/main.css\" rel=\"stylesheet\"><link href=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/styles/overlay.css\" rel=\"stylesheet\"><link href=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/styles/privacy-warning.css\" rel=\"stylesheet\"><link href=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/styles/styles.css\" rel=\"stylesheet\"><link href=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/styles/pipeline.css\" rel=\"stylesheet\"><link href=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/styles/zcookiebot.css\" rel=\"stylesheet\">\n    \n<meta name=\"VIcurrentDateTime\" content=\"638981369080208815\">\n<meta name=\"VirtualFolder\" content=\"/\">\n<script type=\"text/javascript\" src=\"/layouts/system/VisitorIdentification.js\"></script>\n\n    \n\n\n\n\n<!--Header Media Start-->\n            <script src=\"-/media/Foundation/Amgen/JS/jquery-331min.js\"></script><style type=\"text/css\" id=\"CookieConsentStateDisplayStyles\">.cookieconsent-optin-preferences,.cookieconsent-optin-statistics,.cookieconsent-optin-marketing,.cookieconsent-optin{display:none;}.cookieconsent-optout-preferences,.cookieconsent-optout-statistics,.cookieconsent-optout-marketing,.cookieconsent-optout{display:block;display:initial;}</style>\n            <script src=\"-/media/Foundation/Amgen/JS/comboTreePlugin.js\"></script>\n            <script src=\"-/media/Foundation/Amgen/JS/icontains.js\"></script>\n<!--Header Media End-->\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n    \n\n\n\n    <title>Amgen Pipeline</title>\n\n\n\n\n    <link href=\"-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/amgen-pipeline.png\" rel=\"shortcut icon\">\n\n\n\n\n<meta property=\"og:description\" content=\"A robust pipeline leveraging state-of-the-art science and molecular engineering focused on the pursuit of transformative medicines with large effects in serious diseases. Human genetic validation is used whenever possible to strengthen the evidence base for as many of our programs as possible.\"><meta property=\"og:image\" content=\"http://www.amgenpipeline.com/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Desktop/Pipeline/HeroImage5.jpg\"><meta property=\"og:title\" content=\"Amgen Pipeline\"><meta property=\"og:url\" content=\"https://www.amgenpipeline.com/\">\n\n\n\n<meta name=\"description\" content=\"A robust pipeline leveraging state-of-the-art science and molecular engineering focused on the pursuit of transformative medicines with large effects in serious diseases. Human genetic validation is used whenever possible to strengthen the evidence base for as many of our programs as possible.\">\n\n\n\n<meta property=\"twitter:title\" content=\"Amgen Pipeline\"><meta property=\"twitter:card\" content=\"summary_large_image\">\n\n    <meta name=\"viewport\" content=\"width=device-width, initial-scale=1, user-scalable=no\">\n\n    \n\n\n\n\n\n\t\t\t<script>dataLayer = [{'pageType':'Home','actionTier':'Amgen Pipeline'}];</script>\n\t\t<!-- Google Tag Manager -->\n\t\t<script>\n            (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':\n            new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],\n            j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=\n            'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);\n            })(window, document, 'script', 'dataLayer', 'GTM-M4CP89H');\n\t\t</script>\n\t\t<!-- End Google Tag Manager -->\n\n    \n\n<style type=\"text/css\" id=\"CookiebotDialogStyle\">#CybotCookiebotDialog *,#CybotCookiebotDialogBodyUnderlay *{background:transparent;box-sizing:border-box;color:inherit;font-family:inherit;font-size:15px;margin:0;outline:0;padding:0;vertical-align:baseline}#CybotCookiebotDialog #CybotCookiebotDialogNav :after,#CybotCookiebotDialog #CybotCookiebotDialogNav :before{content:none}#CybotCookiebotDialog label{width:auto}#CybotCookiebotDialogBodyUnderlay{background-color:#000;height:100%;left:0;margin:0;opacity:0;overflow:hidden;padding:0;pointer-events:none;position:fixed;top:0;transition:opacity .5s ease;width:100%;z-index:2147483630}#CybotCookiebotDialog.CybotCookiebotDialogActive+#CybotCookiebotDialogBodyUnderlay{opacity:.75;pointer-events:auto}#CybotCookiebotDialog{background-color:#ffffff;border-radius:8px;box-shadow:0 32px 68px rgba(0,0,0,.3);box-sizing:border-box;color:#141414;font-family:sans-serif;font-size:15px;height:auto;left:50%;letter-spacing:.1px;line-height:24px;max-height:calc(100% - 16px);overflow:hidden;position:fixed;text-align:initial;top:50%;transform:translate(-50%,-50%);transition:all .5s ease;transition-property:width,max-width,top,bottom,left,opacity;width:calc(100% - 16px);z-index:2147483631}#CybotCookiebotDialog.CybotCookiebotDialogZoomedXl{max-height:calc(100vh - 10px);width:calc(100vw - 10px)}#CybotCookiebotDialog ol,#CybotCookiebotDialog ul{list-style-position:inside}#CybotCookiebotDialog .CybotCookiebotDialogContentWrapper{align-items:flex-start;display:flex;flex-direction:column;width:100%}#CybotCookiebotDialog .CybotCookiebotDialogSROnly{clip:rect(0,0,0,0);border:0;height:1px;margin:-1px;overflow:hidden;padding:0;position:absolute;width:1px}:root #CybotCookiebotDialog,:root #CybotCookiebotDialog #CybotCookiebotDialogTabContent,_:-ms-fullscreen{height:100%}:root #CybotCookiebotDialogBody,:root #CybotCookiebotDialogTabContent .CybotCookiebotDialogTabPanel,_:-ms-fullscreen{flex:auto}@media screen and (min-width:601px){#CybotCookiebotDialog{max-width:900px}}@media screen and (min-width:1280px){#CybotCookiebotDialog{left:50%;max-height:80vh;top:0;transform:translate(-50%)}#CybotCookiebotDialog.CybotEdge{box-shadow:0 30px 70px rgba(0,0,0,.3);height:auto;max-height:70vh;max-width:100vw;min-width:100vw;padding:24px;transition-property:transform,opacity,top;width:100vw}#CybotCookiebotDialog.CybotEdge .CybotCookiebotDialogContentWrapper{flex-direction:row;margin:0 auto;max-width:1600px;position:relative}#CybotCookiebotDialog[data-template=bottom]{top:100%;transform:translate(-50%,-100%)}#CybotCookiebotDialog[data-template=pushdown],#CybotCookiebotDialog[data-template=slidedown]{transform:translate(-50%,-150%)}#CybotCookiebotDialog[data-template=pushdown].CybotCookiebotDialogActive,#CybotCookiebotDialog[data-template=slidedown].CybotCookiebotDialogActive{transform:translate(-50%)}#CybotCookiebotDialog[data-template=slideup]{top:100%;transform:translate(-50%,50%)}#CybotCookiebotDialog[data-template=slideup].CybotCookiebotDialogActive{transform:translate(-50%,-100%)}#CybotCookiebotDialog[data-template=overlay],#CybotCookiebotDialog[data-template=popup]{opacity:0;top:50%;transform:translate(-50%,-50%)}#CybotCookiebotDialog[data-template=overlay].CybotCookiebotDialogActive,#CybotCookiebotDialog[data-template=popup].CybotCookiebotDialogActive{opacity:1}}#CybotCookiebotDialogHeader{align-items:center;border-bottom:1px solid #D6D6D6;display:flex;padding:1em;width:100%}#CybotCookiebotDialog.CybotCookiebotDialogZoomedXl #CybotCookiebotDialogHeader{padding:.5em 1em}#CybotCookiebotDialogHeaderLogosWrapper{align-items:center;display:flex;flex:1;justify-content:space-between}#CybotCookiebotDialogPoweredbyCybot,#CybotCookiebotDialogPoweredbyLink{align-items:center;display:flex;width:50%}#CybotCookiebotDialogPoweredbyCybot{justify-content:flex-end;width:175px}#CybotCookiebotDialogPoweredbyImage{max-height:1.5em;width:auto}#CybotCookiebotDialogPoweredbyCybot svg{fill:#141414;height:1.7em;max-width:133px}@media screen and (min-width:601px){#CybotCookiebotDialogPoweredbyCybot svg{height:2em}}@media screen and (min-width:1280px){#CybotCookiebotDialogHeader{padding:1.5em}#CybotCookiebotDialogPoweredbyImage{max-height:2.125em}#CybotCookiebotDialog.CybotEdge #CybotCookiebotDialogHeader{align-items:center;align-self:stretch;border:none;justify-content:space-between;padding:0;width:210px}#CybotCookiebotDialog.CybotEdge #CybotCookiebotDialogHeaderLogosWrapper{align-self:stretch;flex-direction:column}#CybotCookiebotDialog.CybotEdge #CybotCookiebotDialogPoweredbyLink{flex:1}#CybotCookiebotDialog.CybotEdge #CybotCookiebotDialogPoweredbyImage{height:auto;max-height:6em;max-width:100%}#CybotCookiebotDialog.CybotEdge #CybotCookiebotDialogPoweredbyCybot{height:2em;margin-top:2em}#CybotCookiebotDialog.CybotEdge #CybotCookiebotDialogPoweredbyCybot,#CybotCookiebotDialog.CybotEdge #CybotCookiebotDialogPoweredbyLink{justify-content:center}}#CybotCookiebotDialogNav{border-bottom:1px solid #D6D6D6;position:relative;width:100%}#CybotCookiebotDialog.CybotEdge #CybotCookiebotDialogNav{display:none}#CybotCookiebotDialogNav .CybotCookiebotDialogNavItems{display:flex;list-style:none;overflow-x:auto}#CybotCookiebotDialogNav .CybotCookiebotDialogNavItems::-webkit-scrollbar{height:0;width:0}#CybotCookiebotDialogNav .CybotCookiebotDialogNavItem{flex:1 1 0%;margin:0 auto}#CybotCookiebotDialogNav .CybotCookiebotDialogNavItemLink{border-bottom:1px solid #ffffff;color:#141414;display:block;font-weight:600;height:100%;outline-offset:-5px;padding:1em;text-align:center;text-decoration:none;white-space:nowrap}#CybotCookiebotDialog.CybotCookiebotDialogZoomedXl #CybotCookiebotDialogNav .CybotCookiebotDialogNavItemLink{padding:.5em}#CybotCookiebotDialogNav .CybotCookiebotDialogNavItemLink:hover{color:#1032CF}#CybotCookiebotDialogNav .CybotCookiebotDialogNavItemLink.CybotCookiebotDialogActive{border-color:transparent;border-bottom:1px solid #1032CF;color:#1032CF}@media screen and (min-width:1280px){#CybotCookiebotDialogNav .CybotCookiebotDialogNavItemLink.CybotCookiebotDialogActive{border-width:3px}}#CybotCookiebotDialogTabContent{display:flex;flex-direction:column;height:auto;min-height:60px;overflow:auto;width:100%}#CybotCookiebotDialogTabContent .CybotCookiebotScrollContainer{display:flex;flex:1;flex-direction:column}#CybotCookiebotDialogTabContent .CybotCookiebotDialogTabPanel{flex:1;overflow-x:hidden;overflow-y:auto;width:100%}#CybotCookiebotDialogSpecialFeaturesText ul{margin:.25em 0 .25em 2em}#CybotCookiebotDialog[dir=rtl] #CybotCookiebotDialogSpecialFeaturesText ul{margin:.25em 2em .25em 0}#CybotCookiebotDialog .CybotCookiebotScrollContainer{border-bottom:1px solid #D6D6D6;height:100%;padding:.375em;position:relative}#CybotCookiebotDialog .CybotCookiebotScrollArea{height:100%}#CybotCookiebotDialog .CybotCookiebotDialogBodyBottomWrapper{width:100%}@media screen and (min-width:601px){#CybotCookiebotDialog .CybotCookiebotScrollContainer{display:flex;min-height:auto}}@media screen and (min-width:1280px){#CybotCookiebotDialog.CybotEdge .CybotCookiebotScrollContainer{border-bottom:none;display:none}#CybotCookiebotDialog.CybotEdge.CybotMultilevel .CybotCookiebotScrollContainer{width:calc(100% - 286px - 1.5em)}#CybotCookiebotDialog.CybotEdge #CybotCookiebotDialogTabContent{flex:1;margin-left:1.5em;overflow:visible}#CybotCookiebotDialog.CybotEdge[dir=rtl] #CybotCookiebotDialogTabContent{margin-left:0;margin-right:1.5em}#CybotCookiebotDialog.CybotEdge #CybotCookiebotDialogTabContent .CybotCookiebotDialogTabPanel{overflow:visible}#CybotCookiebotDialog.CybotEdge .CybotCookiebotDialogBodyBottomWrapper{align-items:flex-end;display:flex;flex-wrap:wrap;justify-content:flex-start;margin-top:1.5em;padding-left:.375em}#CybotCookiebotDialog.CybotEdge[dir=rtl] .CybotCookiebotDialogBodyBottomWrapper{padding-left:0;padding-right:.375em}#CybotCookiebotDialog.CybotEdge.CybotMultilevel .CybotCookiebotDialogBodyBottomWrapper{border-top:1px solid #D6D6D6;padding-top:1em}}@media screen and (min-width:1510px){#CybotCookiebotDialog.CybotEdge:not([lang=ta]):not([lang=bg]):not([lang=is]):not([lang=el]) #CybotCookiebotDialogTabContent{margin:0 1.5em}#CybotCookiebotDialog.CybotEdge:not([lang=ta]):not([lang=bg]):not([lang=is]):not([lang=el]) .CybotCookiebotScrollContainer{width:auto}#CybotCookiebotDialog.CybotEdge:not([lang=ta]):not([lang=bg]):not([lang=is]):not([lang=el]) .CybotCookiebotDialogBodyBottomWrapper{border-top:none;padding-top:0}}#CybotCookiebotDialog .CybotCookiebotFader{bottom:0;height:5em;left:1px;opacity:0;pointer-events:none;position:absolute;transition:opacity .3s;width:calc(100% - 1em);z-index:10}#CybotCookiebotDialog .CybotCookiebotFader:not(.CybotCookiebotFaderRight):not(.CybotCookiebotFaderLeft){max-height:50%}#CybotCookiebotDialog[dir=rtl] .CybotCookiebotFader:not(.CybotCookiebotFaderLeft){left:auto;right:1px}#CybotCookiebotDialog .CybotCookiebotFader.CybotCookiebotDialogActive{opacity:1}#CybotCookiebotDialog .CybotCookiebotFaderLeft,#CybotCookiebotDialog .CybotCookiebotFaderRight{height:100%;width:3.5em}#CybotCookiebotDialog .CybotCookiebotFaderLeft{left:0}#CybotCookiebotDialog .CybotCookiebotFaderRight{left:auto;right:0}#CybotCookiebotDialog .CybotCookiebotFader:not(.CybotCookiebotFaderLeft):not(.CybotCookiebotFaderRight){max-height:30%}@media screen and (min-width:1280px){#CybotCookiebotDialog .CybotCookiebotFader:not(.CybotCookiebotFaderLeft):not(.CybotCookiebotFaderRight){width:calc(100% - 1.5em)}}#CybotCookiebotDialogBody{display:flex;flex-direction:column;height:100%}#CybotCookiebotDialogBody .CybotCookiebotScrollContainer{display:flex;flex-direction:column;max-height:18em}#CybotCookiebotDialog #CybotCookiebotDialogBodyContent{max-height:inherit}#CybotCookiebotDialog .CybotCookiebotDialogBodyContentHeading{font-weight:600;letter-spacing:.25px;line-height:1.6em;margin-bottom:.5em}#CybotCookiebotDialogBodyContent{flex:1;height:100%;letter-spacing:.5px;line-height:1.6em;max-height:100%;overflow-x:hidden;padding:1.625em .625em}#CybotCookiebotDialog.CybotCookiebotDialogZoomedXl #CybotCookiebotDialogBodyContent{padding:.8em}#CybotCookiebotDialog .CybotCookiebotDialogDetailBodyContentCookieTabContent{list-style-type:none}#CybotCookiebotDialogDetailBulkConsent{border:1px solid #D6D6D6;border-radius:.5em;margin:0 .625em 1em;padding:1em}#CybotCookiebotDialogDetailBulkConsent:before{border-top:1px solid #D6D6D6;content:\"\";width:100%}#CybotCookiebotDialogDetailBulkConsentLink{color:#141414;display:block;font-weight:600;line-height:1.6em;margin-bottom:.625em;text-decoration:none}#CybotCookiebotDialogDetailBulkConsentLink:hover{color:#1032CF}#CybotCookiebotDialogTabContent .CybotCookiebotDialogDetailBulkConsentCount{background-color:#D6D6D6;border-radius:5em;display:inline-block;font-size:.8em;font-weight:700;letter-spacing:.25px;line-height:1.2em;margin-left:.5em;padding:.25em .5em}#CybotCookiebotDialog[dir=rtl] #CybotCookiebotDialogTabContent .CybotCookiebotDialogDetailBulkConsentCount{margin-left:0;margin-right:.5em}#CybotCookiebotDialogDetailBulkConsentListWrapper{background-color:#F4F4F4;border:1px solid #D6D6D6;border-radius:.5em;margin-top:1.5em;padding:1em}#CybotCookiebotDialogDetailBulkConsentListWrapper>span{border-bottom:1px solid #D6D6D6;display:block;font-weight:600;padding-bottom:1em}#CybotCookiebotDialogDetailBulkConsentList{margin-top:1em}#CybotCookiebotDialogDetailFooter{letter-spacing:.3px;line-height:1.6em;padding:0 1em 1em}#CybotCookiebotDialogDetailFooter a{color:#141414}#CybotCookiebotDialogDetailBulkConsentList dt:not(:last-of-type){margin-bottom:.5em}@media screen and (min-width:1280px){#CybotCookiebotDialog #CybotCookiebotDialogBody .CybotCookiebotScrollContainer{display:flex;flex:auto;height:auto;max-height:15.5em;overflow:hidden}#CybotCookiebotDialogBodyContent{padding:1.125em}#CybotCookiebotDialogDetailBulkConsent{margin:0 2em 1em;padding:1.5em}#CybotCookiebotDialogDetailFooter{padding:0 2em 1.125em}#CybotCookiebotDialogDetailBulkConsentListWrapper{margin-top:2em;padding:1.5em}#CybotCookiebotDialog.CybotEdge #CybotCookiebotDialogBody{display:flex;justify-content:space-between;overflow:hidden}#CybotCookiebotDialog.CybotEdge #CybotCookiebotDialogBodyContent{height:auto;padding:0 1.125em 0 0}#CybotCookiebotDialog[dir=rtl].CybotEdge #CybotCookiebotDialogBodyContent{padding-left:1.125em;padding-right:0}}#CybotCookiebotDialogDetailBodyContentIABv2Tabs .CybotCookiebotDialogBodyLevelButtonIABHeader{font-weight:600;line-height:1.6em;margin-bottom:1em}#CybotCookiebotDialogDetailBodyContentIABv2Tabs .CybotCookiebotDialogBodyLevelButtonIABWrapper{border:2px solid #D6D6D6;border-radius:1em;margin:1.5em 0 1em;padding:1em}#CybotCookiebotDialogDetailBodyContentIABv2Tabs .CybotCookiebotDialogBodyLevelButtonIABWrapper:last-of-type{margin-bottom:0}#CybotCookiebotDialogDetailBodyContentIABv2Tabs .CybotCookiebotDialogBodyLevelButtonIABContainer,#CybotCookiebotDialogDetailBodyContentIABv2Tabs .CybotCookiebotDialogBodyLevelButtonIABContainerCollapsed{background-color:#F4F4F4;border:2px solid #D6D6D6;border-radius:1em;margin-bottom:.5em;padding:.5em 1em 1em;position:relative}#CybotCookiebotDialogDetailBodyContentIABv2Tabs .CybotCookiebotDialogBodyLevelButtonIABContainer:last-of-type,#CybotCookiebotDialogDetailBodyContentIABv2Tabs .CybotCookiebotDialogBodyLevelButtonIABContainerCollapsed:last-of-type{margin-bottom:0}#CybotCookiebotDialogDetailBodyContentIABv2Tabs .CybotCookiebotDialogBodyLevelButtonWrapper{align-items:center;display:flex;font-weight:600;margin:.5em 2em 0 0}#CybotCookiebotDialog[dir=rtl] #CybotCookiebotDialogDetailBodyContentIABv2Tabs .CybotCookiebotDialogBodyLevelButtonWrapper{margin:.5em 0 0 2em}#CybotCookiebotDialogDetailBodyContentIABv2Tabs .CybotCookiebotDialogBodyLevelButtonWrapper:nth-of-type(2){margin-right:0}#CybotCookiebotDialog[dir=rtl] #CybotCookiebotDialogDetailBodyContentIABv2Tabs .CybotCookiebotDialogBodyLevelButtonWrapper:nth-of-type(2){margin-left:0;margin-right:0}#CybotCookiebotDialogDetailBodyContentIABv2Tabs #CybotCookiebotDialogDetailBodyContentIABv2PartnersBody .CybotCookiebotDialogBodyLevelButtonWrapper:nth-of-type(2){margin-right:3.5em}#CybotCookiebotDialog[dir=rtl] #CybotCookiebotDialogDetailBodyContentIABv2Tabs #CybotCookiebotDialogDetailBodyContentIABv2PartnersBody .CybotCookiebotDialogBodyLevelButtonWrapper:nth-of-type(2){margin-left:3.5em;margin-right:0}#CybotCookiebotDialogDetailBodyContentIABv2Tabs .CybotCookiebotDialogBodyLevelButtonIABDescription{border-top:1px solid #D6D6D6;margin-top:1em;padding-top:1em}#CybotCookiebotDialogDetailBodyContentIABv2Tabs .CybotCookiebotDialogBodyLevelButtonIABPurposeCount{margin-top:2em}#CybotCookiebotDialogDetailBodyContentIABv2Tabs .CybotCookiebotDialogBodyLevelButtonIABPurposeCount .CybotCookiebotDialogDetailBulkConsentCount{margin-left:.4em}#CybotCookiebotDialogDetailBodyContentIABv2Tabs .CybotCookiebotDialogBodyLevelButtonIABLinkWrapper{font-weight:700}#CybotCookiebotDialogDetailBodyContentIABv2Tabs .CybotCookiebotDialogBodyLevelButtonIABLinkWrapper:nth-of-type(2){margin-top:1em}#CybotCookiebotDialogDetailBodyContentIABv2Tabs .CybotCookiebotDialogBodyLevelButtonIABLinkWrapper a{margin-top:0;word-break:break-word}#CybotCookiebotDialogDetailBodyContentIABv2Tabs .CybotCookiebotDialogBodyLevelButtonIABDescription a{align-items:center;display:inline-flex;margin-top:.5em}#CybotCookiebotDialogDetailBodyContentIABv2Tabs .CybotCookiebotDialogBodyLevelButtonIABDescription .CybotCookiebotDialogBodyLevelButtonIABBullet{margin:1em 0 0 1em}#CybotCookiebotDialog[dir=rtl] #CybotCookiebotDialogDetailBodyContentIABv2Tabs .CybotCookiebotDialogBodyLevelButtonIABDescription .CybotCookiebotDialogBodyLevelButtonIABBullet{margin:1em 1em 0 0}#CybotCookiebotDialogDetailBodyContentIABv2Tabs .CybotCookiebotDialogBodyLevelButtonIABDescription .CybotCookiebotDialogBodyLevelButtonIABList{font-weight:700;margin-top:1em}#CybotCookiebotDialogDetailBodyContentIABv2Tabs .CybotCookiebotDialogBodyLevelButtonIABDescription .CybotCookiebotDialogBodyLevelButtonIABList li{font-weight:400;margin-left:2px}#CybotCookiebotDialog[dir=rtl] #CybotCookiebotDialogDetailBodyContentIABv2Tabs .CybotCookiebotDialogBodyLevelButtonIABDescription .CybotCookiebotDialogBodyLevelButtonIABList li{font-weight:400;margin-right:2px}#CybotCookiebotDialogDetailBodyContentIABv2Tabs .CybotCookiebotDialogBodyLevelButtonIABContainerCollapsed .CybotCookiebotDialogBodyLevelButtonIABDescription{display:none}#CybotCookiebotDialogDetailBodyContentIABv2Tabs .CybotCookiebotDialogBodyLevelButtonIABContainer .CybotCookiebotDialogBodyLevelButtonIABDescription,#CybotCookiebotDialogDetailBodyContentIABv2Tabs .CybotCookiebotDialogBodyLevelButtonIABDescription.CybotCookiebotDialogShow{display:block}#CybotCookiebotDialogDetailBodyContentIABv2Tabs .CybotCookiebotDialogBodyLevelButtonIABContainerToggleHide,#CybotCookiebotDialogDetailBodyContentIABv2Tabs .CybotCookiebotDialogBodyLevelButtonIABContainerToggleShow{display:block;height:2em;position:absolute;right:1.35em;top:.75em;width:2em}#CybotCookiebotDialog[dir=rtl] #CybotCookiebotDialogDetailBodyContentIABv2Tabs .CybotCookiebotDialogBodyLevelButtonIABContainerToggleHide,#CybotCookiebotDialog[dir=rtl] #CybotCookiebotDialogDetailBodyContentIABv2Tabs .CybotCookiebotDialogBodyLevelButtonIABContainerToggleShow{left:1.35em;right:auto}#CybotCookiebotDialogDetailBodyContentIABv2PartnersBody .CybotCookiebotDialogBodyLevelButtonIABContainer:before,#CybotCookiebotDialogDetailBodyContentIABv2PartnersBody .CybotCookiebotDialogBodyLevelButtonIABContainerCollapsed:before{border-style:solid;border-width:.15em .15em 0 0;content:\"\";display:inline-block;height:.5em;position:absolute;right:2em;top:1.3em;transform:rotate(-225deg);width:.5em}#CybotCookiebotDialog[dir=rtl] #CybotCookiebotDialogDetailBodyContentIABv2PartnersBody .CybotCookiebotDialogBodyLevelButtonIABContainer:before,#CybotCookiebotDialog[dir=rtl] #CybotCookiebotDialogDetailBodyContentIABv2PartnersBody .CybotCookiebotDialogBodyLevelButtonIABContainerCollapsed:before{left:2em;right:auto}#CybotCookiebotDialogDetailBodyContentIABv2PartnersBody .CybotCookiebotDialogBodyLevelButtonIABContainer:before{top:1.6em;transform:rotate(-45deg)}#CybotCookiebotDialogDetailBodyContentIABv2Tabs .CybotCookiebotDialogBodyIABIntroContainer{padding-bottom:1em}#CybotCookiebotDialogDetailBodyContentIABv2Tabs .CybotCookiebotDialogBodyLevelButtonIABLabel{line-height:1.5em}#CybotCookiebotDialogDetailBodyContentIABv2Tabs p.CybotCookiebotDialogBodyLevelButtonIABLabel{padding-left:2em}@media screen and (min-width:1280px){#CybotCookiebotDialogDetailBodyContentIABv2Tabs .CybotCookiebotDialogBodyLevelButtonIABWrapper{padding:1.5em}#CybotCookiebotDialogDetailBodyContentIABv2Tabs .CybotCookiebotDialogBodyLevelButtonIABHeader{align-items:center;border-bottom:1px solid #D6D6D6;display:flex;margin-bottom:1.5em;padding-bottom:1.5em}#CybotCookiebotDialogDetailBodyContentIABv2Tabs .CybotCookiebotDialogBodyIABIntroContainer{padding-bottom:1.5em}#CybotCookiebotDialogDetailBodyContentIABv2Tabs .CybotCookiebotDialogBodyLevelButtonIABContainerTogglesWrapper{align-items:center;display:flex;justify-content:space-between;width:100%}#CybotCookiebotDialogDetailBodyContentIABv2Tabs .CybotCookiebotDialogBodyLevelButtonIABContainer,#CybotCookiebotDialogDetailBodyContentIABv2Tabs .CybotCookiebotDialogBodyLevelButtonIABContainerCollapsed{padding:1em 1.5em 1.5em}#CybotCookiebotDialogDetailBodyContentIABv2PartnersBody .CybotCookiebotDialogBodyLevelButtonIABContainer:before,#CybotCookiebotDialogDetailBodyContentIABv2PartnersBody .CybotCookiebotDialogBodyLevelButtonIABContainerCollapsed:before{top:1.8em}#CybotCookiebotDialogDetailBodyContentIABv2PartnersBody .CybotCookiebotDialogBodyLevelButtonIABContainer:before{top:2.1em}#CybotCookiebotDialogDetailBodyContentIABv2Tabs .CybotCookiebotDialogBodyLevelButtonIABDescription{width:100%}#CybotCookiebotDialogDetailBodyContentIABv2Tabs .CybotCookiebotDialogBodyLevelButtonIABContainerToggleHide,#CybotCookiebotDialogDetailBodyContentIABv2Tabs .CybotCookiebotDialogBodyLevelButtonIABContainerToggleShow{top:1.2em}}#CybotCookiebotDialogDetailBodyContentTextAbout{padding:1.625em .625em}#CybotCookiebotDialog.CybotCookiebotDialogZoomedXl #CybotCookiebotDialogDetailBodyContentTextAbout{padding:.5em}@media screen and (min-width:1280px){#CybotCookiebotDialogDetailBodyContentTextAbout{padding:1.125em}#CybotCookiebotDialog.CybotCookiebotDialogZoomedXl #CybotCookiebotDialogDetailBodyContentTextAbout{padding:.5em}}#CybotCookiebotDialogFooter.CybotCookiebotScrollContainer{height:auto;min-height:80px;width:100%}#CybotCookiebotDialogFooter .CybotCookiebotScrollArea{padding:1em;width:100%}#CybotCookiebotDialog.CybotCookiebotDialogZoomedXl #CybotCookiebotDialogFooter .CybotCookiebotScrollArea{padding:.5em}#CybotCookiebotDialog:not(.CybotCookiebotDialogZoomedLg):not(.CybotCookiebotDialogZoomedXl) #CybotCookiebotDialogFooter.CybotCookiebotScrollContainer{min-height:auto;padding:0}#CybotCookiebotDialog.CybotCookiebotDialogZoomedLg #CybotCookiebotDialogFooter .CybotCookiebotScrollArea,#CybotCookiebotDialog.CybotCookiebotDialogZoomedXl #CybotCookiebotDialogFooter .CybotCookiebotScrollArea{overflow:auto}#CybotCookiebotDialogBodyButtons{align-items:flex-start;display:flex;flex-direction:column;flex-wrap:wrap}@media screen and (min-width:601px){#CybotCookiebotDialogBodyButtons{align-items:center;flex-direction:row}}@media screen and (min-width:1280px){#CybotCookiebotDialogFooter .CybotCookiebotScrollArea{padding:1em 1.5em 1.5em}#CybotCookiebotDialog.CybotEdge #CybotCookiebotDialogFooter{display:block;padding:0;width:auto}#CybotCookiebotDialog.CybotEdge #CybotCookiebotDialogFooter .CybotCookiebotScrollArea{padding:0}#CybotCookiebotDialog.CybotEdge #CybotCookiebotDialogFooter .CybotCookiebotScrollbarContainer{display:none}#CybotCookiebotDialog.CybotEdge.CybotMultilevel #CybotCookiebotDialogFooter{position:absolute;right:0;top:0}#CybotCookiebotDialog.CybotEdge[dir=rtl] #CybotCookiebotDialogFooter{left:0;right:auto}#CybotCookiebotDialog.CybotEdge.CybotMultilevel.CybotCloseButtonEnabled #CybotCookiebotDialogFooter{right:51px}#CybotCookiebotDialog.CybotEdge[dir=rtl].CybotCloseButtonEnabled #CybotCookiebotDialogFooter{left:51px;right:auto}#CybotCookiebotDialog.CybotEdge #CybotCookiebotDialogBodyButtons{align-items:flex-end;flex-direction:column-reverse;max-width:286px}}@media screen and (min-width:1510px){#CybotCookiebotDialog.CybotEdge:not([lang=ta]):not([lang=bg]):not([lang=is]):not([lang=el]) #CybotCookiebotDialogFooter{position:relative;right:0}#CybotCookiebotDialog.CybotEdge[dir=rtl]:not([lang=ta]):not([lang=bg]):not([lang=is]):not([lang=el]) #CybotCookiebotDialogFooter{left:0;position:relative;right:auto}}#CybotCookiebotDialog .CybotCookiebotScrollContainer>div:first-of-type::-webkit-scrollbar,#CybotCookiebotDialog.CybotCookiebotDialogZoomedLg #CybotCookiebotDialogFooter>div:first-of-type::-webkit-scrollbar,#CybotCookiebotDialog.CybotCookiebotDialogZoomedXl #CybotCookiebotDialogFooter>div:first-of-type::-webkit-scrollbar{width:.25em}#CybotCookiebotDialog .CybotCookiebotScrollContainer>div:first-of-type::-webkit-scrollbar-track,#CybotCookiebotDialog.CybotCookiebotDialogZoomedLg #CybotCookiebotDialogFooter>div:first-of-type::-webkit-scrollbar-track,#CybotCookiebotDialog.CybotCookiebotDialogZoomedXl #CybotCookiebotDialogFooter>div:first-of-type::-webkit-scrollbar-track{background:#f2f2f2;border-radius:.313em}#CybotCookiebotDialog .CybotCookiebotScrollContainer>div:first-of-type::-webkit-scrollbar-thumb,#CybotCookiebotDialog.CybotCookiebotDialogZoomedLg #CybotCookiebotDialogFooter>div:first-of-type::-webkit-scrollbar-thumb,#CybotCookiebotDialog.CybotCookiebotDialogZoomedXl #CybotCookiebotDialogFooter>div:first-of-type::-webkit-scrollbar-thumb{background:#141414;border-radius:.313em}#CybotCookiebotDialog .CybotCookiebotScrollContainer .CybotCookiebotScrollbarContainer{background:#ffffff;display:none;height:100%;pointer-events:none;position:absolute;right:.375em;top:0;transition:opacity .5s;width:.6em}#CybotCookiebotDialog[dir=rtl] .CybotCookiebotScrollContainer .CybotCookiebotScrollbarContainer{left:.375em;right:auto}#CybotCookiebotDialog:hover .CybotCookiebotScrollContainer .CybotCookiebotScrollbarContainer{opacity:0}#CybotCookiebotDialog .CybotCookiebotScrollContainer>div:first-of-type:focus{outline:none}#CybotCookiebotDialog .CybotCookiebotScrollContainer>div:first-of-type:focus::-webkit-scrollbar-thumb,#CybotCookiebotDialog.CybotCookiebotDialogZoomedLg #CybotCookiebotDialogFooter>div:first-of-type:focus::-webkit-scrollbar-thumb,#CybotCookiebotDialog.CybotCookiebotDialogZoomedXl #CybotCookiebotDialogFooter>div:first-of-type:focus::-webkit-scrollbar-thumb{background:#1032CF}@-moz-document url-prefix(){#CybotCookiebotDialog .CybotCookiebotScrollContainer>div:first-of-type,#CybotCookiebotDialog.CybotCookiebotDialogZoomedLg #CybotCookiebotDialogFooter>div:first-of-type,#CybotCookiebotDialog.CybotCookiebotDialogZoomedXl #CybotCookiebotDialogFooter>div:first-of-type{scrollbar-track-color:#f2f2f2;scrollbar-face-color:#141414;scrollbar-color:#141414 #f2f2f2;scrollbar-width:thin}}#CybotCookiebotDialog .CybotCookiebotScrollContainer>div:first-of-type:focus,#CybotCookiebotDialog.CybotCookiebotDialogZoomedLg #CybotCookiebotDialogFooter>div:first-of-type:focus,#CybotCookiebotDialog.CybotCookiebotDialogZoomedXl #CybotCookiebotDialogFooter>div:first-of-type:focus{scrollbar-color:#1032CF #f2f2f2}@media screen and (min-width:1510px){#CybotCookiebotDialog .CybotCookiebotScrollContainer>div:first-of-type::-webkit-scrollbar,#CybotCookiebotDialog.CybotCookiebotDialogZoomedLg #CybotCookiebotDialogFooter>div:first-of-type::-webkit-scrollbar,#CybotCookiebotDialog.CybotCookiebotDialogZoomedXl #CybotCookiebotDialogFooter>div:first-of-type::-webkit-scrollbar{width:.5em}#CybotCookiebotDialog .CybotCookiebotScrollContainer .CybotCookiebotScrollbarContainer{display:block}}#CybotCookiebotDialog .CybotCookiebotDialogBodyLevelButtonIABContainerToggleHide,#CybotCookiebotDialog .CybotCookiebotDialogBodyLevelButtonIABContainerToggleShow,#CybotCookiebotDialog a:after,#CybotCookiebotDialog a:before,#CybotCookiebotDialog button:after,#CybotCookiebotDialog button:before{border-color:#141414}#CybotCookiebotDialog a:hover:after,#CybotCookiebotDialog a:hover:before,#CybotCookiebotDialog button:hover:after,#CybotCookiebotDialog button:hover:before{border-color:#1032CF}#CybotCookiebotDialog #CybotCookiebotBannerCloseButtonE2E,#CybotCookiebotDialog .CybotCookiebotBannerCloseButton{fill:#141414;border:none;display:none}#CybotCookiebotDialog.CybotCloseButtonEnabled .CybotCookiebotBannerCloseButton{display:flex;margin-left:2.313rem}#CybotCookiebotDialog[dir=rtl] .CybotCookiebotBannerCloseButton{margin-left:auto;margin-right:2.313rem}#CybotCookiebotDialogFooter #CybotCookiebotDialogBodyButtonsWrapper{display:flex;flex-direction:column;width:100%}#CybotCookiebotDialogBodyButtons .CybotCookiebotDialogBodyButton:not(:first-of-type),#CybotCookiebotDialogFooter .CybotCookiebotDialogBodyButton:not(:first-of-type){margin-top:.5em}#CybotCookiebotDialogBodyButtons .CybotCookiebotDialogBodyContentControlsWrapper{align-items:center;display:flex;margin-bottom:.5em}#CybotCookiebotDialogBodyButtons .CybotCookiebotDialogBodyContentControlsWrapper .CybotCookiebotDialogBodyLevelButtonSliderWrapper{margin-right:1em}#CybotCookiebotDialogBodyButtons .CybotCookiebotDialogBodyContentControlsWrapper .CybotCookiebotDialogBodyLevelButtonDescription{font-weight:600}#CybotCookiebotDialogFooter .CybotCookiebotDialogBodyButton{background-color:transparent;border:2px solid #1032CF;border-radius:.25em;color:#141414;display:block;font-weight:600;padding:1em;text-align:center;user-select:none;width:100%}#CybotCookiebotDialogFooter .CybotCookiebotDialogBodyButton:hover{opacity:.85}#CybotCookiebotDialogFooter #CybotCookiebotDialogBodyLevelButtonCustomize,#CybotCookiebotDialogFooter #CybotCookiebotDialogBodyLevelButtonLevelOptinAllowallSelection{background-color:transparent;border-color:#1032CF;color:#141414}#CybotCookiebotDialogFooter #CybotCookiebotDialogBodyButtonAccept,#CybotCookiebotDialogFooter #CybotCookiebotDialogBodyLevelButtonAccept,#CybotCookiebotDialogFooter #CybotCookiebotDialogBodyLevelButtonLevelOptinAllowAll{background-color:#1032CF;border-color:#1032CF;color:#ffffff}#CybotCookiebotDialogFooter #CybotCookiebotDialogBodyLevelButtonCustomize{align-items:center}#CybotCookiebotDialogFooter #CybotCookiebotDialogBodyLevelButtonCustomize .CybotCookiebotDialogArrow{border-color:#141414;border-style:solid;border-width:.15em .15em 0 0;display:inline-block;height:.5em;margin-left:1em;transform:rotate(45deg);vertical-align:baseline;width:.5em}#CybotCookiebotDialog[dir=rtl] #CybotCookiebotDialogFooter #CybotCookiebotDialogBodyLevelButtonCustomize .CybotCookiebotDialogArrow{margin-left:0;margin-right:1em;transform:rotate(-135deg)}#CybotCookiebotDialogDetailBodyContentIABv2Tabs .CybotCookiebotDialogBodyLevelButtonIABHeaderToggle{border-bottom:1px solid #D6D6D6;display:flex;flex-wrap:wrap;justify-content:flex-end;margin:1em 0 1.5em auto;padding-bottom:1.5em}#CybotCookiebotDialogDetailBodyContentIABv2Tabs .CybotCookiebotDialogBodyLevelButtonIABHeaderButton,#CybotCookiebotDialogDetailBodyContentIABv2Tabs .CybotCookiebotDialogBodyLevelButtonIABHeaderToggleDeselectVendorsLink,#CybotCookiebotDialogDetailBodyContentIABv2Tabs .CybotCookiebotDialogBodyLevelButtonIABHeaderToggleSelectVendorsLink{align-items:center;background-color:transparent;border:2px solid #1032CF;border-radius:.25em;color:#141414;display:flex;font-weight:600;padding:.75em 1em;text-decoration:none;user-select:none}#CybotCookiebotDialogDetailBodyContentIABv2Tabs .CybotCookiebotDialogBodyLevelButtonIABHeaderButton:hover,#CybotCookiebotDialogDetailBodyContentIABv2Tabs .CybotCookiebotDialogBodyLevelButtonIABHeaderToggleDeselectVendorsLink:hover,#CybotCookiebotDialogDetailBodyContentIABv2Tabs .CybotCookiebotDialogBodyLevelButtonIABHeaderToggleSelectVendorsLink:hover{opacity:.85}#CybotCookiebotDialogDetailBodyContentIABv2Tabs .CybotCookiebotDialogBodyLevelButtonIABHeaderButton.select,#CybotCookiebotDialogDetailBodyContentIABv2Tabs .CybotCookiebotDialogBodyLevelButtonIABHeaderToggleSelectVendorsLink{background-color:#1032CF;border-color:#1032CF;color:#ffffff;margin-left:.5em}#CybotCookiebotDialog[dir=rtl] #CybotCookiebotDialogDetailBodyContentIABv2Tabs .CybotCookiebotDialogBodyLevelButtonIABHeaderButton.select,#CybotCookiebotDialog[dir=rtl] #CybotCookiebotDialogDetailBodyContentIABv2Tabs .CybotCookiebotDialogBodyLevelButtonIABHeaderToggleSelectVendorsLink{margin-left:0;margin-right:.5em}@media screen and (min-width:601px){#CybotCookiebotDialogFooter #CybotCookiebotDialogBodyButtonsWrapper{align-items:stretch;flex:1;flex-direction:row;justify-content:flex-end}#CybotCookiebotDialogFooter #CybotCookiebotDialogBodyButtons .CybotCookiebotDialogBodyButton:not(:first-of-type),#CybotCookiebotDialogFooter .CybotCookiebotDialogBodyButton,#CybotCookiebotDialogFooter .CybotCookiebotDialogBodyButton:not(:first-of-type){margin-top:0;width:33%}#CybotCookiebotDialogBodyButtons .CybotCookiebotDialogBodyContentControlsWrapper:not(.CybotCookiebotDialogHide)+#CybotCookiebotDialogBodyButtonsWrapper .CybotCookiebotDialogBodyButton{max-width:286px;width:100%}#CybotCookiebotDialogBodyButtons .CybotCookiebotDialogBodyButton:not(:last-of-type){margin-right:.5em}#CybotCookiebotDialog[dir=rtl] #CybotCookiebotDialogFooter .CybotCookiebotDialogBodyButton:not(:last-of-type){margin-left:.5em;margin-right:0}#CybotCookiebotDialogBodyButtons .CybotCookiebotDialogBodyContentControlsWrapper{margin-bottom:0;margin-right:1em}}@media screen and (min-width:1280px){#CybotCookiebotDialog.CybotEdge .CybotCookiebotBannerCloseButton{display:none}#CybotCookiebotDialog.CybotEdge.CybotCloseButtonEnabled #CybotCookiebotBannerCloseButtonE2E{display:flex}#CybotCookiebotDialogDetailBodyContentIABv2Tabs .CybotCookiebotDialogBodyLevelButtonIABHeaderToggle{border-bottom:none;justify-content:flex-start;margin:0 0 0 auto;padding:0}#CybotCookiebotDialog[dir=rtl] #CybotCookiebotDialogDetailBodyContentIABv2Tabs .CybotCookiebotDialogBodyLevelButtonIABHeaderToggle{margin-left:0;margin-right:auto}#CybotCookiebotDialog.CybotEdge #CybotCookiebotDialogFooter #CybotCookiebotDialogBodyButtonsWrapper{flex:auto;flex-direction:column}#CybotCookiebotDialog.CybotEdge #CybotCookiebotDialogFooter .CybotCookiebotDialogBodyButton{max-width:none;width:286px}#CybotCookiebotDialog.CybotEdge #CybotCookiebotDialogFooter .CybotCookiebotDialogBodyButton:not(:first-of-type){margin-top:.5em}}#CybotCookiebotDialogBodyLevelWrapper{width:100%}#CybotCookiebotDialogBodyEdgeMoreDetails{display:none}#CybotCookiebotDialogDetailBodyContentCookieContainerTypes{list-style-type:none}#CybotCookiebotDialog.CybotEdge #CybotCookiebotDialogBodyEdgeMoreDetails{display:flex;justify-content:flex-end;margin:1.5em 2em .5em 0}#CybotCookiebotDialog.CybotEdge[dir=rtl] #CybotCookiebotDialogBodyEdgeMoreDetails{margin-left:1.125em;margin-right:0}#CybotCookiebotDialog.CybotEdge #CybotCookiebotDialogBodyEdgeMoreDetails a{align-items:center;color:#1032CF;display:flex;font-weight:600;text-decoration:none}#CybotCookiebotDialog.CybotEdge #CybotCookiebotDialogBodyEdgeMoreDetails a:after{border-style:solid;border-width:.15em .15em 0 0;color:#141414;content:\"\";display:block;height:.563em;margin-left:1em;transform:rotate(45deg);width:.563em}#CybotCookiebotDialog.CybotEdge[dir=rtl] #CybotCookiebotDialogBodyEdgeMoreDetails a:after{margin-left:0;margin-right:1em;transform:rotate(225deg)}#CybotCookiebotDialogBodyLevelButtons{width:100%}#CybotCookiebotDialog .CybotCookiebotDialogBodyLevelButtonSliderWrapper{-webkit-backface-visibility:hidden;backface-visibility:hidden;display:flex;flex-shrink:0;height:32px;position:relative;width:57px}#CybotCookiebotDialog .CybotCookiebotDialogBodyLevelButtonSliderWrapper:hover input[type=checkbox]:not(:disabled)+.CybotCookiebotDialogBodyLevelButtonSlider{opacity:.85}#CybotCookiebotDialog .CybotCookiebotDialogBodyLevelButtonSliderWrapper input[type=checkbox].CybotCookiebotDialogBodyLevelButton{opacity:0}#CybotCookiebotDialog .CybotCookiebotDialogBodyLevelButtonSlider{background-color:#141414;border-radius:32px;bottom:0;left:0;pointer-events:none;position:absolute;right:0;top:0;transition:background-color .4s}#CybotCookiebotDialog .CybotCookiebotDialogBodyLevelButtonSlider:before{background-color:#ffffff;border-radius:50%;bottom:4px;content:\"\";height:24px;left:4px;position:absolute;transition:transform .4s;width:24px}#CybotCookiebotDialog input:checked+.CybotCookiebotDialogBodyLevelButtonSlider{background-color:#1032CF}#CybotCookiebotDialog input:checked+.CybotCookiebotDialogBodyLevelButtonSlider:before,#CybotCookiebotDialog[dir=rtl] #CybotCookiebotDialogTabContent input+.CybotCookiebotDialogBodyLevelButtonSlider:before{background-color:#ffffff;transform:translateX(26px)}#CybotCookiebotDialog[dir=rtl] #CybotCookiebotDialogTabContent input:checked+.CybotCookiebotDialogBodyLevelButtonSlider:before{transform:translateX(0)}#CybotCookiebotDialog form input[type=checkbox][disabled]:checked+.CybotCookiebotDialogBodyLevelButtonSlider{background-color:#D6D6D6;pointer-events:none}#CybotCookiebotDialogBodyLevelButtonsSelectPane{border-bottom:1px solid #D6D6D6;padding:1em 0}#CybotCookiebotDialogBodyLevelButtonsSelectPane .CybotCookiebotDialogBodyLevelButtonWrapper{align-items:center;display:flex;justify-content:space-between;padding:1em;text-align:center;width:100%}#CybotCookiebotDialogDetailBodyContentIABv2Tabs .CybotCookiebotDialogBodyLevelButtonWrapper+.CybotCookiebotDialogBodyLevelButtonWrapper label{font-size:.875em;font-style:italic;font-weight:400;letter-spacing:.15px;padding-bottom:0}#CybotCookiebotDialogBodyLevelButtonsSelectPane .CybotCookiebotDialogBodyLevelButtonDescription{font-weight:700}#CybotCookiebotDialogBodyLevelButtonsSelectPane label:not([for=CybotCookiebotDialogBodyLevelButtonNecessary]) .CybotCookiebotDialogBodyLevelButtonDescription:hover{color:#1032CF}@media screen and (min-width:601px){#CybotCookiebotDialog #CybotCookiebotDialogBodyLevelButtonsSelectPane{padding:0}#CybotCookiebotDialogBodyLevelButtonsSelectPane .CybotCookiebotDialogBodyLevelButtonWrapper{flex-direction:column;padding:1.5em 1em;width:25%}#CybotCookiebotDialogBodyLevelButtonsSelectPane .CybotCookiebotDialogBodyLevelButtonWrapper:not(:last-of-type){border-right:1px solid #D6D6D6}#CybotCookiebotDialog[dir=rtl] #CybotCookiebotDialogBodyLevelButtonsSelectPane .CybotCookiebotDialogBodyLevelButtonWrapper:not(:last-of-type){border-left:1px solid #D6D6D6;border-right:none}#CybotCookiebotDialogBodyLevelButtonsSelectPane .CybotCookiebotDialogBodyLevelButtonLabel{margin-bottom:.75em}#CybotCookiebotDialogTabContent input:focus+.CybotCookiebotDialogBodyLevelButtonSlider{box-shadow:0 0 1px #1032CF}}@media screen and (min-width:1280px){#CybotCookiebotDialog.CybotEdge #CybotCookiebotDialogBodyLevelButtonsSelectPane{border-bottom:none}#CybotCookiebotDialog.CybotEdge #CybotCookiebotDialogBodyLevelButtonsSelectPane .CybotCookiebotDialogBodyLevelButtonWrapper{border:none;flex-direction:row;margin:.5em 2.5em 0 0;padding:0;width:auto}#CybotCookiebotDialog.CybotEdge #CybotCookiebotDialogBodyLevelButtonsSelectPane .CybotCookiebotDialogBodyLevelButtonLabel{margin-bottom:0}#CybotCookiebotDialog.CybotEdge #CybotCookiebotDialogBodyLevelWrapper{width:auto}#CybotCookiebotDialog.CybotEdge .CybotCookiebotDialogBodyLevelButtonLabel{margin-right:1em}#CybotCookiebotDialog.CybotEdge[dir=rtl] .CybotCookiebotDialogBodyLevelButtonLabel{margin-left:1em;margin-right:0}#CybotCookiebotDialog.CybotEdge[dir=rtl] #CybotCookiebotDialogBodyLevelButtonsSelectPane .CybotCookiebotDialogBodyLevelButtonWrapper{border-left:none;margin:.5em 0 0 2.5em}#CybotCookiebotDialog.CybotEdge #CybotCookiebotDialogBodyEdgeMoreDetails{display:inline-flex;height:2em;margin:0}}#CybotCookiebotDialog input[type=checkbox]{height:1.5em;margin-right:.5em;width:1.5em}#CybotCookiebotDialog[dir=rtl] input[type=checkbox]{margin-left:.5em;margin-right:0}#CybotCookiebotDialog .CybotCookiebotDialogBodyLevelButtonSliderWrapper form{height:100%;width:100%}#CybotCookiebotDialog .CybotCookiebotDialogBodyLevelButtonSliderWrapper input[type=checkbox]{height:100%;margin-right:0;width:100%}#CybotCookiebotDialog #CybotCookiebotDialogDetailBodyContentIABv2Tabs input[type=checkbox]{-moz-appearance:none;-webkit-appearance:none;-o-appearance:none;background-color:#ffffff;border:2px solid #D6D6D6;border-radius:4px;position:relative}#CybotCookiebotDialog #CybotCookiebotDialogDetailBodyContentIABv2Tabs input[type=checkbox]:not(:checked):hover{border-color:#141414}#CybotCookiebotDialog #CybotCookiebotDialogDetailBodyContentIABv2Tabs input[type=checkbox]:checked{background-color:#1032CF;border-color:#1032CF}#CybotCookiebotDialog #CybotCookiebotDialogDetailBodyContentIABv2Tabs input[type=checkbox]:checked:after{border-bottom:2px solid #ffffff;border-right:2px solid #ffffff;content:\"\";display:inline-block;height:50%;left:50%;position:absolute;top:calc(50% - 2px);transform:translate(-50%,-50%) rotate(45deg);width:25%}#CybotCookiebotDialogDetailBodyContentCookieContainerTypes,#CybotCookiebotDialogDetailBodyContentIABv2Tabs{padding:0 .625em;width:100%}#CybotCookiebotDialogDetailBodyContentIABv2Tabs .CybotCookiebotDialogDetailBodyContentIABv2TabsIntro{padding:1.125em 1.125em .25em}#CybotCookiebotDialog.CybotCookiebotDialogZoomedXl #CybotCookiebotDialogDetailBodyContentIABv2Tabs .CybotCookiebotDialogDetailBodyContentIABv2TabsIntro{padding:.5em}#CybotCookiebotDialogDetailBodyContentIABv2Tabs .CybotCookiebotDialogDetailBodyContentIABv2TabsIntro:nth-child(3){margin-bottom:1.5em}.CybotCookiebotDialogDetailBodyContentCookieContainerHeader{display:flex;justify-content:space-between}.CybotCookiebotDialogDetailBodyContentCookieContainerButton:before,.CybotCookiebotDialogDetailBodyContentIABv2Tab:before{border-style:solid;border-width:.15em .15em 0 0;content:\"\";display:inline-block;height:.5em;left:0;margin-right:1.875em;position:relative;top:.625em;transform:rotate(-45deg);vertical-align:top;width:.5em}#CybotCookiebotDialog[dir=rtl] .CybotCookiebotDialogDetailBodyContentCookieContainerButton:before,#CybotCookiebotDialog[dir=rtl] .CybotCookiebotDialogDetailBodyContentIABv2Tab:before{margin-left:1.875em;margin-right:0}.CybotCookiebotDialogDetailBodyContentCookieContainerButton.CybotCookiebotDialogCollapsed:before,.CybotCookiebotDialogDetailBodyContentIABv2Tab.CybotCookiebotDialogCollapsed:before{top:.25em;transform:rotate(-225deg)}#CybotCookiebotDialog .CookieCard{border-bottom:1px solid #D6D6D6;padding:1.5em 0}#CybotCookiebotDialog.CybotCookiebotDialogZoomedXl .CookieCard:first-of-type{padding-top:.5em}#CybotCookiebotDialog .CookieCard:not(:first-child){padding-top:1.5em}#CybotCookiebotDialog #CybotCookiebotDialogDetailBodyContentIABContainer .CookieCard{border-bottom:none;border-top:1px solid #D6D6D6}#CybotCookiebotDialogDetailBodyContentCookieContainerTypes .CookieCard:last-of-type{margin-bottom:1em}#CybotCookiebotDialogDetailBodyContentIABv2Tabs .CookieCard:first-of-type{padding-top:1.625em}#CybotCookiebotDialog .CookieCard .CybotCookiebotDialogDetailBodyContentCookieContainerButton,#CybotCookiebotDialog .CookieCard .CybotCookiebotDialogDetailBodyContentIABv2Tab{border:1px solid transparent;font-weight:700;line-height:1.5em;padding-right:.75em;user-select:none}#CybotCookiebotDialog[dir=rtl] .CookieCard .CybotCookiebotDialogDetailBodyContentCookieContainerButton,#CybotCookiebotDialog[dir=rtl] .CookieCard .CybotCookiebotDialogDetailBodyContentIABv2Tab{padding-left:.75em;padding-right:0}#CybotCookiebotDialog .CookieCard .CybotCookiebotDialogDetailBodyContentCookieContainerButton:hover,#CybotCookiebotDialog .CookieCard .CybotCookiebotDialogDetailBodyContentIABv2Tab:hover,#CybotCookiebotDialogDetailBodyContentCookieContainerTypes .CybotCookiebotDialogDetailBodyContentCookieProvider:not(.CybotCookiebotDialogDetailBodyContentCookieInfoCount):hover{color:#1032CF}#CybotCookiebotDialog .CookieCard .CybotCookiebotDialogDetailBodyContentCookieTypeIntro,#CybotCookiebotDialogDetailBodyContentCookieContainerTypes .CybotCookiebotDialogDetailBodyContentCookieTypeTableContainer,#CybotCookiebotDialogDetailBodyContentIABv2Tabs .CollapseCard{padding-top:1em}#CybotCookiebotDialogDetailBodyContentIABv2Tabs .CollapseCard>div:not(.CybotCookiebotDialogBodyLevelButtonIABWrapper){letter-spacing:.3px;line-height:1.6em;margin-left:2.9em}#CybotCookiebotDialogDetailBodyContentIABv2Tabs .CybotCookiebotDialogDetailBodyContentIABv2CardIntro{letter-spacing:.3px;line-height:1.6em;margin-left:2.9em;padding-top:1em}#CybotCookiebotDialog[dir=rtl] #CybotCookiebotDialogDetailBodyContentIABv2Tabs .CollapseCard>div:not(.CybotCookiebotDialogBodyLevelButtonIABWrapper),#CybotCookiebotDialog[dir=rtl] #CybotCookiebotDialogDetailBodyContentIABv2Tabs .CybotCookiebotDialogDetailBodyContentIABv2CardIntro{margin-left:0;margin-right:2.9em}#CybotCookiebotDialogDetailBodyContentCookieContainerTypes .CybotCookiebotDialogDetailBodyEmptyCategoryMessage{border:1px solid #D6D6D6;border-radius:.5em;font-weight:600;margin:1em 0;padding:1em 1.5em}#CybotCookiebotDialogDetailBodyContentCookieContainerTypes .CybotCookiebotDialogDetailBodyContentCookieGroup{border:1px solid #D6D6D6;border-radius:.5em;margin-bottom:.5em;padding:1em}#CybotCookiebotDialogDetailBodyContentCookieContainerTypes .CybotCookiebotDialogDetailBodyContentCookieGroup:not(.open):hover{background-color:rgba(0,0,0,.05)}#CybotCookiebotDialogDetailBodyContentCookieContainerTypes .CybotCookiebotDialogDetailBodyContentCookieGroup:last-of-type{margin-bottom:0}#CybotCookiebotDialogDetailBodyContentCookieContainerTypes .CybotCookiebotDialogDetailBodyContentCookieProvider{display:block;font-weight:700;position:relative;text-decoration:none}#CybotCookiebotDialogDetailBodyContentCookieContainerTypes .CybotCookiebotDialogDetailBodyContentCookieProvider>div{pointer-events:none}#CybotCookiebotDialogDetailBodyContentCookieContainerTypes .CybotCookiebotDialogDetailBodyContentCookieProvider:not(.CybotCookiebotDialogDetailBodyContentCookieInfoCount){color:#141414}#CybotCookiebotDialogDetailBodyContentCookieContainerTypes .CybotCookiebotDialogDetailBodyContentCookieProvider.CybotCookiebotDialogCollapsed:after,#CybotCookiebotDialogDetailBodyContentCookieContainerTypes .CybotCookiebotDialogDetailBodyContentCookieProvider:after{border-style:solid;border-width:.15em .15em 0 0;content:\"\";display:inline-block;height:.5em;position:absolute;right:1em;top:.5em;transform:rotate(-45deg);width:.5em}#CybotCookiebotDialog[dir=rtl] #CybotCookiebotDialogDetailBodyContentCookieContainerTypes .CybotCookiebotDialogDetailBodyContentCookieProvider.CybotCookiebotDialogCollapsed:after,#CybotCookiebotDialog[dir=rtl] #CybotCookiebotDialogDetailBodyContentCookieContainerTypes .CybotCookiebotDialogDetailBodyContentCookieProvider:after{left:1em;right:auto}#CybotCookiebotDialogDetailBodyContentCookieContainerTypes .CybotCookiebotDialogDetailBodyContentCookieProvider.CybotCookiebotDialogCollapsed:after{transform:rotate(-225deg)}#CybotCookiebotDialogDetailBodyContentCookieContainerTypes .CybotCookiebotDialogDetailBodyContentCookieLink{align-items:center;display:inline-flex;padding-top:1em;position:relative}#CybotCookiebotDialogDetailBodyContentCookieContainerTypes .CybotCookiebotDialogDetailBodyContentCookieInfo{background-color:#F4F4F4;border:1px solid #D6D6D6;border-radius:1em;margin-bottom:.5em;padding:1em}#CybotCookiebotDialogDetailBodyContentCookieContainerTypes .CybotCookiebotDialogDetailBodyContentCookieInfo:last-of-type{margin-bottom:0}#CybotCookiebotDialogDetailBodyContentCookieContainerTypes .CybotCookiebotDialogDetailBodyContentCookieInfoWrapper.CybotCookiebotDialogShow{display:block}#CybotCookiebotDialogDetailBodyContentCookieContainerTypes .CybotCookiebotDialogDetailBodyContentCookieInfoWrapper{margin-top:3.125em;position:relative}#CybotCookiebotDialogDetailBodyContentCookieContainerTypes .CybotCookiebotDialogDetailBodyContentCookieInfoWrapper:before{border-top:1px solid #D6D6D6;content:\"\";left:0;position:absolute;top:-1.5em;width:100%}#CybotCookiebotDialogDetailBodyContentCookieContainerTypes .CybotCookiebotDialogDetailBodyContentCookieProviderDescription{margin-bottom:1.56em}#CybotCookiebotDialogDetailBodyContentCookieContainerTypes .CybotCookiebotDialogDetailBodyContentCookieInfoTitle{display:block;font-weight:700;line-height:1.6em;margin-bottom:.5em}#CybotCookiebotDialogDetailBodyContentCookieContainerTypes .CybotCookiebotDialogDetailBodyContentCookieInfoDescription{display:block;letter-spacing:.3px;padding-bottom:1em}#CybotCookiebotDialogDetailBodyContentCookieContainerTypes .CybotCookiebotDialogDetailBodyContentCookieInfoFooter{border-top:1px solid #D6D6D6;display:flex;flex-wrap:wrap;padding-top:.5em}#CybotCookiebotDialogDetailBodyContentCookieContainerTypes .CybotCookiebotDialogDetailBodyContentCookieInfoFooterContent{margin-top:.5em;width:100%}@media screen and (min-width:1280px){#CybotCookiebotDialogDetailBodyContentCookieContainerTypes,#CybotCookiebotDialogDetailBodyContentIABv2Tabs{padding:0 1.125em}#CybotCookiebotDialogDetailBodyContentCookieContainerTypes .CybotCookiebotDialogDetailBodyContentCookieTypeTableContainer{margin-top:2em}#CybotCookiebotDialogDetailBodyContentCookieContainerTypes .CybotCookiebotDialogDetailBodyContentCookieTypeTableContainer,#CybotCookiebotDialogDetailBodyContentIABv2Tabs .CollapseCard{margin-left:3em;padding-top:.5em}#CybotCookiebotDialog[dir=rtl] #CybotCookiebotDialogDetailBodyContentCookieContainerTypes .CybotCookiebotDialogDetailBodyContentCookieTypeTableContainer,#CybotCookiebotDialog[dir=rtl] #CybotCookiebotDialogDetailBodyContentIABv2Tabs .CollapseCard{margin-left:0;margin-right:3em}#CybotCookiebotDialogDetailBodyContentIABv2Tabs .CollapseCard>div:not(.CybotCookiebotDialogBodyLevelButtonIABWrapper){margin-left:0}#CybotCookiebotDialog .CookieCard{padding:1.125em 0 1.5em}#CybotCookiebotDialogDetailBodyContentCookieContainerTypes .CookieCard:last-of-type{margin-bottom:1.5em;padding-bottom:2em}#CybotCookiebotDialogDetailBodyContentIABv2Tabs .CookieCard:first-of-type{padding-top:1.125em}#CybotCookiebotDialogDetailBodyContentIABv2Tabs .CookieCard:last-of-type{padding-bottom:1.125em}#CybotCookiebotDialog .CookieCard .CybotCookiebotDialogDetailBodyContentCookieTypeIntro{padding-left:3em}#CybotCookiebotDialog[dir=rtl] .CookieCard .CybotCookiebotDialogDetailBodyContentCookieTypeIntro{padding-left:0;padding-right:3em}#CybotCookiebotDialogDetailBodyContentCookieContainerTypes .CybotCookiebotDialogDetailBodyEmptyCategoryMessage{margin:0 0 1.5em;padding:1.5em}#CybotCookiebotDialogDetailBodyContentCookieContainerTypes .CybotCookiebotDialogDetailBodyContentCookieGroup,#CybotCookiebotDialogDetailBodyContentCookieContainerTypes .CybotCookiebotDialogDetailBodyContentCookieInfo{padding:1.5em}#CybotCookiebotDialogDetailBodyContentCookieContainerTypes .CybotCookiebotDialogDetailBodyContentCookieInfoWrapper{margin-top:3.75em}#CybotCookiebotDialogDetailBodyContentCookieContainerTypes .CybotCookiebotDialogDetailBodyContentCookieInfoWrapper:before{top:-2em}#CybotCookiebotDialogDetailBodyContentCookieContainerTypes .CybotCookiebotDialogDetailBodyContentCookieProviderDescription{margin-bottom:1.875em}#CybotCookiebotDialogDetailBodyContentCookieContainerTypes .CybotCookiebotDialogDetailBodyContentCookieInfoFooterContent{width:50%}}#CybotCookiebotDialog .CybotCookiebotDialogHide{display:none}.CybotExpandLink{position:relative}.CybotExpandLink.CybotCookiebotDialogCollapsed:after,.CybotExpandLink:after{border-style:solid;border-width:.15em .15em 0 0;content:\"\";height:.5em;position:absolute;right:1em;top:.3em;transform:rotate(-45deg);width:.5em}#CybotCookiebotDialog[dir=rtl] .CybotExpandLink.CybotCookiebotDialogCollapsed:after,#CybotCookiebotDialog[dir=rtl] .CybotExpandLink:after{left:0;right:auto}.CybotExpandLink.CybotCookiebotDialogCollapsed:after{transform:rotate(-225deg)}#CybotCookiebotDialog .CybotExternalLinkArrow{margin-left:.625em}#CybotCookiebotDialog[dir=rtl] .CybotExternalLinkArrow{margin-left:0;margin-right:.625em;transform:scaleX(-1)}#CybotCookiebotDialog .CookieCard .CybotCookiebotDialogDetailBodyContentCookieContainerButton:not(:disabled):not(.disabled),#CybotCookiebotDialog .CookieCard .CybotCookiebotDialogDetailBodyContentIABv2Tab:not(:disabled):not(.disabled),#CybotCookiebotDialog .CybotCookiebotDialogBodyLevelButtonSliderWrapper input[type=checkbox],#CybotCookiebotDialog button,#CybotCookiebotDialog input,#CybotCookiebotDialog label:not([for=CybotCookiebotDialogBodyLevelButtonNecessary]){cursor:pointer}#CybotCookiebotDialog .CybotCookiebotDialogBodyLevelButtonSliderWrapper input[type=checkbox]:disabled{pointer-events:none}#CybotCookiebotDialog .CybotCookiebotDialogBodyLevelButtonSliderWrapperDisabled{cursor:not-allowed}#CybotCookiebotDialog dt{word-break:break-all}#CybotCookiebotDialog fieldset{border:none;width:100%}#CybotCookiebotDialog fieldset #CybotCookiebotDialogBodyFieldsetInnerContainer{display:flex;flex-wrap:wrap;width:100%}#CybotCookiebotDialog legend.visuallyhidden{display:block}#CybotCookiebotDialog .visuallyhidden{height:1px;margin:-1px;overflow:hidden;padding:0;position:absolute;width:1px}#CybotCookiebotDialog #CybotCookiebotDialogBodyContentText a,#CybotCookiebotDialog #CybotCookiebotDialogBodyLevelButtonIABHeaderViewPartnersLink,#CybotCookiebotDialog #CybotCookiebotDialogDetailBulkConsentList dt a,#CybotCookiebotDialog #CybotCookiebotDialogDetailFooter a,#CybotCookiebotDialog .CybotCookiebotDialogBodyLevelButtonIABDescription a,#CybotCookiebotDialog .CybotCookiebotDialogDetailBodyContentCookieLink,#CybotCookiebotDialogDetailBodyContentTextAbout a{color:#2A4EEF;font-weight:600;text-decoration:none}#CybotCookiebotDialog #CybotCookiebotDialogBodyContentText a:focus,#CybotCookiebotDialog #CybotCookiebotDialogBodyContentText a:hover,#CybotCookiebotDialog #CybotCookiebotDialogBodyLevelButtonIABHeaderViewPartnersLink:focus,#CybotCookiebotDialog #CybotCookiebotDialogBodyLevelButtonIABHeaderViewPartnersLink:hover,#CybotCookiebotDialog #CybotCookiebotDialogDetailBulkConsentList dt a:focus,#CybotCookiebotDialog #CybotCookiebotDialogDetailBulkConsentList dt a:hover,#CybotCookiebotDialog #CybotCookiebotDialogDetailFooter a:focus,#CybotCookiebotDialog #CybotCookiebotDialogDetailFooter a:hover,#CybotCookiebotDialog .CybotCookiebotDialogBodyLevelButtonIABDescription a:focus,#CybotCookiebotDialog .CybotCookiebotDialogBodyLevelButtonIABDescription a:hover,#CybotCookiebotDialog .CybotCookiebotDialogDetailBodyContentCookieLink:focus,#CybotCookiebotDialog .CybotCookiebotDialogDetailBodyContentCookieLink:hover,#CybotCookiebotDialogDetailBodyContentTextAbout a:focus,#CybotCookiebotDialogDetailBodyContentTextAbout a:hover{text-decoration:underline}#CybotCookiebotDialog .CybotCookiebotDialogBodyLevelButtonSliderWrapper input:focus-visible+span,#CybotCookiebotDialog :focus-visible,#CybotCookiebotDialog:focus-visible{outline:none}@media screen and (min-width:601px){#CybotCookiebotDialog .CybotCookiebotDialogBodyLevelButtonSliderWrapper input:focus-visible+span,#CybotCookiebotDialog :focus-visible{outline:2px solid #1032CF}#CybotCookiebotDialog .CybotCookiebotBannerCloseButton:focus-visible,#CybotCookiebotDialog .CybotCookiebotDialogBodyButton:focus-visible,#CybotCookiebotDialog .CybotCookiebotDialogBodyLevelButtonIABHeaderButton:focus-visible,#CybotCookiebotDialog .CybotCookiebotDialogBodyLevelButtonIABHeaderToggleDeselectVendorsLink:focus-visible,#CybotCookiebotDialog .CybotCookiebotDialogBodyLevelButtonIABHeaderToggleSelectVendorsLink:focus-visible,#CybotCookiebotDialog .CybotCookiebotDialogBodyLevelButtonSliderWrapper input:focus-visible+span{outline-offset:2px}}@media not all and (min-resolution:.001dpcm){@media screen and (min-width:1280px){#CybotCookiebotDialog #CybotCookiebotDialogBody .CybotCookiebotScrollContainer{display:block}}}#CookiebotSessionPixel{display:none}\n    #CybotCookiebotDialog[dir=\"rtl\"] .CybotCookiebotScrollContainer .CybotCookiebotScrollbarContainer {\n      right: auto;\n      left: 0.375em;\n    }\n\n    #CybotCookiebotDialogDetailBodyContentIABv2Tabs .CybotCookiebotDialogBodyLevelButtonIABContainerToggleShow,\n    #CybotCookiebotDialogDetailBodyContentIABv2Tabs .CybotCookiebotDialogBodyLevelButtonIABContainerToggleHide {\n        top: .75em;\n        right: 1.35em;\n    }\n\n    #CybotCookiebotDialog[dir=\"rtl\"] #CybotCookiebotDialogDetailBodyContentIABv2Tabs .CybotCookiebotDialogBodyLevelButtonIABContainerToggleShow,\n    #CybotCookiebotDialog[dir=\"rtl\"] #CybotCookiebotDialogDetailBodyContentIABv2Tabs .CybotCookiebotDialogBodyLevelButtonIABContainerToggleHide {\n        left: 1.35em;\n    }\n\n    #CybotCookiebotDialogDetailBodyContentIABv2Tabs #CybotCookiebotDialogDetailBodyContentIABv2PartnersBody .CybotCookiebotDialogBodyLevelButtonWrapper:nth-of-type(2) {\n      margin-right: 3.5em;\n    }\n\n    #CybotCookiebotDialog[dir=\"rtl\"] #CybotCookiebotDialogDetailBodyContentIABv2Tabs #CybotCookiebotDialogDetailBodyContentIABv2PartnersBody .CybotCookiebotDialogBodyLevelButtonWrapper:nth-of-type(2) {\n        margin-right: 0;\n        margin-left: 3.5em;\n    }\n\n    #CybotCookiebotDialog .CybotCookiebotDialogBodyContentHeading {\n      margin-bottom: 0.5em;\n      font-weight: 600;\n      line-height: 1.6em;\n      letter-spacing: 0.25px;\n    }\n\n    #CybotCookiebotDialog .CybotCookiebotDialogSROnly {\n      position: absolute;\n      width: 1px;\n      height: 1px;\n      padding: 0;\n      margin: -1px;\n      overflow: hidden;\n      clip: rect(0, 0, 0, 0);\n      border: 0;\n    }\n\n    #CybotCookiebotDialog #CybotCookiebotDialogBodyContentText a,\n    #CybotCookiebotDialog #CybotCookiebotDialogDetailFooter a,\n    #CybotCookiebotDialog #CybotCookiebotDialogDetailBulkConsentList dt a,\n    #CybotCookiebotDialog .CybotCookiebotDialogBodyLevelButtonIABDescription a,\n    #CybotCookiebotDialog .CybotCookiebotDialogDetailBodyContentCookieLink,\n    #CybotCookiebotDialog #CybotCookiebotDialogBodyLevelButtonIABHeaderViewPartnersLink,\n    #CybotCookiebotDialogDetailBodyContentTextAbout a {\n        color: #2A4EEF;\n    }\n\n    #CybotCookiebotDialog #CybotCookiebotDialogBodyContentText a:hover,\n    #CybotCookiebotDialog #CybotCookiebotDialogDetailFooter a:hover,\n    #CybotCookiebotDialog #CybotCookiebotDialogDetailBulkConsentList dt a:hover,\n    #CybotCookiebotDialog .CybotCookiebotDialogBodyLevelButtonIABDescription a:hover,\n    #CybotCookiebotDialog .CybotCookiebotDialogDetailBodyContentCookieLink:hover,\n    #CybotCookiebotDialog #CybotCookiebotDialogBodyLevelButtonIABHeaderViewPartnersLink:hover,\n    #CybotCookiebotDialogDetailBodyContentTextAbout a:hover,\n    #CybotCookiebotDialog #CybotCookiebotDialogBodyContentText a:focus,\n    #CybotCookiebotDialog #CybotCookiebotDialogDetailFooter a:focus,\n    #CybotCookiebotDialog #CybotCookiebotDialogDetailBulkConsentList dt a:focus,\n    #CybotCookiebotDialog .CybotCookiebotDialogBodyLevelButtonIABDescription a:focus,\n    #CybotCookiebotDialog .CybotCookiebotDialogDetailBodyContentCookieLink:focus,\n    #CybotCookiebotDialog #CybotCookiebotDialogBodyLevelButtonIABHeaderViewPartnersLink:focus,\n    #CybotCookiebotDialogDetailBodyContentTextAbout a:focus {\n        text-decoration: underline;\n    }\n\n    #CybotCookiebotDialogTabContent {\n      min-height: 60px;\n    }\n\n    #CybotCookiebotDialog .CybotCookiebotScrollContainer {\n      min-height: auto;\n    }\n\n    #CybotCookiebotDialogFooter.CybotCookiebotScrollContainer {\n      height: auto;\n      min-height: 80px;\n      width: 100%;\n    }\n\n    #CybotCookiebotDialogFooter .CybotCookiebotScrollArea {\n      width: 100%;\n      padding: 1em;\n    }\n\n    #CybotCookiebotDialog:not(.CybotCookiebotDialogZoomed) #CybotCookiebotDialogFooter.CybotCookiebotScrollContainer {\n      min-height: 80px;\n      padding: .375em;\n    }\n\n    #CybotCookiebotDialog:not(.CybotCookiebotDialogZoomedLg):not(.CybotCookiebotDialogZoomedXl) #CybotCookiebotDialogFooter.CybotCookiebotScrollContainer {\n      min-height: auto;\n      padding: 0;\n    }\n\n    #CybotCookiebotDialog.CybotCookiebotDialogZoomedLg #CybotCookiebotDialogFooter .CybotCookiebotScrollArea,\n    #CybotCookiebotDialog.CybotCookiebotDialogZoomedXl #CybotCookiebotDialogFooter .CybotCookiebotScrollArea {\n      overflow: auto;\n    }\n\n    #CybotCookiebotDialog.CybotCookiebotDialogZoomedLg #CybotCookiebotDialogFooter > div:first-of-type::-webkit-scrollbar,\n    #CybotCookiebotDialog.CybotCookiebotDialogZoomedXl #CybotCookiebotDialogFooter > div:first-of-type::-webkit-scrollbar {\n      width: .25em;\n    }\n\n    #CybotCookiebotDialog.CybotCookiebotDialogZoomedLg #CybotCookiebotDialogFooter > div:first-of-type::-webkit-scrollbar-track,\n    #CybotCookiebotDialog.CybotCookiebotDialogZoomedXl #CybotCookiebotDialogFooter > div:first-of-type::-webkit-scrollbar-track {\n        background: #f2f2f2;\n        border-radius: .313em;\n    }\n\n    #CybotCookiebotDialog.CybotCookiebotDialogZoomedLg #CybotCookiebotDialogFooter > div:first-of-type::-webkit-scrollbar-thumb,\n    #CybotCookiebotDialog.CybotCookiebotDialogZoomedXl #CybotCookiebotDialogFooter > div:first-of-type::-webkit-scrollbar-thumb {\n        background: #141414;\n        border-radius: .313em;\n    }\n\n    #CybotCookiebotDialog.CybotCookiebotDialogZoomedLg #CybotCookiebotDialogFooter > div:first-of-type:focus::-webkit-scrollbar-thumb,\n    #CybotCookiebotDialog.CybotCookiebotDialogZoomedXl #CybotCookiebotDialogFooter > div:first-of-type:focus::-webkit-scrollbar-thumb {\n        background: #1032CF;\n    }\n\n    @-moz-document url-prefix() {\n        #CybotCookiebotDialog .CybotCookiebotScrollContainer > div:first-of-type,\n        #CybotCookiebotDialog.CybotCookiebotDialogZoomedLg #CybotCookiebotDialogFooter > div:first-of-type,\n        #CybotCookiebotDialog.CybotCookiebotDialogZoomedXl #CybotCookiebotDialogFooter > div:first-of-type {\n            scrollbar-width: thin;\n            scrollbar-color: #141414 #f2f2f2;\n            scrollbar-track-color: #f2f2f2;\n            scrollbar-face-color: #141414;\n        }\n    }\n\n    #CybotCookiebotDialog.CybotCookiebotDialogZoomedLg #CybotCookiebotDialogFooter > div:first-of-type:focus,\n    #CybotCookiebotDialog.CybotCookiebotDialogZoomedXl #CybotCookiebotDialogFooter > div:first-of-type:focus {\n      scrollbar-color: #1032CF #f2f2f2;\n    }\n\n    #CybotCookiebotDialog.CybotCookiebotDialogZoomedXl {\n      width: calc(100vw - 10px);\n      max-height: calc(100vh - 10px);\n    }\n\n    #CybotCookiebotDialog.CybotCookiebotDialogZoomedXl #CybotCookiebotDialogHeader {\n      padding: .5em 1em;\n    }\n\n    #CybotCookiebotDialog.CybotCookiebotDialogZoomedXl #CybotCookiebotDialogNav .CybotCookiebotDialogNavItemLink,\n    #CybotCookiebotDialog.CybotCookiebotDialogZoomedXl #CybotCookiebotDialogFooter .CybotCookiebotScrollArea,\n    #CybotCookiebotDialog.CybotCookiebotDialogZoomedXl #CybotCookiebotDialogDetailBodyContentIABv2Tabs .CybotCookiebotDialogDetailBodyContentIABv2TabsIntro,\n    #CybotCookiebotDialog.CybotCookiebotDialogZoomedXl #CybotCookiebotDialogDetailBodyContentTextAbout {\n      padding: .5em;\n    }\n\n    #CybotCookiebotDialog.CybotCookiebotDialogZoomedXl #CybotCookiebotDialogBodyContent {\n      padding: .8em;\n    }\n\n    #CybotCookiebotDialog.CybotCookiebotDialogZoomedXl .CookieCard:first-of-type {\n      padding-top: .5em;\n    }\n\n    #CybotCookiebotDialog .CybotCookiebotFader:not(.CybotCookiebotFaderRight):not(.CybotCookiebotFaderLeft) {\n      max-height: 50%;\n    }\n\n    #CybotCookiebotDialogBodyButtons .CybotCookiebotDialogBodyButton:not(:first-of-type) {\n      margin-top: 0.5em;\n    }\n\n    #CybotCookiebotDialog.CybotEdge #CybotCookiebotDialogFooter .CybotCookiebotDialogBodyButton,\n    #CybotCookiebotDialogBodyButtons .CybotCookiebotDialogBodyButton:not(:last-of-type) {\n      margin-bottom: 0;\n    }\n\n    #CybotCookiebotDialog.CybotCookiebotDialogZoomedLg #CybotCookiebotDialogFooter,\n    #CybotCookiebotDialog.CybotCookiebotDialogZoomedXl #CybotCookiebotDialogFooter {\n      overflow: auto;\n    }\n\n    #CybotCookiebotDialogFooter #CybotCookiebotDialogBodyButtonsWrapper {\n      flex-direction: column;\n    }\n\n    #CybotCookiebotDialog.CybotEdge #CybotCookiebotDialogFooter .CybotCookiebotDialogBodyButton:last-of-type {\n        margin-bottom: 0;\n    }\n\n    #CybotCookiebotDialogDetailBodyContentIABv2Tabs .CybotCookiebotDialogBodyLevelButtonIABHeaderToggle {\n      flex-direction: row;\n    }\n\n    #CybotCookiebotDialogPoweredbyCybot svg {\n      display: block;\n      height: 1.7em;\n      opacity: 1;\n      max-width: 133px;\n    }\n\n    #CybotCookiebotDialogPoweredByText {\n      display: none;\n    }\n\n    #CybotCookiebotDialog .CybotCookiebotBannerCloseButton {\n      margin-left: 2.313rem;\n    }\n\n    #CybotCookiebotDialog[dir=\"rtl\"] .CybotCookiebotBannerCloseButton {\n      margin-left: auto;\n      margin-right: 2.313rem;\n    }\n\n    #CybotCookiebotDialogDetailBodyContentCookieContainerTypes .CybotCookiebotDialogDetailBodyContentCookieInfoWrapper {\n      position: relative;\n      margin-top: 3.125em;\n    }\n\n    #CybotCookiebotDialogDetailBodyContentCookieContainerTypes .CybotCookiebotDialogDetailBodyContentCookieInfoWrapper.CybotCookiebotDialogShow {\n      display: block;\n    }\n\n    #CybotCookiebotDialogDetailBodyContentCookieContainerTypes .CybotCookiebotDialogDetailBodyContentCookieInfoWrapper:before {\n      content: '';\n      position: absolute;\n      top: -1.5em;\n      left: 0;\n      width: 100%;\n      border-top: 1px solid #D6D6D6;\n    }\n\n    #CybotCookiebotDialogDetailBodyContentCookieContainerTypes .CybotCookiebotDialogDetailBodyContentCookieProviderDescription {\n      margin-bottom: 1.56em;\n    }\n\n    #CybotCookiebotDialogDetailBodyContentCookieContainerTypes .CybotCookiebotDialogDetailBodyContentCookieInfo:before {\n      display: none;\n    }\n\n    @media screen and (min-width: 601px) {\n      #CybotCookiebotDialogFooter .CybotCookiebotDialogBodyButton,\n      #CybotCookiebotDialogFooter .CybotCookiebotDialogBodyButton:not(:first-of-type),\n      #CybotCookiebotDialogFooter #CybotCookiebotDialogBodyButtons .CybotCookiebotDialogBodyButton:not(:last-of-type),\n        #CybotCookiebotDialogFooter #CybotCookiebotDialogBodyButtons .CybotCookiebotDialogBodyButton:not(:first-of-type) {\n          margin-bottom: 0;\n          margin-top: 0;\n          width: 33%;\n      }\n\n      #CybotCookiebotDialogFooter #CybotCookiebotDialogBodyButtonsWrapper {\n        flex-direction: row;\n      }\n\n      #CybotCookiebotDialogPoweredbyCybot svg {\n          height: 2em;\n      }\n\n      #CybotCookiebotDialog .CybotCookiebotDialogBodyButton:focus-visible,\n      #CybotCookiebotDialog .CybotCookiebotDialogBodyLevelButtonIABHeaderToggleDeselectVendorsLink:focus-visible,\n      #CybotCookiebotDialog .CybotCookiebotDialogBodyLevelButtonIABHeaderToggleSelectVendorsLink:focus-visible,\n      #CybotCookiebotDialog .CybotCookiebotDialogBodyLevelButtonIABHeaderButton:focus-visible,\n      #CybotCookiebotDialog .CybotCookiebotBannerCloseButton:focus-visible,\n      #CybotCookiebotDialog .CybotCookiebotDialogBodyLevelButtonSliderWrapper input:focus-visible + span {\n          outline-offset: 2px;\n      }\n    }\n\n    @media screen and (min-width: 1280px) {\n      #CybotCookiebotDialog.CybotCookiebotDialogZoomedLg #CybotCookiebotDialogFooter > div:first-of-type::-webkit-scrollbar,\n      #CybotCookiebotDialog.CybotCookiebotDialogZoomedXl #CybotCookiebotDialogFooter > div:first-of-type::-webkit-scrollbar {\n        width: .5em;\n      }\n\n      #CybotCookiebotDialogDetailBodyContentIABv2Tabs .CybotCookiebotDialogBodyLevelButtonIABContainerToggleShow,\n      #CybotCookiebotDialogDetailBodyContentIABv2Tabs .CybotCookiebotDialogBodyLevelButtonIABContainerToggleHide {\n          top: 1.2em;\n      }\n\n      #CybotCookiebotDialogFooter {\n        padding: 0;\n      }\n\n      #CybotCookiebotDialogFooter .CybotCookiebotScrollArea {\n        padding: 1em 1.5em 1.5em;\n      }\n\n      #CybotCookiebotDialog.CybotEdge #CybotCookiebotDialogFooter {\n          display: block;\n      }\n\n      #CybotCookiebotDialog.CybotEdge #CybotCookiebotDialogFooter .CybotCookiebotDialogBodyButton:not(:first-of-type) {\n        margin-top: 0.5em;\n      }\n\n      #CybotCookiebotDialog.CybotEdge #CybotCookiebotDialogFooter .CybotCookiebotDialogBodyButton,\n      #CybotCookiebotDialog.CybotEdge #CybotCookiebotDialogFooter .CybotCookiebotDialogBodyButton:not(:last-of-type) {\n        margin-bottom: 0;\n      }\n\n      #CybotCookiebotDialog.CybotEdge #CybotCookiebotDialogFooter .CybotCookiebotDialogBodyButton {\n        width: 286px;\n        max-width: none;\n      }\n\n      #CybotCookiebotDialog.CybotEdge #CybotCookiebotDialogFooter .CybotCookiebotScrollArea {\n        padding: 0;\n      }\n\n      #CybotCookiebotDialog.CybotEdge #CybotCookiebotDialogFooter .CybotCookiebotScrollbarContainer {\n        display: none;\n      }\n\n      #CybotCookiebotDialog.CybotEdge #CybotCookiebotDialogFooter #CybotCookiebotDialogBodyButtonsWrapper {\n        flex-direction: column;\n      }\n\n      #CybotCookiebotDialogDetailBodyContentCookieContainerTypes .CybotCookiebotDialogDetailBodyContentCookieInfoWrapper {\n        margin-top: 3.75em;\n      }\n\n      #CybotCookiebotDialogDetailBodyContentCookieContainerTypes .CybotCookiebotDialogDetailBodyContentCookieProviderDescription {\n        margin-bottom: 1.875em;\n      }\n\n      #CybotCookiebotDialogDetailBodyContentCookieContainerTypes .CybotCookiebotDialogDetailBodyContentCookieInfoWrapper:before {\n        top: -2em;\n      }\n  \n    }\n  </style></head>\n<body class=\"default-device bodyclass\" style=\"padding-top: 0px;\"><div id=\"CybotCookiebotDialog\" name=\"CybotCookiebotDialog\" role=\"dialog\" aria-modal=\"true\" aria-labelledby=\"CybotCookiebotDialogBodyContentTitle\" tabindex=\"0\" lang=\"en\" dir=\"ltr\" ng-non-bindable=\"\" data-template=\"bottom\" class=\"CybotEdge CybotCookiebotDialogActive US\" style=\"display: flex;\"><div class=\"CybotCookiebotDialogContentWrapper\"><div id=\"CybotCookiebotDialogHeader\"><div id=\"CybotCookiebotDialogHeaderLogosWrapper\"><div id=\"CybotCookiebotDialogPoweredbyLink\"><img id=\"CybotCookiebotDialogPoweredbyImage\" src=\"data:,\" alt=\"logo\" style=\"display: none;\"></div><a href=\"https://www.cookiebot.com/en/what-is-behind-powered-by-cookiebot/\" rel=\"noopener nofollow\" target=\"_blank\" id=\"CybotCookiebotDialogPoweredbyCybot\" aria-label=\"Usercentrics Cookiebot - opens in a new window\"><svg viewBox=\"0 0 843 248\" aria-hidden=\"true\" xmlns=\"http://www.w3.org/2000/svg\"><path d=\"M249.651 182.059C246.815 181.906 243.999 182.606 241.573 184.067C239.147 185.528 237.225 187.681 236.06 190.244H235.469V167.003H226.162V229.564H235.174V222.256H235.912C237.11 224.825 239.06 226.979 241.51 228.439C243.959 229.898 246.796 230.596 249.651 230.441C261.174 230.441 269.447 221.379 269.447 206.177C269.447 190.975 261.174 182.059 249.651 182.059ZM247.731 222.694C239.753 222.694 235.321 215.97 235.321 206.031C235.321 196.091 239.606 189.659 247.731 189.659C256.151 189.659 260.288 196.676 260.288 206.031C260.288 215.386 256.004 222.694 247.731 222.694Z\"></path><path d=\"M294.854 219.182H294.411L282.445 182.786H272.547L289.979 230.291L288.797 233.361C286.433 239.646 283.183 240.085 278.013 238.769L275.797 246.224C277.841 246.916 279.989 247.262 282.149 247.247C289.831 247.247 294.559 243.3 297.366 235.846L316.866 182.64H306.968L294.854 219.182Z\"></path><path d=\"M385.555 207.488C385.555 215.966 379.646 222.105 370.044 222.105C360.441 222.105 354.532 215.966 354.532 207.488V167.145H344.93V208.365C344.93 221.52 354.828 230.875 370.044 230.875C385.26 230.875 395.158 221.52 395.158 208.365V167.145H385.555V207.488Z\"></path><path d=\"M429.594 203.412L422.06 201.658C416.89 200.489 414.526 198.735 414.674 195.519C414.674 191.865 418.662 189.38 423.833 189.38C429.594 189.38 432.254 192.596 433.288 195.665L441.708 194.203C439.788 186.895 434.026 182.071 423.833 182.071C413.049 182.071 405.514 187.626 405.514 195.958C405.514 202.681 409.651 207.067 418.515 208.967L426.492 210.721C431.072 211.744 433.14 213.79 433.14 216.714C433.14 220.368 429.151 223.145 423.094 223.145C417.628 223.145 414.083 220.807 412.901 216.129L404.037 217.445C405.514 225.776 412.605 230.454 423.242 230.454C434.765 230.454 442.595 224.461 442.595 215.983C442.595 209.405 438.311 205.312 429.594 203.412Z\"></path><path d=\"M470.358 182.071C457.062 182.071 448.494 192.011 448.494 206.482C448.494 220.953 457.062 230.6 471.097 230.6C481.438 230.6 488.824 225.484 490.892 217.883L482.176 216.275C480.551 220.66 476.563 222.999 471.244 222.999C463.267 222.999 457.949 217.883 457.801 208.821H491.483V205.605C491.336 188.649 481.142 182.071 470.358 182.071ZM457.653 202.097C458.097 195.373 462.972 189.672 470.358 189.672C477.744 189.672 482.176 194.934 482.324 202.097H457.653Z\"></path><path d=\"M508.912 190.117H508.469V182.663H499.605V229.583H508.912V200.934C508.912 194.795 513.64 190.41 520.288 190.41C521.932 190.383 523.572 190.58 525.163 190.994V182.224C523.837 182.097 522.505 182.048 521.174 182.078C518.527 181.93 515.903 182.634 513.694 184.082C511.484 185.531 509.807 187.648 508.912 190.117Z\"></path><path d=\"M549.091 189.818C551.519 189.708 553.908 190.456 555.83 191.929C557.752 193.402 559.081 195.504 559.58 197.858H568.592C567.557 188.357 559.728 182.071 548.943 182.071C535.5 182.071 526.932 192.011 526.932 206.336C526.932 220.66 535.205 230.6 549.091 230.6C560.319 230.6 567.557 223.876 568.592 214.814H559.58C559.106 217.18 557.784 219.298 555.856 220.775C553.928 222.253 551.526 222.991 549.091 222.853C541.261 222.853 536.239 216.421 536.239 206.189C536.239 195.958 541.261 189.818 549.091 189.818Z\"></path><path d=\"M596.077 182.071C582.929 182.071 574.213 192.011 574.213 206.482C574.213 220.953 582.781 230.6 596.816 230.6C607.157 230.6 614.543 225.484 616.612 217.883L607.895 216.275C606.27 220.66 602.282 222.999 596.963 222.999C588.986 222.999 583.815 217.883 583.52 208.821H617.203V205.605C617.055 188.649 606.861 182.071 596.077 182.071ZM583.372 202.097C583.815 195.373 588.69 189.672 596.077 189.672C603.464 189.672 607.896 194.934 608.043 202.097H583.372Z\"></path><path d=\"M648.673 182.071C641.582 182.071 636.854 185.287 634.638 190.257H634.047V182.656H625.184V229.577H634.491V201.658C634.491 194.204 639.07 189.818 645.57 189.818C651.775 189.818 655.616 193.911 655.616 200.635V229.431H664.923V199.612C664.775 188.21 658.275 182.071 648.673 182.071Z\"></path><path d=\"M692.999 222.117C690.044 222.117 687.385 221.094 687.385 215.832V189.959H697.135V182.651H687.385V171.396H678.078V182.651H671.135V189.959H678.078V217.732C678.078 226.21 684.578 230.449 691.965 230.302C694.03 230.338 696.085 229.991 698.021 229.279L696.396 221.678C695.285 221.957 694.145 222.104 692.999 222.117V222.117Z\"></path><path d=\"M714.571 190.117H714.127V182.663H705.264V229.583H714.571V200.934C714.571 194.795 719.298 190.41 725.945 190.41C727.59 190.383 729.23 190.58 730.821 190.994V182.224C729.495 182.097 728.163 182.048 726.832 182.078C724.185 181.93 721.561 182.634 719.352 184.082C717.142 185.531 715.465 187.648 714.571 190.117V190.117Z\"></path><path d=\"M741.007 164.516C739.502 164.472 738.04 165.014 736.935 166.025C735.83 167.036 735.171 168.436 735.098 169.924C735.122 170.664 735.295 171.393 735.606 172.066C735.918 172.74 736.361 173.346 736.911 173.849C737.46 174.352 738.105 174.742 738.808 174.997C739.512 175.251 740.259 175.365 741.007 175.332C741.758 175.387 742.513 175.288 743.224 175.041C743.935 174.794 744.587 174.404 745.139 173.897C745.692 173.389 746.132 172.774 746.433 172.091C746.734 171.407 746.89 170.67 746.89 169.924C746.89 169.178 746.734 168.441 746.433 167.757C746.132 167.073 745.692 166.459 745.139 165.951C744.587 165.444 743.935 165.054 743.224 164.807C742.513 164.56 741.758 164.461 741.007 164.516V164.516Z\"></path><path d=\"M745.739 182.64H736.432V229.56H745.739V182.64Z\"></path><path d=\"M775.853 189.818C778.281 189.708 780.67 190.456 782.591 191.929C784.513 193.402 785.842 195.504 786.341 197.858H795.353C794.319 188.357 786.489 182.071 775.705 182.071C762.262 182.071 753.693 192.011 753.693 206.336C753.693 220.66 761.966 230.6 775.853 230.6C787.08 230.6 794.319 223.876 795.353 214.814H786.341C785.868 217.18 784.545 219.298 782.617 220.775C780.69 222.253 778.287 222.991 775.853 222.853C768.023 222.853 763 216.421 763 206.189C763 195.958 768.171 189.818 775.853 189.818Z\"></path><path d=\"M826.532 203.412L818.998 201.658C813.827 200.489 811.463 198.735 811.611 195.519C811.611 191.865 815.6 189.38 820.771 189.38C826.532 189.38 829.191 192.596 830.225 195.665L838.646 194.203C836.725 186.895 830.964 182.071 820.771 182.071C809.986 182.071 802.452 187.626 802.452 195.958C802.452 202.681 806.588 207.067 815.452 208.967L823.43 210.721C828.009 211.744 830.078 213.79 830.078 216.714C830.078 220.368 826.089 223.145 820.032 223.145C814.566 223.145 811.02 220.807 809.838 216.129L800.975 217.445C802.452 225.776 809.543 230.454 820.18 230.454C831.703 230.454 839.532 224.461 839.532 215.983C839.532 209.405 835.248 205.312 826.532 203.412Z\"></path><path d=\"M428.098 136.595L388.359 84.2654L426.916 40.5603H395.45L359.108 83.6807V4.01758H333.551V136.741H359.108V112.184L370.483 100.198L396.041 136.741H428.098V136.595Z\"></path><path d=\"M444.939 30.9215H445.382C449.435 30.8502 453.301 29.2257 456.167 26.3901C459.032 23.5545 460.674 19.7292 460.746 15.7197C460.674 11.7103 459.032 7.88492 456.167 5.04934C453.301 2.21377 449.435 0.589264 445.382 0.517951C441.375 0.490103 437.518 2.02279 434.644 4.78502C431.769 7.54725 430.108 11.3174 430.019 15.2812V15.7197C429.979 17.6899 430.335 19.6482 431.066 21.4814C431.796 23.3146 432.887 24.9863 434.274 26.3999C435.662 27.8135 437.319 28.941 439.149 29.7171C440.98 30.4932 442.948 30.9026 444.939 30.9215V30.9215Z\"></path><path d=\"M432.086 137.925H456.905V41.7441H432.086V137.925Z\"></path><path d=\"M794.165 113.808C794.165 131.495 803.767 140.411 821.642 140.411C829.047 140.746 836.374 138.806 842.62 134.857L837.597 115.855C834.995 117.617 831.883 118.489 828.733 118.34H828.142C825.606 117.97 823.317 116.629 821.77 114.606C820.222 112.583 819.54 110.039 819.87 107.523V63.964H839.665V41.8922H819.87V15.2891H794.312V41.8922H778.357V63.964H794.312V113.808H794.165Z\"></path><path d=\"M601.247 125.337C604.819 129.867 609.393 133.526 614.617 136.035C619.841 138.543 625.577 139.834 631.384 139.808C655.611 139.808 674.225 121.537 674.225 89.233C674.225 57.66 655.759 38.6578 631.384 38.6578C625.58 38.6472 619.849 39.9448 614.627 42.4522C609.406 44.9595 604.83 48.6107 601.247 53.1287V3.86914H575.689V136.592H601.247V125.337ZM601.247 72.131C603.744 68.7245 607.003 65.9359 610.771 63.9834C614.538 62.0308 618.711 60.9672 622.963 60.8758C637.588 60.8758 647.191 72.131 647.191 88.6483C647.191 105.166 637.588 116.421 622.963 116.421C618.752 116.364 614.608 115.361 610.846 113.487C607.084 111.613 603.801 108.918 601.247 105.604V72.131Z\"></path><path d=\"M533.583 111.188C528.083 114.821 521.394 116.253 514.868 115.195C508.341 114.137 502.464 110.667 498.423 105.487L560.47 70.1137L557.959 65.1439C542.004 38.1023 514.526 29.0397 489.56 43.0721C488.821 43.5106 488.082 43.9491 487.491 44.3876C481.985 47.7516 477.206 52.1599 473.428 57.3587C469.651 62.5575 466.95 68.4442 465.481 74.6799C464.012 80.9157 463.803 87.3773 464.868 93.693C465.933 100.009 468.249 106.054 471.684 111.48C472.423 112.796 473.162 113.965 473.753 115.134C477.248 120.525 481.785 125.181 487.102 128.835C492.419 132.488 498.412 135.068 504.739 136.426C511.065 137.784 517.6 137.893 523.97 136.748C530.339 135.602 536.417 133.225 541.856 129.751C554.233 123.118 563.817 112.339 568.891 99.3479L551.015 90.5776C547.936 99.3191 541.737 106.648 533.583 111.188ZM499.753 60.1741C499.901 60.0279 500.049 60.0279 500.196 59.8817C502.689 58.3111 505.473 57.2495 508.386 56.7594C511.299 56.2693 514.282 56.3607 517.159 57.028C520.036 57.6954 522.749 58.9253 525.138 60.6454C527.527 62.3655 529.545 64.5411 531.072 67.0441L490.151 90.5776C487.573 85.247 487.131 79.1486 488.912 73.5083C490.693 67.868 494.567 63.104 499.753 60.1741V60.1741Z\"></path><path d=\"M122.747 125.073C117.827 130.28 111.88 134.432 105.273 137.273C98.6668 140.114 91.5411 141.584 84.3374 141.59C70.0953 141.552 56.4521 135.916 46.4091 125.925C36.3661 115.933 30.7461 102.403 30.7852 88.3111C30.8244 74.2193 36.5196 60.7201 46.618 50.7831C56.7164 40.8461 70.3907 35.2853 84.6328 35.3241C98.6314 35.3093 112.068 40.7741 122.009 50.5259C128.016 42.2847 135.914 35.5718 145.054 30.939C133.725 18.5119 118.836 9.79775 102.373 5.9589C85.9098 2.12005 68.655 3.33893 52.9099 9.45299C37.1648 15.567 23.6779 26.2856 14.2481 40.1792C4.81822 54.0727 -0.106318 70.4807 0.131255 87.2148C-0.0261505 109.171 8.62812 130.291 24.1941 145.94C39.7602 161.588 60.9657 170.485 83.1555 170.678H83.7464C95.4187 170.591 106.949 168.132 117.621 163.456C128.294 158.779 137.883 151.984 145.793 143.491C136.936 138.95 129.097 132.686 122.747 125.073V125.073Z\"></path><path d=\"M170.624 36.9093C157.088 37.0838 144.175 42.5718 134.728 52.1661C125.281 61.7605 120.072 74.6752 120.248 88.0691C120.425 101.463 125.971 114.239 135.668 123.587C145.365 132.934 158.417 138.088 171.954 137.913C172.102 137.913 172.102 137.913 172.102 138.06C185.533 137.921 198.362 132.52 207.776 123.04C217.191 113.56 222.425 100.775 222.33 87.4845V86.7536C222.259 80.1169 220.863 73.5595 218.223 67.458C215.583 61.3566 211.751 55.8314 206.946 51.1998C202.141 46.5682 196.459 42.9214 190.226 40.469C183.993 38.0166 177.332 36.8069 170.624 36.9093ZM171.954 113.795C164.854 113.697 158.073 110.863 153.052 105.895C148.031 100.927 145.166 94.2171 145.067 87.1921C145.067 81.9305 146.644 76.7871 149.598 72.4122C152.553 68.0374 156.752 64.6276 161.665 62.614C166.578 60.6005 171.984 60.0737 177.199 61.1002C182.415 62.1267 187.206 64.6604 190.966 68.3809C194.726 72.1014 197.287 76.8416 198.324 82.0021C199.362 87.1626 198.829 92.5116 196.794 97.3727C194.759 102.234 191.313 106.389 186.892 109.312C182.47 112.235 177.272 113.795 171.954 113.795V113.795Z\"></path><path d=\"M276.685 36.9093C269.982 36.9957 263.362 38.3875 257.203 41.0053C251.044 43.623 245.466 47.4155 240.788 52.1661C231.341 61.7605 226.133 74.6752 226.309 88.0691C226.485 101.463 232.032 114.239 241.729 123.587C251.425 132.934 264.478 138.088 278.015 137.913C278.162 137.913 278.162 137.913 278.162 138.06C291.594 137.921 304.422 132.52 313.837 123.04C323.252 113.56 328.485 100.775 328.39 87.4845V86.7536C328.319 80.1169 326.924 73.5595 324.284 67.458C321.643 61.3566 317.811 55.8314 313.006 51.1998C308.202 46.5682 302.52 42.9214 296.287 40.469C290.054 38.0166 283.392 36.8069 276.685 36.9093V36.9093ZM278.015 113.795C270.908 113.719 264.113 110.892 259.088 105.919C254.062 100.947 251.204 94.2241 251.128 87.1921C251.128 81.9305 252.705 76.7871 255.659 72.4122C258.613 68.0374 262.812 64.6276 267.725 62.614C272.638 60.6005 278.044 60.0737 283.26 61.1002C288.475 62.1267 293.266 64.6604 297.026 68.3809C300.787 72.1014 303.347 76.8416 304.385 82.0021C305.422 87.1626 304.89 92.5116 302.855 97.3727C300.82 102.234 297.374 106.389 292.952 109.312C288.531 112.235 283.332 113.795 278.015 113.795V113.795Z\"></path><path d=\"M729.639 137.91C736.297 137.885 742.885 136.56 749.024 134.009C755.163 131.459 760.733 127.734 765.413 123.049C770.094 118.363 773.793 112.809 776.299 106.706C778.805 100.602 780.067 94.0688 780.015 87.4811V86.7502C779.883 76.7631 776.76 67.039 771.043 58.8076C765.325 50.5763 757.269 44.2072 747.893 40.5059C738.517 36.8045 728.243 35.9371 718.369 38.0133C708.495 40.0895 699.464 45.016 692.42 52.17C685.376 59.3239 680.633 68.384 678.793 78.2046C676.953 88.0252 678.097 98.1652 682.08 107.343C686.064 116.52 692.709 124.322 701.174 129.763C709.639 135.204 719.545 138.039 729.639 137.91V137.91ZM730.377 60.7318C737.508 60.7318 744.347 63.5346 749.389 68.5237C754.432 73.5127 757.264 80.2793 757.264 87.3349C757.264 94.3905 754.432 101.157 749.389 106.146C744.347 111.135 737.508 113.938 730.377 113.938C723.247 113.938 716.408 111.135 711.366 106.146C706.323 101.157 703.491 94.3905 703.491 87.3349C703.491 80.2793 706.323 73.5127 711.366 68.5237C716.408 63.5346 723.247 60.7318 730.377 60.7318Z\"></path></svg></a></div><button class=\"CybotCookiebotBannerCloseButton\" aria-label=\"\"><svg xmlns=\"http://www.w3.org/2000/svg\" width=\"14\" height=\"14\" viewBox=\"0 0 14 14\"><path d=\"M14 1.41L12.59 0L7 5.59L1.41 0L0 1.41L5.59 7L0 12.59L1.41 14L7 8.41L12.59 14L14 12.59L8.41 7L14 1.41Z\"></path></svg></button></div><div id=\"CybotCookiebotDialogNav\" class=\"CybotCookiebotScrollAreaSide\"><div class=\"CybotCookiebotFader CybotCookiebotFaderLeft\" style=\"background-image: linear-gradient(to right, rgb(255, 255, 255), rgba(255, 255, 255, 0.8), rgba(255, 255, 255, 0));\"></div><div class=\"CybotCookiebotFader CybotCookiebotFaderRight\" style=\"background-image: linear-gradient(to left, rgb(255, 255, 255), rgba(255, 255, 255, 0.8), rgba(255, 255, 255, 0));\"></div><ul id=\"CybotCookiebotDialogNavList\" class=\"CybotCookiebotDialogNavItems\" role=\"tablist\"><li class=\"CybotCookiebotDialogNavItem\" role=\"presentation\"><a id=\"CybotCookiebotDialogNavDeclaration\" class=\"CybotCookiebotDialogNavItemLink CybotCookiebotDialogActive\" href=\"#\" data-target=\"CybotCookiebotDialogBody\" tabindex=\"0\" role=\"tab\" aria-selected=\"false\" lang=\"en\">Consent</a></li><li class=\"CybotCookiebotDialogNavItem\" role=\"presentation\"><a id=\"CybotCookiebotDialogNavDetails\" class=\"CybotCookiebotDialogNavItemLink\" href=\"#\" data-target=\"CybotCookiebotDialogTabContentDetails\" tabindex=\"0\" role=\"tab\" aria-selected=\"false\" lang=\"en\">Details</a></li><li id=\"CybotCookiebotDialogNavItemAdSettings\" class=\"CybotCookiebotDialogNavItem CybotCookiebotDialogHide\" role=\"presentation\"><a id=\"CybotCookiebotDialogNavAdSettings\" class=\"CybotCookiebotDialogNavItemLink\" href=\"#\" data-target=\"CybotCookiebotDialogDetailBodyContentTextIABv2\" tabindex=\"0\" role=\"tab\" aria-selected=\"false\" lang=\"en\">[#IABV2SETTINGS#]</a></li><li class=\"CybotCookiebotDialogNavItem\" role=\"presentation\"><a id=\"CybotCookiebotDialogNavAbout\" class=\"CybotCookiebotDialogNavItemLink\" href=\"#\" data-target=\"CybotCookiebotDialogDetailBodyContentTextAbout\" tabindex=\"0\" role=\"tab\" aria-selected=\"false\" lang=\"en\">About</a></li></ul></div><div id=\"CybotCookiebotDialogTabContent\"><div id=\"CybotCookiebotDialogBody\" class=\"CybotCookiebotDialogTabPanel\" role=\"tabpanel\" aria-labelledby=\"CybotCookiebotDialogNavDeclaration\" lang=\"en\"><div class=\"CybotCookiebotScrollContainer\"><div id=\"CybotCookiebotDialogBodyContent\" class=\"CybotCookiebotScrollArea\"><div class=\"CybotCookiebotFader\" style=\"background-image: linear-gradient(to top, rgb(255, 255, 255), rgba(255, 255, 255, 0.8), rgba(255, 255, 255, 0));\"></div><div id=\"CybotCookiebotDialogBodyContentTitle\" class=\"CybotCookiebotDialogBodyContentHeading\" lang=\"en\" role=\"heading\" aria-level=\"2\">Welcome!</div><div id=\"CybotCookiebotDialogBodyContentText\" lang=\"en\"><p style=\"\">We would like to use cookies and other similar technologies to personalize content and ads, as well as to provide social media features on this website.<span id=\"dots\" style=\"display: none\">..</span><a id=\"readmorebtn\" style=\"display: none\" onclick=\"readmore()\">Read more</a>&nbsp;</p><p id=\"readmore\" style=\"\">This may include collecting your sensitive data,  such as information identifying you as seeking treatment for a health condition. We may also share this information with third party providers, a list of which may be viewed by clicking on \u201cDetails\u201d.</p><p id=\"readmoretwo\" style=\"\">By clicking \u201cAccept\u201d you are consenting to both the collection and sharing of your sensitive data by Amgen. If you do not wish to consent, choose \u201cDecline\u201d. To manage your preferences or withdraw your consent, please visit \u201cYour Cookie Preferences\u201d on the bottom of the website at any time.&nbsp;<a id=\"realessbtn\" style=\"display: none\" onclick=\"readless()\">Read less</a></p><p style=\"display: none\" id=\"nvtext\"><strong style=\"\">Nevada/Washington/Maryland Residents: you must select Decline.</strong></p><p style=\"\">By using any of our websites, you are agreeing to our&nbsp;<a href=\"https://wwwext.amgen.com/terms-of-use\" target=\"_blank\" style=\"\">Terms of Use</a>.</p></div></div><div class=\"CybotCookiebotScrollbarContainer\"></div></div><div class=\"CybotCookiebotDialogBodyBottomWrapper\"><div id=\"CybotCookiebotDialogBodyLevelWrapper\" class=\"CybotCookiebotDialogHide\"><div id=\"CybotCookiebotDialogBodyLevelButtons\"><div id=\"CybotCookiebotDialogBodyLevelButtonsTable\"><div id=\"CybotCookiebotDialogBodyLevelButtonsRow\"><div id=\"CybotCookiebotDialogBodyLevelButtonsSelectPane\"><form><fieldset><legend class=\"visuallyhidden\">Consent Selection</legend><div id=\"CybotCookiebotDialogBodyFieldsetInnerContainer\"><div class=\"CybotCookiebotDialogBodyLevelButtonWrapper\"><label class=\"CybotCookiebotDialogBodyLevelButtonLabel\" for=\"CybotCookiebotDialogBodyLevelButtonNecessary\"><strong class=\"CybotCookiebotDialogBodyLevelButtonDescription\">Strictly Necessary Cookies</strong></label><div class=\"CybotCookiebotDialogBodyLevelButtonSliderWrapper CybotCookiebotDialogBodyLevelButtonSliderWrapperDisabled\"><input type=\"checkbox\" id=\"CybotCookiebotDialogBodyLevelButtonNecessary\" class=\"CybotCookiebotDialogBodyLevelButton CybotCookiebotDialogBodyLevelButtonDisabled\" disabled=\"disabled\" checked=\"checked\"> <span class=\"CybotCookiebotDialogBodyLevelButtonSlider\"></span></div></div><div class=\"CybotCookiebotDialogBodyLevelButtonWrapper\"><label class=\"CybotCookiebotDialogBodyLevelButtonLabel\" for=\"CybotCookiebotDialogBodyLevelButtonPreferences\"><strong class=\"CybotCookiebotDialogBodyLevelButtonDescription\">Functional Cookies</strong></label><div class=\"CybotCookiebotDialogBodyLevelButtonSliderWrapper\"><input type=\"checkbox\" id=\"CybotCookiebotDialogBodyLevelButtonPreferences\" class=\"CybotCookiebotDialogBodyLevelButton CybotCookiebotDialogBodyLevelConsentCheckbox\" data-target=\"CybotCookiebotDialogBodyLevelButtonPreferencesInline\" checked=\"checked\" tabindex=\"0\"> <span class=\"CybotCookiebotDialogBodyLevelButtonSlider\"></span></div></div><div class=\"CybotCookiebotDialogBodyLevelButtonWrapper\"><label class=\"CybotCookiebotDialogBodyLevelButtonLabel\" for=\"CybotCookiebotDialogBodyLevelButtonStatistics\"><strong class=\"CybotCookiebotDialogBodyLevelButtonDescription\">Performance</strong></label><div class=\"CybotCookiebotDialogBodyLevelButtonSliderWrapper\"><input type=\"checkbox\" id=\"CybotCookiebotDialogBodyLevelButtonStatistics\" class=\"CybotCookiebotDialogBodyLevelButton CybotCookiebotDialogBodyLevelConsentCheckbox\" data-target=\"CybotCookiebotDialogBodyLevelButtonStatisticsInline\" checked=\"checked\" tabindex=\"0\"> <span class=\"CybotCookiebotDialogBodyLevelButtonSlider\"></span></div></div><div class=\"CybotCookiebotDialogBodyLevelButtonWrapper\"><label class=\"CybotCookiebotDialogBodyLevelButtonLabel\" for=\"CybotCookiebotDialogBodyLevelButtonMarketing\"><strong class=\"CybotCookiebotDialogBodyLevelButtonDescription\">Social Media Cookies</strong></label><div class=\"CybotCookiebotDialogBodyLevelButtonSliderWrapper\"><input type=\"checkbox\" id=\"CybotCookiebotDialogBodyLevelButtonMarketing\" class=\"CybotCookiebotDialogBodyLevelButton CybotCookiebotDialogBodyLevelConsentCheckbox\" data-target=\"CybotCookiebotDialogBodyLevelButtonMarketingInline\" checked=\"checked\" tabindex=\"0\"> <span class=\"CybotCookiebotDialogBodyLevelButtonSlider\"></span></div></div></div></fieldset></form></div></div></div></div></div><div id=\"CybotCookiebotDialogBodyEdgeMoreDetails\"><a id=\"CybotCookiebotDialogBodyEdgeMoreDetailsLink\" href=\"#\" class=\"\">Details</a></div></div></div><div class=\"CybotCookiebotScrollContainer CybotCookiebotDialogHide\"><div id=\"CybotCookiebotDialogTabContentDetails\" class=\"CybotCookiebotDialogTabPanel CybotCookiebotDialogHide CybotCookiebotScrollArea\" role=\"tabpanel\" aria-labelledby=\"CybotCookiebotDialogNavDetails\" lang=\"en\"><div class=\"CybotCookiebotFader\" style=\"background-image: linear-gradient(to top, rgb(255, 255, 255), rgba(255, 255, 255, 0.8), rgba(255, 255, 255, 0));\"></div><div class=\"CybotCookiebotDialogSROnly\" role=\"heading\" aria-level=\"2\">Details</div><div id=\"CybotCookiebotDialogDetailBody\"><div id=\"CybotCookiebotDialogDetailBodyContent\"><div id=\"CybotCookiebotDialogDetailBodyContentTextOverview\" lang=\"en\"><div id=\"CybotCookiebotDialogDetailBodyContentCookieContainer\"><ul id=\"CybotCookiebotDialogDetailBodyContentCookieContainerTypes\" style=\"list-style-type: none;\"><li class=\"CookieCard\"><div id=\"CybotCookiebotDialogDetailBodyContentCookieContainerNecessaryCard\"><div class=\"CybotCookiebotDialogDetailBodyContentCookieContainerHeader\"><button id=\"CybotCookiebotDialogDetailBodyContentCookieContainerNecessary\" class=\"CybotCookiebotDialogDetailBodyContentCookieContainerButton CybotCookiebotDialogCollapsed\" lang=\"en\" data-target=\"CybotCookiebotDialogDetailBodyContentCookieTabsNecessary\" aria-label=\"Strictly Necessary Cookies (6)\" aria-controls=\"CybotCookiebotDialogDetailBodyContentCookieTabsNecessary\" aria-expanded=\"false\"><label for=\"CybotCookiebotDialogBodyLevelButtonNecessaryInline\">Strictly Necessary Cookies </label> <span class=\"CybotCookiebotDialogDetailBulkConsentCount\">6</span></button><div class=\"CybotCookiebotDialogBodyLevelButtonSliderWrapper CybotCookiebotDialogBodyLevelButtonSliderWrapperDisabled CybotCookiebotDialogHide\"><form><input type=\"checkbox\" id=\"CybotCookiebotDialogBodyLevelButtonNecessaryInline\" class=\"CybotCookiebotDialogBodyLevelButton CybotCookiebotDialogBodyLevelButtonDisabled\" disabled=\"disabled\" checked=\"checked\"> <span class=\"CybotCookiebotDialogBodyLevelButtonSlider\"></span></form></div></div><div class=\"CybotCookiebotDialogDetailBodyContentCookieTypeIntro\"></div><div id=\"CybotCookiebotDialogDetailBodyContentCookieTabsNecessary\" class=\"CollapseCard CybotCookiebotDialogHide\" aria-labelledby=\"CybotCookiebotDialogDetailBodyContentCookieContainerNecessaryCard\"><div class=\"CybotCookiebotDialogDetailBodyContentCookieTypeTableContainer\"><ul class=\"CybotCookiebotDialogDetailBodyContentCookieTabContent\" style=\"list-style-type: none;\"><li class=\"CybotCookiebotDialogDetailBodyContentCookieGroup\"><a class=\"CybotCookiebotDialogDetailBodyContentCookieProvider CybotCookiebotDialogCollapsed\" role=\"button\" aria-expanded=\"false\" href=\"#\">Cookiebot<div class=\"CybotCookiebotDialogDetailBodyContentCookieInfoCount CybotCookiebotDialogDetailBulkConsentCount\">2</div></a><a class=\"CybotCookiebotDialogDetailBodyContentCookieLink\" target=\"_blank\" rel=\"noopener noreferrer nofollow\" aria-label=\"Cookiebot's privacy policy - opens in a new window\" href=\"https://www.cookiebot.com/goto/privacy-policy/\" title=\"Cookiebot's privacy policy\">Learn more about this provider<img class=\"CybotExternalLinkArrow\" src=\"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAABIAAAASCAYAAABWzo5XAAAACXBIWXMAAAsTAAALEwEAmpwYAAAAAXNSR0IArs4c6QAAAARnQU1BAACxjwv8YQUAAAC6SURBVHgBpdTdCcMgEAdwT/vk04EOkBG6QifpHH3rCF2hk3SVvBaEuoDYu4IgRRMv/iEkD/Hn+QnOuatS6gEAqDoJIQC/vfe594+m576FjAZKL6XXkSDiYox5UQFLXZEoNZJzXg9B/0hK6SKGWkiMcRVBewjnNIuURdIzyFBFo0jZPnoGqaMbCEqRJkSNIiFPCfILj7F1GLkySfvuqnFlShDxWesF6D76zF4jPJ/GWvum7/NRjBCegtsXQuuTY/odOJIAAAAASUVORK5CYII=\" alt=\"\"></a><div class=\"CybotCookiebotDialogDetailBodyContentCookieInfoWrapper CybotCookiebotDialogHide\"><div class=\"CybotCookiebotDialogDetailBodyContentCookieInfo\"><strong class=\"CybotCookiebotDialogDetailBodyContentCookieInfoTitle\">1.gif</strong><span class=\"CybotCookiebotDialogDetailBodyContentCookieInfoDescription\">Used to count the number of sessions to the website, necessary for optimizing CMP product delivery. </span><div class=\"CybotCookiebotDialogDetailBodyContentCookieInfoFooter\"><span class=\"CybotCookiebotDialogDetailBodyContentCookieInfoFooterContent\"><b>Maximum Storage Duration</b>: Session</span><span class=\"CybotCookiebotDialogDetailBodyContentCookieInfoFooterContent\"><b>Type</b>: Pixel Tracker</span></div></div><div class=\"CybotCookiebotDialogDetailBodyContentCookieInfo\"><strong class=\"CybotCookiebotDialogDetailBodyContentCookieInfoTitle\">CookieConsent</strong><span class=\"CybotCookiebotDialogDetailBodyContentCookieInfoDescription\">Stores the user's cookie consent state for the current domain</span><div class=\"CybotCookiebotDialogDetailBodyContentCookieInfoFooter\"><span class=\"CybotCookiebotDialogDetailBodyContentCookieInfoFooterContent\"><b>Maximum Storage Duration</b>: 1 year</span><span class=\"CybotCookiebotDialogDetailBodyContentCookieInfoFooterContent\"><b>Type</b>: HTTP Cookie</span></div></div></div></li><li class=\"CybotCookiebotDialogDetailBodyContentCookieGroup\"><a class=\"CybotCookiebotDialogDetailBodyContentCookieProvider CybotCookiebotDialogCollapsed\" role=\"button\" aria-expanded=\"false\" href=\"#\">www.amgenpipeline.com<div class=\"CybotCookiebotDialogDetailBodyContentCookieInfoCount CybotCookiebotDialogDetailBulkConsentCount\">4</div></a><div class=\"CybotCookiebotDialogDetailBodyContentCookieInfoWrapper CybotCookiebotDialogHide\"><div class=\"CybotCookiebotDialogDetailBodyContentCookieInfo\"><strong class=\"CybotCookiebotDialogDetailBodyContentCookieInfoTitle\">__RequestVerificationToken</strong><span class=\"CybotCookiebotDialogDetailBodyContentCookieInfoDescription\">Helps prevent Cross-Site Request Forgery (CSRF) attacks.</span><div class=\"CybotCookiebotDialogDetailBodyContentCookieInfoFooter\"><span class=\"CybotCookiebotDialogDetailBodyContentCookieInfoFooterContent\"><b>Maximum Storage Duration</b>: Session</span><span class=\"CybotCookiebotDialogDetailBodyContentCookieInfoFooterContent\"><b>Type</b>: HTTP Cookie</span></div></div><div class=\"CybotCookiebotDialogDetailBodyContentCookieInfo\"><strong class=\"CybotCookiebotDialogDetailBodyContentCookieInfoTitle\">ASP.NET_SessionId</strong><span class=\"CybotCookiebotDialogDetailBodyContentCookieInfoDescription\">Preserves the visitor's session state across page requests.</span><div class=\"CybotCookiebotDialogDetailBodyContentCookieInfoFooter\"><span class=\"CybotCookiebotDialogDetailBodyContentCookieInfoFooterContent\"><b>Maximum Storage Duration</b>: Session</span><span class=\"CybotCookiebotDialogDetailBodyContentCookieInfoFooterContent\"><b>Type</b>: HTTP Cookie</span></div></div><div class=\"CybotCookiebotDialogDetailBodyContentCookieInfo\"><strong class=\"CybotCookiebotDialogDetailBodyContentCookieInfoTitle\">RegionCode</strong><span class=\"CybotCookiebotDialogDetailBodyContentCookieInfoDescription\">Saves the user's current geographical location based on the user's IP address.</span><div class=\"CybotCookiebotDialogDetailBodyContentCookieInfoFooter\"><span class=\"CybotCookiebotDialogDetailBodyContentCookieInfoFooterContent\"><b>Maximum Storage Duration</b>: 1 year</span><span class=\"CybotCookiebotDialogDetailBodyContentCookieInfoFooterContent\"><b>Type</b>: HTTP Cookie</span></div></div><div class=\"CybotCookiebotDialogDetailBodyContentCookieInfo\"><strong class=\"CybotCookiebotDialogDetailBodyContentCookieInfoTitle\">sxa_site</strong><span class=\"CybotCookiebotDialogDetailBodyContentCookieInfoDescription\">Improves website speed and implements content through a Content Delivery Network (CDN). </span><div class=\"CybotCookiebotDialogDetailBodyContentCookieInfoFooter\"><span class=\"CybotCookiebotDialogDetailBodyContentCookieInfoFooterContent\"><b>Maximum Storage Duration</b>: Session</span><span class=\"CybotCookiebotDialogDetailBodyContentCookieInfoFooterContent\"><b>Type</b>: HTTP Cookie</span></div></div></div></li></ul></div></div></div></li><li class=\"CookieCard\"><div id=\"CybotCookiebotDialogDetailBodyContentCookieContainerPreferenceCard\"><div class=\"CybotCookiebotDialogDetailBodyContentCookieContainerHeader\"><button id=\"CybotCookiebotDialogDetailBodyContentCookieContainerPreference\" class=\"CybotCookiebotDialogDetailBodyContentCookieContainerButton CybotCookiebotDialogCollapsed\" lang=\"en\" data-target=\"CybotCookiebotDialogDetailBodyContentCookieTabsPreference\" aria-label=\"Functional Cookies (2)\" aria-controls=\"CybotCookiebotDialogDetailBodyContentCookieTabsPreference\" aria-expanded=\"false\"><label for=\"CybotCookiebotDialogBodyLevelButtonPreferencesInline\">Functional Cookies </label> <span class=\"CybotCookiebotDialogDetailBulkConsentCount\">2</span></button><div class=\"CybotCookiebotDialogBodyLevelButtonSliderWrapper CybotCookiebotDialogHide\"><form><input type=\"checkbox\" id=\"CybotCookiebotDialogBodyLevelButtonPreferencesInline\" class=\"CybotCookiebotDialogBodyLevelButton CybotCookiebotDialogBodyLevelConsentCheckbox\" data-target=\"CybotCookiebotDialogBodyLevelButtonPreferences\" checked=\"checked\" tabindex=\"0\"> <span class=\"CybotCookiebotDialogBodyLevelButtonSlider\"></span></form></div></div><div class=\"CybotCookiebotDialogDetailBodyContentCookieTypeIntro\">These cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then some or all of these services may not function properly.</div><div id=\"CybotCookiebotDialogDetailBodyContentCookieTabsPreference\" class=\"CollapseCard CybotCookiebotDialogHide\" aria-labelledby=\"CybotCookiebotDialogDetailBodyContentCookieContainerPreferenceCard\"><div class=\"CybotCookiebotDialogDetailBodyContentCookieTypeTableContainer\"><ul class=\"CybotCookiebotDialogDetailBodyContentCookieTabContent\" style=\"list-style-type: none;\"><li class=\"CybotCookiebotDialogDetailBodyContentCookieGroup\"><a class=\"CybotCookiebotDialogDetailBodyContentCookieProvider CybotCookiebotDialogCollapsed\" role=\"button\" aria-expanded=\"false\" href=\"#\">www.amgenpipeline.com<div class=\"CybotCookiebotDialogDetailBodyContentCookieInfoCount CybotCookiebotDialogDetailBulkConsentCount\">2</div></a><div class=\"CybotCookiebotDialogDetailBodyContentCookieInfoWrapper CybotCookiebotDialogHide\"><div class=\"CybotCookiebotDialogDetailBodyContentCookieInfo\"><strong class=\"CybotCookiebotDialogDetailBodyContentCookieInfoTitle\">IgnoreTrackerSpotting</strong><span class=\"CybotCookiebotDialogDetailBodyContentCookieInfoDescription\">Pending</span><div class=\"CybotCookiebotDialogDetailBodyContentCookieInfoFooter\"><span class=\"CybotCookiebotDialogDetailBodyContentCookieInfoFooterContent\"><b>Maximum Storage Duration</b>: 1 day</span><span class=\"CybotCookiebotDialogDetailBodyContentCookieInfoFooterContent\"><b>Type</b>: HTTP Cookie</span></div></div><div class=\"CybotCookiebotDialogDetailBodyContentCookieInfo\"><strong class=\"CybotCookiebotDialogDetailBodyContentCookieInfoTitle\">shell#lang</strong><span class=\"CybotCookiebotDialogDetailBodyContentCookieInfoDescription\">This cookie is used to determine the preferred language of the visitor and sets the language accordingly on the website, if possible.</span><div class=\"CybotCookiebotDialogDetailBodyContentCookieInfoFooter\"><span class=\"CybotCookiebotDialogDetailBodyContentCookieInfoFooterContent\"><b>Maximum Storage Duration</b>: Session</span><span class=\"CybotCookiebotDialogDetailBodyContentCookieInfoFooterContent\"><b>Type</b>: HTTP Cookie</span></div></div></div></li></ul></div></div></div></li><li class=\"CookieCard\"><div id=\"CybotCookiebotDialogDetailBodyContentCookieContainerStatisticsCard\"><div class=\"CybotCookiebotDialogDetailBodyContentCookieContainerHeader\"><button id=\"CybotCookiebotDialogDetailBodyContentCookieContainerStatistics\" class=\"CybotCookiebotDialogDetailBodyContentCookieContainerButton CybotCookiebotDialogCollapsed\" lang=\"en\" data-target=\"CybotCookiebotDialogDetailBodyContentCookieTabsStatistics\" aria-label=\"Performance (1)\" aria-controls=\"CybotCookiebotDialogDetailBodyContentCookieTabsStatistics\" aria-expanded=\"false\"><label for=\"CybotCookiebotDialogBodyLevelButtonStatisticsInline\">Performance </label> <span class=\"CybotCookiebotDialogDetailBulkConsentCount\">1</span></button><div class=\"CybotCookiebotDialogBodyLevelButtonSliderWrapper CybotCookiebotDialogHide\"><form><input type=\"checkbox\" id=\"CybotCookiebotDialogBodyLevelButtonStatisticsInline\" class=\"CybotCookiebotDialogBodyLevelButton CybotCookiebotDialogBodyLevelConsentCheckbox\" data-target=\"CybotCookiebotDialogBodyLevelButtonStatistics\" checked=\"checked\" tabindex=\"0\"> <span class=\"CybotCookiebotDialogBodyLevelButtonSlider\"></span></form></div></div><div class=\"CybotCookiebotDialogDetailBodyContentCookieTypeIntro\">These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.</div><div id=\"CybotCookiebotDialogDetailBodyContentCookieTabsStatistics\" class=\"CollapseCard CybotCookiebotDialogHide\" aria-labelledby=\"CybotCookiebotDialogDetailBodyContentCookieContainerStatisticsCard\"><div class=\"CybotCookiebotDialogDetailBodyContentCookieTypeTableContainer\"><ul class=\"CybotCookiebotDialogDetailBodyContentCookieTabContent\" style=\"list-style-type: none;\"><li class=\"CybotCookiebotDialogDetailBodyContentCookieGroup\"><a class=\"CybotCookiebotDialogDetailBodyContentCookieProvider CybotCookiebotDialogCollapsed\" role=\"button\" aria-expanded=\"false\" href=\"#\">www.amgenpipeline.com<div class=\"CybotCookiebotDialogDetailBodyContentCookieInfoCount CybotCookiebotDialogDetailBulkConsentCount\">1</div></a><div class=\"CybotCookiebotDialogDetailBodyContentCookieInfoWrapper CybotCookiebotDialogHide\"><div class=\"CybotCookiebotDialogDetailBodyContentCookieInfo\"><strong class=\"CybotCookiebotDialogDetailBodyContentCookieInfoTitle\">SC_ANALYTICS_GLOBAL_COOKIE</strong><span class=\"CybotCookiebotDialogDetailBodyContentCookieInfoDescription\">Used by Sitecore Engagement Analytics to identify the visitor on repeat visits to the website.</span><div class=\"CybotCookiebotDialogDetailBodyContentCookieInfoFooter\"><span class=\"CybotCookiebotDialogDetailBodyContentCookieInfoFooterContent\"><b>Maximum Storage Duration</b>: 400 days</span><span class=\"CybotCookiebotDialogDetailBodyContentCookieInfoFooterContent\"><b>Type</b>: HTTP Cookie</span></div></div></div></li></ul></div></div></div></li><li class=\"CookieCard\"><div id=\"CybotCookiebotDialogDetailBodyContentCookieContainerAdvertisingCard\"><div class=\"CybotCookiebotDialogDetailBodyContentCookieContainerHeader\"><button id=\"CybotCookiebotDialogDetailBodyContentCookieContainerAdvertising\" class=\"CybotCookiebotDialogDetailBodyContentCookieContainerButton CybotCookiebotDialogCollapsed\" lang=\"en\" data-target=\"CybotCookiebotDialogDetailBodyContentCookieTabsAdvertising\" aria-label=\"Social Media Cookies (0)\" aria-controls=\"CybotCookiebotDialogDetailBodyContentCookieTabsAdvertising\" aria-expanded=\"false\"><label for=\"CybotCookiebotDialogBodyLevelButtonMarketingInline\">Social Media Cookies </label> <span class=\"CybotCookiebotDialogDetailBulkConsentCount\">0</span></button><div class=\"CybotCookiebotDialogBodyLevelButtonSliderWrapper CybotCookiebotDialogHide\"><form><input type=\"checkbox\" id=\"CybotCookiebotDialogBodyLevelButtonMarketingInline\" class=\"CybotCookiebotDialogBodyLevelButton CybotCookiebotDialogBodyLevelConsentCheckbox\" data-target=\"CybotCookiebotDialogBodyLevelButtonMarketing\" checked=\"checked\" tabindex=\"0\"> <span class=\"CybotCookiebotDialogBodyLevelButtonSlider\"></span></form></div></div><div class=\"CybotCookiebotDialogDetailBodyContentCookieTypeIntro\">These cookies are set by a range of social media services that we have added to the site to enable you to share our content with your friends and networks. They are capable of tracking your browser across other sites and building up a profile of your interests. This may impact the content and messages you see on other websites you visit. If you do not allow these cookies you may not be able to use or see these sharing tools.</div><div id=\"CybotCookiebotDialogDetailBodyContentCookieTabsAdvertising\" class=\"CollapseCard CybotCookiebotDialogHide\" aria-labelledby=\"CybotCookiebotDialogDetailBodyContentCookieContainerAdvertisingCard\"><div class=\"CybotCookiebotDialogDetailBodyContentCookieTypeTableContainer\"><ul class=\"CybotCookiebotDialogDetailBodyContentCookieTabContent\" style=\"list-style-type: none;\"><p class=\"CybotCookiebotDialogDetailBodyEmptyCategoryMessage\">We do not use cookies of this type.</p></ul></div></div></div></li><li class=\"CookieCard\"><div id=\"CybotCookiebotDialogDetailBodyContentCookieContainerUnclassifiedCard\"><button id=\"CybotCookiebotDialogDetailBodyContentCookieContainerUnclassified\" class=\"CybotCookiebotDialogDetailBodyContentCookieContainerButton CybotCookiebotDialogCollapsed\" lang=\"en\" data-target=\"CybotCookiebotDialogDetailBodyContentCookieTabsUnclassified\" aria-label=\"Unknown (0)\" aria-controls=\"CybotCookiebotDialogDetailBodyContentCookieTabsUnclassified\" aria-expanded=\"false\">Unknown  <span class=\"CybotCookiebotDialogDetailBulkConsentCount\">0</span></button><div class=\"CybotCookiebotDialogDetailBodyContentCookieTypeIntro\">Unclassified cookies are cookies that we are in the process of classifying, together with the providers of individual cookies.</div></div><div id=\"CybotCookiebotDialogDetailBodyContentCookieTabsUnclassified\" class=\"CollapseCard CybotCookiebotDialogHide\" aria-labelledby=\"CybotCookiebotDialogDetailBodyContentCookieContainerUnclassifiedCard\" aria-expanded=\"false\"><div class=\"CybotCookiebotDialogDetailBodyContentCookieTypeTableContainer\"><ul class=\"CybotCookiebotDialogDetailBodyContentCookieTabContent\" style=\"list-style-type: none;\"><p class=\"CybotCookiebotDialogDetailBodyEmptyCategoryMessage\">We do not use cookies of this type.</p></ul></div></div></li></ul></div></div></div><div id=\"CybotCookiebotDialogDetailBulkConsent\" lang=\"en\" style=\"display: none;\"><a id=\"CybotCookiebotDialogDetailBulkConsentLink\" href=\"#\" class=\"CybotExpandLink CybotCookiebotDialogCollapsed\" data-target=\"CybotCookiebotDialogDetailBulkConsentListWrapper\">Cross-domain consent<span class=\"CybotCookiebotDialogDetailBulkConsentCount\">[#BULK_CONSENT_DOMAINS_COUNT#]</span></a> [#BULK_CONSENT_TITLE#]<div id=\"CybotCookiebotDialogDetailBulkConsentListWrapper\" class=\"CybotCookiebotDialogHide\" aria-expanded=\"false\"><span>List of domains your consent applies to:</span> [#BULK_CONSENT_DOMAINS#]</div></div><div id=\"CybotCookiebotDialogDetailFooter\" lang=\"en\">Cookie declaration last updated on 10/18/25 by <a href=\"https://www.cookiebot.com\" target=\"_blank\" rel=\"noopener\" title=\"Cookiebot\">Cookiebot</a></div></div></div><div class=\"CybotCookiebotScrollbarContainer\"></div></div><div class=\"CybotCookiebotScrollContainer CybotCookiebotDialogHide\"><div id=\"CybotCookiebotDialogDetailBodyContentTextIABv2\" class=\"CybotCookiebotDialogTabPanel CybotCookiebotDialogHide CybotCookiebotScrollArea\" role=\"tabpanel\" aria-labelledby=\"CybotCookiebotDialogNavAdSettings\" lang=\"en\"><div class=\"CybotCookiebotFader\" style=\"background-image: linear-gradient(to top, rgb(255, 255, 255), rgba(255, 255, 255, 0.8), rgba(255, 255, 255, 0));\"></div><div id=\"CybotCookiebotDialogDetailBodyContentIABContainer\"><div id=\"CybotCookiebotDialogDetailBodyContentIABv2Tabs\"><div class=\"CybotCookiebotDialogDetailBodyContentIABv2TabsIntro\"><div class=\"CybotCookiebotDialogBodyContentHeading\" role=\"heading\" aria-level=\"2\">[#IABV2_TITLE#]</div>[#IABV2_BODY_INTRO#]</div><div class=\"CybotCookiebotDialogDetailBodyContentIABv2TabsIntro\">[#IABV2_BODY_LEGITIMATE_INTEREST_INTRO#]</div><div class=\"CybotCookiebotDialogDetailBodyContentIABv2TabsIntro\">[#IABV2_BODY_PREFERENCE_INTRO#]</div><div class=\"CookieCard\"><div id=\"CybotCookiebotDialogDetailBodyContentIABv2PurposesCard\"><button id=\"CybotCookiebotDialogDetailBodyContentIABv2Purposes\" class=\"CybotCookiebotDialogDetailBodyContentIABv2Tab CybotCookiebotDialogCollapsed\" tabindex=\"0\" data-target=\"CybotCookiebotDialogDetailBodyContentIABv2PurposesBody\" lang=\"en\" aria-label=\"[#IABV2_LABEL_PURPOSES_ARIA_LABEL#]\" aria-controls=\"CybotCookiebotDialogDetailBodyContentIABv2PurposesBody\">[#IABV2_LABEL_PURPOSES#]</button><div class=\"CybotCookiebotDialogDetailBodyContentIABv2CardIntro\">[#IABV2_BODY_PURPOSES_INTRO#]</div></div><div id=\"CybotCookiebotDialogDetailBodyContentIABv2PurposesBody\" class=\"CollapseCard CybotCookiebotDialogHide\" aria-labelledby=\"CybotCookiebotDialogDetailBodyContentIABv2PurposesCard\" aria-expanded=\"false\">[#IABV2_BODY_PURPOSES#]</div></div><div class=\"CookieCard\"><div id=\"CybotCookiebotDialogDetailBodyContentIABv2FeaturesCard\"><button id=\"CybotCookiebotDialogDetailBodyContentIABv2Features\" class=\"CybotCookiebotDialogDetailBodyContentIABv2Tab CybotCookiebotDialogCollapsed\" tabindex=\"0\" data-target=\"CybotCookiebotDialogDetailBodyContentIABv2FeaturesBody\" lang=\"en\" aria-label=\"[#IABV2_LABEL_FEATURES_ARIA_LABEL#]\" aria-controls=\"CybotCookiebotDialogDetailBodyContentIABv2FeaturesBody\">[#IABV2_LABEL_FEATURES#]</button><div class=\"CybotCookiebotDialogDetailBodyContentIABv2CardIntro\">[#IABV2_BODY_FEATURES_INTRO#]</div></div><div id=\"CybotCookiebotDialogDetailBodyContentIABv2FeaturesBody\" class=\"CollapseCard CybotCookiebotDialogHide\" aria-labelledby=\"CybotCookiebotDialogDetailBodyContentIABv2FeaturesCard\" aria-expanded=\"false\">[#IABV2_BODY_FEATURES#]</div></div><div class=\"CookieCard\"><div id=\"CybotCookiebotDialogDetailBodyContentIABv2PartnersCard\"><button id=\"CybotCookiebotDialogDetailBodyContentIABv2Partners\" class=\"CybotCookiebotDialogDetailBodyContentIABv2Tab CybotCookiebotDialogCollapsed\" tabindex=\"0\" data-target=\"CybotCookiebotDialogDetailBodyContentIABv2PartnersBody\" lang=\"en\" aria-label=\"[#IABV2_LABEL_PARTNERS_ARIA_LABEL#]\" aria-controls=\"CybotCookiebotDialogDetailBodyContentIABv2PartnersBody\">[#IABV2_LABEL_PARTNERS#]</button><div class=\"CybotCookiebotDialogDetailBodyContentIABv2CardIntro\">[#IABV2_BODY_PARTNERS_INTRO#]</div></div><div id=\"CybotCookiebotDialogDetailBodyContentIABv2PartnersBody\" class=\"CollapseCard CybotCookiebotDialogHide\" aria-labelledby=\"CybotCookiebotDialogDetailBodyContentIABv2PartnersCard\" aria-expanded=\"false\">[#IABV2_BODY_PARTNERS#]</div></div></div></div></div><div class=\"CybotCookiebotScrollbarContainer\"></div></div><div class=\"CybotCookiebotScrollContainer CybotCookiebotDialogHide\"><div id=\"CybotCookiebotDialogDetailBodyContentTextAbout\" class=\"CybotCookiebotDialogTabPanel CybotCookiebotDialogHide CybotCookiebotScrollArea\" role=\"tabpanel\" aria-labelledby=\"CybotCookiebotDialogNavAbout\" lang=\"en\"><div class=\"CybotCookiebotDialogSROnly\" role=\"heading\" aria-level=\"2\">About</div><div class=\"CybotCookiebotFader\" style=\"background-image: linear-gradient(to top, rgb(255, 255, 255), rgba(255, 255, 255, 0.8), rgba(255, 255, 255, 0));\"></div><p style=\"\">Cookies are small text files that can be used by websites to enhance functionality, improve user experience, and track site interactions. We can store cookies on your device without your permission if they are strictly necessary for the operation of this site. For all other types of cookies, we will obtain your permission.</p><p style=\"\">This site uses different types of cookies. Some cookies are placed by third party services that appear on our pages.</p><p style=\"\">For further information, please visit <a target=\"_blank\" href=\"http://www.amgen.com/privacy\" style=\"\">www.amgen.com/privacy</a>&nbsp; &nbsp;</p></div><div class=\"CybotCookiebotScrollbarContainer\"></div></div></div><div id=\"CybotCookiebotDialogFooter\" class=\"CybotCookiebotScrollContainer\"><div class=\"CybotCookiebotScrollArea\"><div id=\"CybotCookiebotDialogBodyButtons\"><div class=\"CybotCookiebotDialogBodyLevelButtonWrapper CybotCookiebotDialogBodyContentControlsWrapper CybotCookiebotDialogHide\"><form class=\"CybotCookiebotDialogBodyLevelButtonSliderWrapper\"><input type=\"checkbox\" id=\"CybotCookiebotDialogBodyContentCheckboxPersonalInformation\" class=\"CybotCookiebotDialogBodyLevelButton\"> <span class=\"CybotCookiebotDialogBodyLevelButtonSlider\"></span></form><label class=\"CybotCookiebotDialogBodyLevelButtonLabel\" for=\"CybotCookiebotDialogBodyContentCheckboxPersonalInformation\"><strong class=\"CybotCookiebotDialogBodyLevelButtonDescription\">Do not sell or share my personal information</strong></label></div><div id=\"CybotCookiebotDialogBodyButtonsWrapper\"><button id=\"CybotCookiebotDialogBodyButtonAccept\" class=\"CybotCookiebotDialogBodyButton\" tabindex=\"0\" lang=\"en\">Accept</button><button id=\"CybotCookiebotDialogBodyLevelButtonCustomize\" class=\"CybotCookiebotDialogBodyButton CybotCookiebotDialogHide\" tabindex=\"0\" lang=\"en\">Customize<div class=\"CybotCookiebotDialogArrow\"></div></button><button id=\"CybotCookiebotDialogBodyLevelButtonLevelOptinAllowallSelection\" class=\"CybotCookiebotDialogBodyButton CybotCookiebotDialogHide\" tabindex=\"0\" lang=\"en\"></button><button id=\"CybotCookiebotDialogBodyButtonDecline\" class=\"CybotCookiebotDialogBodyButton\" tabindex=\"0\" lang=\"en\">Decline</button></div></div></div><div class=\"CybotCookiebotScrollbarContainer\"></div></div><button id=\"CybotCookiebotBannerCloseButtonE2E\" class=\"CybotCookiebotBannerCloseButton\" aria-label=\"\"><svg xmlns=\"http://www.w3.org/2000/svg\" width=\"14\" height=\"14\" viewBox=\"0 0 14 14\"><path d=\"M14 1.41L12.59 0L7 5.59L1.41 0L0 1.41L5.59 7L0 12.59L1.41 14L7 8.41L12.59 14L14 12.59L8.41 7L14 1.41Z\"></path></svg></button></div></div>\n    \n    \n    \n\n\n\n    <!-- Google Tag Manager (noscript) -->\n    <noscript>\n        <iframe src=\"https://www.googletagmanager.com/ns.html?id=GTM-M4CP89H\"\n                height=\"0\" width=\"0\" style=\"display:none;visibility:hidden\"></iframe>\n    </noscript>\n    <!-- End Google Tag Manager (noscript) -->\n\n\n    <div id=\"fb-root\"></div>\n    <div id=\"wrapper\">\n    </div>\n\n    <header class=\"header-nav\">\n        \n\n\n\n\n<div class=\"component container col-12\" id=\"pipeline-header\">\n    <div class=\"component-content\">\n\n\n<div class=\"component row-splitter\">\n        <div class=\"container-fluid\">\n            <div>\n                \n<div class=\"row component column-splitter\">\n        <div class=\"col-6\">\n                    <a class=\"quantum-header__logo gtm-header\" href=\"/\">\n            <img src=\"-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/amgen-logo.svg?la=en&amp;h=36&amp;w=151&amp;hash=01EF16D7756AF458A6C8E51C7C001BDA\" class=\"quantum-header__logo\" alt=\"logo\" rel=\"preload\" fetchpriority=\"high\">\n        </a>\n\n\n        </div>\n        <div class=\"col-6 position-right\">\n            \n        <button class=\"quantum-button quantum-hero__button\" type=\"button\"><span class=\"quantum-button__text\"><a href=\"/-/media/themes/amgen/amgenpipeline-com/amgenpipeline-com/pdf/amgen-pipeline-chart.pdf\" class=\"quantum-button__text \" target=\"_blank\" data-click-type=\"download\" data-click-text=\"Download Pipeline Chart\">Download pipeline chart</a></span></button></div>\n</div>\n            </div>\n        </div>\n</div>    </div>\n</div>\n    </header>\n\n    <div class=\"hero-div\">\n        \n\n    <div class=\"quantum-hero quantum-hero--image-position-default quantum-container--primary quantum-hero--multiple-background-images\">\n        <div class=\"quantum-hero__inner lozad-background lozad\" style=\"background-image:url(-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Desktop/Pipeline/HeroImage2.jpg),url(-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Mobile/Pipeline/heroimage.jpg)\">\n\n        </div>\n        <div class=\"quantum-hero__text\">\n            <div class=\"quantum-hero__text-inner quantum-long-form-text\">\n\n                <h5>A robust pipeline leveraging state-of-the-art science and molecular engineering focused on the pursuit of transformative medicines with large effects in serious diseases. Human genetic validation is used to strengthen the evidence base of as many of our programs as possible.</h5>\n\n                <h2> PIPELINE</h2>\n\n\n\n                    <button class=\"quantum-button quantum-hero__button\" type=\"button\">\n                        <span class=\"quantum-button__text\">\n                            <a href=\"-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/PDF/amgen-pipeline-chart.pdf\" class=\"quantum-button__text \" data-click-type=\"download\" data-click-text=\"Download Pipeline Chart\" target=\"_blank\">\n                                Download Pipeline Chart\n                            </a>\n                        </span>\n                    </button>\n\n\n            </div>\n\n        </div>\n    </div>\n\n    </div>\n    <div class=\"banner-div\">\n        \n    </div>\n    \n    \n\n<div class=\"filter-section filter-section-fixed\" id=\"filter-section\">\n    <input name=\"__RequestVerificationToken\" type=\"hidden\" value=\"6C1Tv76lUChf6HFOMdLrEBwNOXm7qPVinW3GJlry78pCbksHj8pl_SOnAa7nY6sKPmqiEWR31kKUquAL_zXPFpymjWwqx9prZqnmkRI7GbA1\">\n    <div class=\"filter-block\">\n        <div class=\"container filter-container\">\n            <div class=\"row searchActive\">\n                <div class=\"filter-btn-container\">\n                    <a class=\"filter-btn\">\n                        \n                        <img src=\"-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/icon-filter.png?la=en&amp;h=22&amp;w=22&amp;hash=236EEFA9FAF4A072433E83E622EB2B0C\" class=\"icon-filter lozad\" alt=\"icon-filter\">\n                        \n                        <img src=\"-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/icon-filter-close.png?la=en&amp;h=33&amp;w=33&amp;hash=DEE3EA9BAEE7BCC6D27104F7E6EF39B7\" class=\"icon-filter-close lozad\" alt=\"close\">\n                        <span class=\"filter-text\">FILTER</span>\n                    </a>\n                </div>\n                <div class=\"search-btn-container \">\n                    <div class=\"input-group d-none d-md-block\">\n                        <input type=\"search\" class=\"form-control search-input\" placeholder=\"Search our pipeline\">\n                        <a class=\"search-btn\" data-click-type=\"promo\" data-click-text=\"search\">\n                            \n                            <img src=\"-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/icon-search.png?la=en&amp;h=20&amp;w=20&amp;hash=57959CD6FC2BC14922FEFE02C3522BFF\" class=\"icon-search lozad\" alt=\"icon-filter\">\n                        </a>\n                    </div>\n                    <div class=\"mobileSearch d-block d-md-none\">\n                        <button type=\"button\" class=\"btn mblButtonSearch\">\n                            SEARCH\n                            \n                            <img src=\"-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/icon-search.png?la=en&amp;h=20&amp;w=20&amp;hash=57959CD6FC2BC14922FEFE02C3522BFF\" class=\"icon-search lozad\" alt=\"icon-filter\">\n\n                        </button>\n                    </div>\n                </div>\n            </div>\n            <div class=\"mblSearchContent\">\n                <div class=\"row clearfix\">\n                    <div class=\" mbl-input-group\">\n                        <div class=\"input-group \">\n                            <input type=\"search\" class=\"form-control search-input\" placeholder=\"Search our pipeline\">\n                            <a class=\"search-btn\" data-click-type=\"promo\" data-click-text=\"search\">\n                                \n                                <img src=\"-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/icon-search.png?la=en&amp;h=20&amp;w=20&amp;hash=57959CD6FC2BC14922FEFE02C3522BFF\" class=\"icon-search lozad\" alt=\"icon-filter\">\n                            </a>\n                        </div>\n                    </div>\n                    <a class=\"closeSearch\">\n                        \n                        <img src=\"-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/icon-filter-close.png?la=en&amp;h=33&amp;w=33&amp;hash=DEE3EA9BAEE7BCC6D27104F7E6EF39B7\" class=\"close lozad\" alt=\"close\">\n                    </a>\n                </div>\n            </div>\n        </div>\n    </div>\n    <div class=\"filter-element-block\">\n        <div class=\"container filter-element-container\">\n            <div class=\"row\">\n                <div class=\"col-md-3\">\n                    <div class=\"filter-box-area\" id=\"therapeuticAreaContainer\"><p class=\"filter-box-title\">THERAPEUTIC AREA</p><p><input type=\"checkbox\" checked=\"\" id=\"TAall\" name=\"TAall\"><label for=\"TAall\"> All Areas</label></p><p><input type=\"checkbox\" id=\"TA1\" name=\"TA1\"><label for=\"TA1\"> Bone</label></p><p><input type=\"checkbox\" id=\"TA2\" name=\"TA2\"><label for=\"TA2\"> Cardiometabolic</label></p><p><input type=\"checkbox\" id=\"TA3\" name=\"TA3\"><label for=\"TA3\"> Diabetes</label></p><p><input type=\"checkbox\" id=\"TA4\" name=\"TA4\"><label for=\"TA4\"> Hematology / Oncology</label></p><p><input type=\"checkbox\" id=\"TA5\" name=\"TA5\"><label for=\"TA5\"> Inflammation</label></p><p><input type=\"checkbox\" id=\"TA6\" name=\"TA6\"><label for=\"TA6\"> Nephrology</label></p><p><input type=\"checkbox\" id=\"TA7\" name=\"TA7\"><label for=\"TA7\"> Neuroscience</label></p><p><input type=\"checkbox\" id=\"TA8\" name=\"TA8\"><label for=\"TA8\"> Rare Disease</label></p></div>\n                </div>\n                <div class=\"col-md-3 \">\n                    <div class=\"filter-box-area\">\n                        <p class=\"filter-box-title\">\n                            Investigational Indication\n                        </p>\n                        <div class=\"dropdown\">\n                            <div id=\"indicationContainerId\" class=\"indicationContainer\"><div id=\"comboTree719758Wrapper\" class=\"comboTreeWrapper\"><div id=\"comboTree719758InputWrapper\" class=\"comboTreeInputWrapper\"><input type=\"text\" id=\"indicationDropdown\" placeholder=\"Please select\" readonly=\"\" class=\"comboTreeInputBox\"><button id=\"comboTree719758ArrowBtn\" class=\"comboTreeArrowBtn\" type=\"button\"><span class=\"comboTreeArrowBtnImg\"><img src=\"/-/media/themes/amgen/amgenpipeline-com/amgenpipeline-com/images/common/indication-arrow.png\" class=\"down-arrow\"></span></button></div><div id=\"comboTree719758DropDownContainer\" class=\"comboTreeDropDownContainer\"><input id=\"comboTree719758MultiFilter\" type=\"text\" class=\"multiplesFilter\" placeholder=\"Search here...\"><ul><li class=\"ComboTreeItemChlid\"> <span data-id=\"IN1\" class=\"comboTreeItemTitle\"><input type=\"checkbox\" id=\"IN1\" name=\"IN1\"><label class=\"indication-checkbox-title\" name=\"indicationLabel\" for=\"IN1\"> Acute Lymphoblastic Leukemia</label></span></li><li class=\"ComboTreeItemChlid\"> <span data-id=\"IN2\" class=\"comboTreeItemTitle\"><input type=\"checkbox\" id=\"IN2\" name=\"IN2\"><label class=\"indication-checkbox-title\" name=\"indicationLabel\" for=\"IN2\"> Advanced Colorectal Cancer</label></span></li><li class=\"ComboTreeItemChlid\"> <span data-id=\"IN3\" class=\"comboTreeItemTitle\"><input type=\"checkbox\" id=\"IN3\" name=\"IN3\"><label class=\"indication-checkbox-title\" name=\"indicationLabel\" for=\"IN3\"> Asthma</label></span></li><li class=\"ComboTreeItemChlid\"> <span data-id=\"IN4\" class=\"comboTreeItemTitle\"><input type=\"checkbox\" id=\"IN4\" name=\"IN4\"><label class=\"indication-checkbox-title\" name=\"indicationLabel\" for=\"IN4\"> Atopic Dermatitis</label></span></li><li class=\"ComboTreeItemChlid\"> <span data-id=\"IN5\" class=\"comboTreeItemTitle\"><input type=\"checkbox\" id=\"IN5\" name=\"IN5\"><label class=\"indication-checkbox-title\" name=\"indicationLabel\" for=\"IN5\"> Autoimmune Diseases</label></span></li><li class=\"ComboTreeItemChlid\"> <span data-id=\"IN6\" class=\"comboTreeItemTitle\"><input type=\"checkbox\" id=\"IN6\" name=\"IN6\"><label class=\"indication-checkbox-title\" name=\"indicationLabel\" for=\"IN6\"> Biosimilar candidate to EYLEA</label></span></li><li class=\"ComboTreeItemChlid\"> <span data-id=\"IN7\" class=\"comboTreeItemTitle\"><input type=\"checkbox\" id=\"IN7\" name=\"IN7\"><label class=\"indication-checkbox-title\" name=\"indicationLabel\" for=\"IN7\"> Biosimilar candidate to Soliris</label></span></li><li class=\"ComboTreeItemChlid\"> <span data-id=\"IN8\" class=\"comboTreeItemTitle\"><input type=\"checkbox\" id=\"IN8\" name=\"IN8\"><label class=\"indication-checkbox-title\" name=\"indicationLabel\" for=\"IN8\"> Biosimilar candidate to STELARA</label></span></li><li class=\"ComboTreeItemChlid\"> <span data-id=\"IN9\" class=\"comboTreeItemTitle\"><input type=\"checkbox\" id=\"IN9\" name=\"IN9\"><label class=\"indication-checkbox-title\" name=\"indicationLabel\" for=\"IN9\"> Cardiovascular Disease</label></span></li><li class=\"ComboTreeItemChlid\"> <span data-id=\"IN10\" class=\"comboTreeItemTitle\"><input type=\"checkbox\" id=\"IN10\" name=\"IN10\"><label class=\"indication-checkbox-title\" name=\"indicationLabel\" for=\"IN10\"> Celiac Disease</label></span></li><li class=\"ComboTreeItemChlid\"> <span data-id=\"IN11\" class=\"comboTreeItemTitle\"><input type=\"checkbox\" id=\"IN11\" name=\"IN11\"><label class=\"indication-checkbox-title\" name=\"indicationLabel\" for=\"IN11\"> Chemotherapy-Induced Thrombocytopenia</label></span></li><li class=\"ComboTreeItemChlid\"> <span data-id=\"IN12\" class=\"comboTreeItemTitle\"><input type=\"checkbox\" id=\"IN12\" name=\"IN12\"><label class=\"indication-checkbox-title\" name=\"indicationLabel\" for=\"IN12\"> Chronic Kidney Disease</label></span></li><li class=\"ComboTreeItemChlid\"> <span data-id=\"IN13\" class=\"comboTreeItemTitle\"><input type=\"checkbox\" id=\"IN13\" name=\"IN13\"><label class=\"indication-checkbox-title\" name=\"indicationLabel\" for=\"IN13\"> Chronic Obstructive Pulmonary Disease</label></span></li><li class=\"ComboTreeItemChlid\"> <span data-id=\"IN14\" class=\"comboTreeItemTitle\"><input type=\"checkbox\" id=\"IN14\" name=\"IN14\"><label class=\"indication-checkbox-title\" name=\"indicationLabel\" for=\"IN14\"> Chronic Rhinosinusitis with Nasal Polyps</label></span></li><li class=\"ComboTreeItemChlid\"> <span data-id=\"IN15\" class=\"comboTreeItemTitle\"><input type=\"checkbox\" id=\"IN15\" name=\"IN15\"><label class=\"indication-checkbox-title\" name=\"indicationLabel\" for=\"IN15\"> Colorectal Cancer</label></span></li><li class=\"ComboTreeItemChlid\"> <span data-id=\"IN16\" class=\"comboTreeItemTitle\"><input type=\"checkbox\" id=\"IN16\" name=\"IN16\"><label class=\"indication-checkbox-title\" name=\"indicationLabel\" for=\"IN16\"> Dermatomyositis and Anti-Synthetase Inflammatory Myositis</label></span></li><li class=\"ComboTreeItemChlid\"> <span data-id=\"IN17\" class=\"comboTreeItemTitle\"><input type=\"checkbox\" id=\"IN17\" name=\"IN17\"><label class=\"indication-checkbox-title\" name=\"indicationLabel\" for=\"IN17\"> Diffuse Cutaneous Systemic Sclerosis</label></span></li><li class=\"ComboTreeItemChlid\"> <span data-id=\"IN18\" class=\"comboTreeItemTitle\"><input type=\"checkbox\" id=\"IN18\" name=\"IN18\"><label class=\"indication-checkbox-title\" name=\"indicationLabel\" for=\"IN18\"> Discoid Lupus Erythematosus</label></span></li><li class=\"ComboTreeItemChlid\"> <span data-id=\"IN19\" class=\"comboTreeItemTitle\"><input type=\"checkbox\" id=\"IN19\" name=\"IN19\"><label class=\"indication-checkbox-title\" name=\"indicationLabel\" for=\"IN19\"> Eosinophilic Esophagitis</label></span></li><li class=\"ComboTreeItemChlid\"> <span data-id=\"IN20\" class=\"comboTreeItemTitle\"><input type=\"checkbox\" id=\"IN20\" name=\"IN20\"><label class=\"indication-checkbox-title\" name=\"indicationLabel\" for=\"IN20\"> Gastric and Gastroesophageal Junction (GEJ) Cancers</label></span></li><li class=\"ComboTreeItemChlid\"> <span data-id=\"IN21\" class=\"comboTreeItemTitle\"><input type=\"checkbox\" id=\"IN21\" name=\"IN21\"><label class=\"indication-checkbox-title\" name=\"indicationLabel\" for=\"IN21\"> Generalized Myasthenia Gravis</label></span></li><li class=\"ComboTreeItemChlid\"> <span data-id=\"IN22\" class=\"comboTreeItemTitle\"><input type=\"checkbox\" id=\"IN22\" name=\"IN22\"><label class=\"indication-checkbox-title\" name=\"indicationLabel\" for=\"IN22\"> Heart Failure</label></span></li><li class=\"ComboTreeItemChlid\"> <span data-id=\"IN23\" class=\"comboTreeItemTitle\"><input type=\"checkbox\" id=\"IN23\" name=\"IN23\"><label class=\"indication-checkbox-title\" name=\"indicationLabel\" for=\"IN23\"> Hematology</label></span></li><li class=\"ComboTreeItemChlid\"> <span data-id=\"IN24\" class=\"comboTreeItemTitle\"><input type=\"checkbox\" id=\"IN24\" name=\"IN24\"><label class=\"indication-checkbox-title\" name=\"indicationLabel\" for=\"IN24\"> Hypercholesterolemia</label></span></li><li class=\"ComboTreeItemChlid\"> <span data-id=\"IN25\" class=\"comboTreeItemTitle\"><input type=\"checkbox\" id=\"IN25\" name=\"IN25\"><label class=\"indication-checkbox-title\" name=\"indicationLabel\" for=\"IN25\"> Idiopathic Pulmonary Fibrosis</label></span></li><li class=\"ComboTreeItemChlid\"> <span data-id=\"IN26\" class=\"comboTreeItemTitle\"><input type=\"checkbox\" id=\"IN26\" name=\"IN26\"><label class=\"indication-checkbox-title\" name=\"indicationLabel\" for=\"IN26\"> IgG4-Related Disease</label></span></li><li class=\"ComboTreeItemChlid\"> <span data-id=\"IN27\" class=\"comboTreeItemTitle\"><input type=\"checkbox\" id=\"IN27\" name=\"IN27\"><label class=\"indication-checkbox-title\" name=\"indicationLabel\" for=\"IN27\"> Inflammatory Disease</label></span></li><li class=\"ComboTreeItemChlid\"> <span data-id=\"IN28\" class=\"comboTreeItemTitle\"><input type=\"checkbox\" id=\"IN28\" name=\"IN28\"><label class=\"indication-checkbox-title\" name=\"indicationLabel\" for=\"IN28\"> Interchangeability</label></span></li><li class=\"ComboTreeItemChlid\"> <span data-id=\"IN29\" class=\"comboTreeItemTitle\"><input type=\"checkbox\" id=\"IN29\" name=\"IN29\"><label class=\"indication-checkbox-title\" name=\"indicationLabel\" for=\"IN29\"> Investigational Biosimilar</label></span></li><li class=\"ComboTreeItemChlid\"> <span data-id=\"IN30\" class=\"comboTreeItemTitle\"><input type=\"checkbox\" id=\"IN30\" name=\"IN30\"><label class=\"indication-checkbox-title\" name=\"indicationLabel\" for=\"IN30\"> Juvenile Psoriatic Arthritis</label></span></li><li class=\"ComboTreeItemChlid\"> <span data-id=\"IN31\" class=\"comboTreeItemTitle\"><input type=\"checkbox\" id=\"IN31\" name=\"IN31\"><label class=\"indication-checkbox-title\" name=\"indicationLabel\" for=\"IN31\"> Male Osteoporosis</label></span></li><li class=\"ComboTreeItemChlid\"> <span data-id=\"IN32\" class=\"comboTreeItemTitle\"><input type=\"checkbox\" id=\"IN32\" name=\"IN32\"><label class=\"indication-checkbox-title\" name=\"indicationLabel\" for=\"IN32\"> Multiple Myeloma</label></span></li><li class=\"ComboTreeItemChlid\"> <span data-id=\"IN33\" class=\"comboTreeItemTitle\"><input type=\"checkbox\" id=\"IN33\" name=\"IN33\"><label class=\"indication-checkbox-title\" name=\"indicationLabel\" for=\"IN33\"> Neuroendocrine Prostate Cancer</label></span></li><li class=\"ComboTreeItemChlid\"> <span data-id=\"IN34\" class=\"comboTreeItemTitle\"><input type=\"checkbox\" id=\"IN34\" name=\"IN34\"><label class=\"indication-checkbox-title\" name=\"indicationLabel\" for=\"IN34\"> Non-Small Cell Lung Cancer</label></span></li><li class=\"ComboTreeItemChlid\"> <span data-id=\"IN35\" class=\"comboTreeItemTitle\"><input type=\"checkbox\" id=\"IN35\" name=\"IN35\"><label class=\"indication-checkbox-title\" name=\"indicationLabel\" for=\"IN35\"> Obesity</label></span></li><li class=\"ComboTreeItemChlid\"> <span data-id=\"IN36\" class=\"comboTreeItemTitle\"><input type=\"checkbox\" id=\"IN36\" name=\"IN36\"><label class=\"indication-checkbox-title\" name=\"indicationLabel\" for=\"IN36\"> Other Tumors</label></span></li><li class=\"ComboTreeItemChlid\"> <span data-id=\"IN37\" class=\"comboTreeItemTitle\"><input type=\"checkbox\" id=\"IN37\" name=\"IN37\"><label class=\"indication-checkbox-title\" name=\"indicationLabel\" for=\"IN37\"> Palmoplantar Pustulosis</label></span></li><li class=\"ComboTreeItemChlid\"> <span data-id=\"IN38\" class=\"comboTreeItemTitle\"><input type=\"checkbox\" id=\"IN38\" name=\"IN38\"><label class=\"indication-checkbox-title\" name=\"indicationLabel\" for=\"IN38\"> Pediatric Acute Lymphoblastic Leukemia</label></span></li><li class=\"ComboTreeItemChlid\"> <span data-id=\"IN39\" class=\"comboTreeItemTitle\"><input type=\"checkbox\" id=\"IN39\" name=\"IN39\"><label class=\"indication-checkbox-title\" name=\"indicationLabel\" for=\"IN39\"> Pediatric Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis</label></span></li><li class=\"ComboTreeItemChlid\"> <span data-id=\"IN40\" class=\"comboTreeItemTitle\"><input type=\"checkbox\" id=\"IN40\" name=\"IN40\"><label class=\"indication-checkbox-title\" name=\"indicationLabel\" for=\"IN40\"> Pediatric Behcet\u2019s Disease</label></span></li><li class=\"ComboTreeItemChlid\"> <span data-id=\"IN41\" class=\"comboTreeItemTitle\"><input type=\"checkbox\" id=\"IN41\" name=\"IN41\"><label class=\"indication-checkbox-title\" name=\"indicationLabel\" for=\"IN41\"> Pediatric Glucocorticoid-Induced Osteoporosis</label></span></li><li class=\"ComboTreeItemChlid\"> <span data-id=\"IN42\" class=\"comboTreeItemTitle\"><input type=\"checkbox\" id=\"IN42\" name=\"IN42\"><label class=\"indication-checkbox-title\" name=\"indicationLabel\" for=\"IN42\"> Pediatric Migraine</label></span></li><li class=\"ComboTreeItemChlid\"> <span data-id=\"IN43\" class=\"comboTreeItemTitle\"><input type=\"checkbox\" id=\"IN43\" name=\"IN43\"><label class=\"indication-checkbox-title\" name=\"indicationLabel\" for=\"IN43\"> Pediatric Osteogenesis Imperfecta</label></span></li><li class=\"ComboTreeItemChlid\"> <span data-id=\"IN44\" class=\"comboTreeItemTitle\"><input type=\"checkbox\" id=\"IN44\" name=\"IN44\"><label class=\"indication-checkbox-title\" name=\"indicationLabel\" for=\"IN44\"> Pediatric Secondary Hyperparathyroidism</label></span></li><li class=\"ComboTreeItemChlid\"> <span data-id=\"IN45\" class=\"comboTreeItemTitle\"><input type=\"checkbox\" id=\"IN45\" name=\"IN45\"><label class=\"indication-checkbox-title\" name=\"indicationLabel\" for=\"IN45\"> Pediatric Plaque Psoriasis</label></span></li><li class=\"ComboTreeItemChlid\"> <span data-id=\"IN46\" class=\"comboTreeItemTitle\"><input type=\"checkbox\" id=\"IN46\" name=\"IN46\"><label class=\"indication-checkbox-title\" name=\"indicationLabel\" for=\"IN46\"> Prostate Cancer</label></span></li><li class=\"ComboTreeItemChlid\"> <span data-id=\"IN47\" class=\"comboTreeItemTitle\"><input type=\"checkbox\" id=\"IN47\" name=\"IN47\"><label class=\"indication-checkbox-title\" name=\"indicationLabel\" for=\"IN47\"> Prurigo Nodularis</label></span></li><li class=\"ComboTreeItemChlid\"> <span data-id=\"IN48\" class=\"comboTreeItemTitle\"><input type=\"checkbox\" id=\"IN48\" name=\"IN48\"><label class=\"indication-checkbox-title\" name=\"indicationLabel\" for=\"IN48\"> Psoriasis</label></span></li><li class=\"ComboTreeItemChlid\"> <span data-id=\"IN49\" class=\"comboTreeItemTitle\"><input type=\"checkbox\" id=\"IN49\" name=\"IN49\"><label class=\"indication-checkbox-title\" name=\"indicationLabel\" for=\"IN49\"> Refractory Rheumatoid Arthritis</label></span></li><li class=\"ComboTreeItemChlid\"> <span data-id=\"IN50\" class=\"comboTreeItemTitle\"><input type=\"checkbox\" id=\"IN50\" name=\"IN50\"><label class=\"indication-checkbox-title\" name=\"indicationLabel\" for=\"IN50\"> Respiratory Disease</label></span></li><li class=\"ComboTreeItemChlid\"> <span data-id=\"IN51\" class=\"comboTreeItemTitle\"><input type=\"checkbox\" id=\"IN51\" name=\"IN51\"><label class=\"indication-checkbox-title\" name=\"indicationLabel\" for=\"IN51\"> Severe Asthma</label></span></li><li class=\"ComboTreeItemChlid\"> <span data-id=\"IN52\" class=\"comboTreeItemTitle\"><input type=\"checkbox\" id=\"IN52\" name=\"IN52\"><label class=\"indication-checkbox-title\" name=\"indicationLabel\" for=\"IN52\"> Sj\u00f6gren\u2019s Disease</label></span></li><li class=\"ComboTreeItemChlid\"> <span data-id=\"IN53\" class=\"comboTreeItemTitle\"><input type=\"checkbox\" id=\"IN53\" name=\"IN53\"><label class=\"indication-checkbox-title\" name=\"indicationLabel\" for=\"IN53\"> Small Cell Lung Cancer</label></span></li><li class=\"ComboTreeItemChlid\"> <span data-id=\"IN54\" class=\"comboTreeItemTitle\"><input type=\"checkbox\" id=\"IN54\" name=\"IN54\"><label class=\"indication-checkbox-title\" name=\"indicationLabel\" for=\"IN54\"> Solid Tumors</label></span></li><li class=\"ComboTreeItemChlid\"> <span data-id=\"IN55\" class=\"comboTreeItemTitle\"><input type=\"checkbox\" id=\"IN55\" name=\"IN55\"><label class=\"indication-checkbox-title\" name=\"indicationLabel\" for=\"IN55\"> STELARA\u00ae biosimilarity</label></span></li><li class=\"ComboTreeItemChlid\"> <span data-id=\"IN56\" class=\"comboTreeItemTitle\"><input type=\"checkbox\" id=\"IN56\" name=\"IN56\"><label class=\"indication-checkbox-title\" name=\"indicationLabel\" for=\"IN56\"> Systemic Lupus Erythematosus with Nephritis</label></span></li><li class=\"ComboTreeItemChlid\"> <span data-id=\"IN57\" class=\"comboTreeItemTitle\"><input type=\"checkbox\" id=\"IN57\" name=\"IN57\"><label class=\"indication-checkbox-title\" name=\"indicationLabel\" for=\"IN57\"> Thyroid Eye Disease</label></span></li><li class=\"ComboTreeItemChlid\"> <span data-id=\"IN58\" class=\"comboTreeItemTitle\"><input type=\"checkbox\" id=\"IN58\" name=\"IN58\"><label class=\"indication-checkbox-title\" name=\"indicationLabel\" for=\"IN58\"> Type 2 Diabetes</label></span></li><li class=\"ComboTreeItemChlid\"> <span data-id=\"IN59\" class=\"comboTreeItemTitle\"><input type=\"checkbox\" id=\"IN59\" name=\"IN59\"><label class=\"indication-checkbox-title\" name=\"indicationLabel\" for=\"IN59\"> Ulcerative Colitis</label></span></li></ul></div></div></div>\n                        </div>\n                    </div>\n                </div>\n                <div class=\"col-md-2 \">\n                    <div class=\"filter-box-area\" id=\"phaseContainer\"><p class=\"filter-box-title\">PHASE</p><p><input type=\"checkbox\" checked=\"\" id=\"PHall\" name=\"PHall\"><label for=\"PHall\"> All</label></p><p><input type=\"checkbox\" id=\"PH1\" name=\"PH1\"><label for=\"PH1\"> 1</label></p><p><input type=\"checkbox\" id=\"PH2\" name=\"PH2\"><label for=\"PH2\"> 2</label></p><p><input type=\"checkbox\" id=\"PH3\" name=\"PH3\"><label for=\"PH3\"> 3</label></p></div>\n                </div>\n                <div class=\"col-md-2 \">\n                    <div class=\"filter-box-area\">\n                        <a class=\"filter-reset-title\" data-click-type=\"promo\" data-click-text=\"Reset All Filters\" style=\"display: none;\">\n                            \n                            <img src=\"-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/filter-result-close-icon.svg?la=en&amp;hash=90C5D90E6412274F7082CA7BE84E6751\" class=\"icon-close lozad\" alt=\"icon-close\">\n                            <span>Reset All Filters</span>\n                        </a>\n                    </div>\n                </div>\n                <div class=\"col-md-2 \">\n                    <button type=\"button\" class=\"apply-filter\" data-click-type=\"promo\" data-click-text=\"APPLY FILTERS\">\n                        <span>APPLY FILTERS</span>\n                    </button>\n                </div>\n            </div>\n        </div>\n    </div>\n</div>\n<!--Filter Facets-->\n<!--No Results-->\n<div class=\"collapseContainer\">\n    <div class=\" container\">\n        <div class=\"row filter-result-container\" style=\"display: none;\">\n            <div class=\"col-md-2 filter-result-count\">\n                <p class=\"rs-filters d-none\">Showing <span class=\"filterCount\">35</span> result<span class=\"rs-multiple\">s</span> <img src=\"-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/filter-result-arrow.svg\" class=\"result-arrow-icon\" alt=\"Filter Close Icon\"> </p>\n<p class=\"rs-search\">\n            </p></div>\n            <div class=\"col-md-8 selectedFilterList\">\n            </div>\n            <div class=\"col-md-2 filterResultReset\" style=\"display: none;\">\n                <!-- <a href=\"#\" class=\"filter-result-reset\"><span class=\"Icon-Close-test\">s</span> -->\n                <!-- <span>Reset all filters</span> -->\n                <!-- </a> -->\n                <a href=\"#\" class=\"filter-result-reset\" data-click-type=\"promo\" data-click-text=\"Clear Filters\">\n                    <span class=\"filterClearIcon\"></span>\n                    <span class=\"rs-filters\">\n<img src=\"-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/clear-filter-close-icon.svg\" class=\"result-close-icon\" alt=\"clear Filter Icon\">\nClear Filters \n</span>\n<span class=\"rs-search d-none\">\n<img src=\"-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/clear-filter-close-icon.svg\" class=\"result-close-icon\" alt=\"clear Filter Icon\">\nClear Search \n</span>\n \n \n\n                </a>\n            </div>\n        </div>\n        <div class=\"moleculeListContainer\">\n            <div class=\"row moleculeTitle\">\n                <div class=\"col-sm-3 p-pad-0\">\n                    <div class=\"textContentTitle\">\n                        <p>MOLECULE NAME</p>\n                    </div>\n                </div>\n                <div class=\"col-sm-9 p-pad-0\">\n                    <div class=\"wrapper row\">\n                        <div class=\"col-sm-4\">\n                            <div class=\"card card-block\"> THERAPEUTIC AREA</div>\n                        </div>\n                        <div class=\"col-sm-4\">\n                            <div class=\"card card-block\">Investigational Indication</div>\n                        </div>\n                        <div class=\"col-sm-3\">\n                            <div class=\"card card-block\">MODALITY</div>\n                        </div>\n                        <div class=\"col-sm-1\">\n                            <div class=\"card card-block\">PHASE</div>\n                        </div>\n                    </div>\n                </div>\n            </div>\n            <div class=\"molecule-list-container desktop-view\"><div class=\"row collapsibleContent\"><div class=\"col-sm-3 border-right\" style=\"padding:0px !important\"><div class=\"textContent\"><p>Aimovig<sup>\u00ae</sup><br> <span>(erenumab-aooe)</span></p> </div> </div> <div class=\"col-sm-9\" style=\"padding:0px !important\"> <div class=\"wrapper row\">  <div class=\"col-sm-4 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"><h4 class=\"panel-title\"><a href=\"javascript:void(0)\" data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span><span class=\"tarea-text\">Neuroscience</span> </a> </h4> </div> </div>  </div>  <div class=\"col-sm-4 second-column\"> <div class=\"card card-block\"> <a href=\"javascript:void(0)\">Pediatric Migraine </a></div> </div> <div class=\"col-sm-3 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Monoclonal Antibody</a></div> </div> <div class=\"col-sm-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH3 \">3</span> </a>  </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-sm-8\"> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> Aimovig is a monoclonal antibody that inhibits the calcitonin gene-related peptide receptor (CGRP-R). It is being investigated for the prevention of chronic and episodic migraine in pediatric patients.\n </p> <label class=\"innerContentTitle\">ADDITIONAL INFORMATION</label> <p class=\"innterContentText\">Aimovig is developed in collaboration with Novartis.</p> <ul class=\"customBreadcrumb\"> <li><a href=\"https://pi.amgen.com/united_states/Aimovig/Aimovig_pi_hcp_english.pdf\" target=\"_blank\" data-click-type=\"outbound\" data-click-text=\"Prescribing Information \">Prescribing Information <img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/arrow-long.png\"></a></li> </ul> </div> <div class=\"col-sm-4 pronunce-content\"> </div> </div> <p></p> </div> </div> </div><div class=\"row collapsibleContent\"><div class=\"col-sm-3 border-right\" style=\"padding:0px !important\"><div class=\"textContent\"><p>BEMARITUZUMAB<br> <span></span></p> </div> </div> <div class=\"col-sm-9\" style=\"padding:0px !important\"> <div class=\"wrapper row\">  <div class=\"col-sm-4 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"><h4 class=\"panel-title\"><a href=\"javascript:void(0)\" data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span><span class=\"tarea-text\">Hematology / Oncology</span> </a> </h4> </div> </div>  </div>  <div class=\"col-sm-4 second-column\"> <div class=\"card card-block\"> <a href=\"javascript:void(0)\">Gastric and Gastroesophageal Junction (GEJ) Cancers </a></div> </div> <div class=\"col-sm-3 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Monoclonal Antibody</a></div> </div> <div class=\"col-sm-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH3 \">3</span> </a>  </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-sm-8\"> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> Bemarituzumab is a monoclonal antibody that inhibits fibroblast growth factor receptor 2b (FGFR2b). It is being investigated for the treatment of advanced Gastric and Gastroesophageal Junction (GEJ) Cancers. </p> <label class=\"innerContentTitle\">ADDITIONAL INFORMATION</label> <p class=\"innterContentText\">In April 2021, Amgen announced that the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy Designation for bemarituzumab.\n\n\n</p><p class=\"innerContentTitle\"><strong>ADDITIONAL CLINICAL STUDIES</strong></p>\n\n<p class=\"innterContentText\">Bemarituzumab is also in Phase 1 and Phase 2 development for the treatment of advanced Gastric and Gastroesophageal cancers in combination with other therapies.</p><p></p>  </div> <div class=\"col-sm-4 pronunce-content\"> </div> </div> <p></p> </div> <div class=\"wrapper row\">  <div class=\"col-sm-4 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"><h4 class=\"panel-title\"><a href=\"javascript:void(0)\" data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span><span class=\"tarea-text\">Hematology / Oncology</span> </a> </h4> </div> </div>  </div>  <div class=\"col-sm-4 second-column\"> <div class=\"card card-block\"> <a href=\"javascript:void(0)\">Other Tumors </a></div> </div> <div class=\"col-sm-3 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Monoclonal Antibody</a></div> </div> <div class=\"col-sm-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH2 \">2</span> </a>  </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-sm-8\"> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> Bemarituzumab is a monoclonal antibody that inhibits fibroblast growth factor receptor 2b (FGFR2b). It is being investigated for the treatment of advanced solid tumors other than advanced squamous non-small cell lung cancer. </p>  </div> <div class=\"col-sm-4 pronunce-content\"> </div> </div> <p></p> </div> </div> </div><div class=\"row collapsibleContent\"><div class=\"col-sm-3 border-right\" style=\"padding:0px !important\"><div class=\"textContent\"><p>BLINCYTO<sup>\u00ae</sup><br> <span>(blinatumomab)</span></p> </div> </div> <div class=\"col-sm-9\" style=\"padding:0px !important\"> <div class=\"wrapper row\">  <div class=\"col-sm-4 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"><h4 class=\"panel-title\"><a href=\"javascript:void(0)\" data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span><span class=\"tarea-text\">Hematology / Oncology</span> </a> </h4> </div> </div>  </div>  <div class=\"col-sm-4 second-column\"> <div class=\"card card-block\"> <a href=\"javascript:void(0)\">Acute Lymphoblastic Leukemia </a></div> </div> <div class=\"col-sm-3 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">BiTE<sup>\u00ae</sup> Molecule</a></div> </div> <div class=\"col-sm-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH3 \">3</span> </a>  </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-sm-8\"> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> BLINCYTO is an anti-CD19 x anti-CD3 BiTE (bispecific T cell engager) molecule. It is being investigated for the treatment of newly diagnosed adults and pediatric patients with B-Cell precursor Acute Lymphoblastic Leukemia (ALL).\n\n</p><p class=\"innerContentTitle\"><strong>ADDITIONAL CLINICAL STUDIES</strong></p>\n\n<p class=\"innterContentText\">Blinatumomab is also in Phase 1 development being investigated for subcutaneous administration for the treatment of adults with relapsed/refractory Acute Lymphoblastic Leukemia (ALL).</p> <p></p><label class=\"innerContentTitle\">ADDITIONAL INFORMATION</label> <ul class=\"customBreadcrumb\"> <li><a href=\"http://pi.amgen.com/united_states/blincyto/blincyto_pi_hcp_english.pdf\" target=\"_blank\" data-click-type=\"outbound\" data-click-text=\"Prescribing Information \">Prescribing Information <img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/arrow-long.png\"></a></li> </ul> </div> <div class=\"col-sm-4 pronunce-content\"> </div> </div> <p></p> </div> <div class=\"wrapper row\">  <div class=\"col-sm-4 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"><h4 class=\"panel-title\"><a href=\"javascript:void(0)\" data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span><span class=\"tarea-text\">Inflammation</span> </a> </h4> </div> </div>  </div>  <div class=\"col-sm-4 second-column\"> <div class=\"card card-block\"> <a href=\"javascript:void(0)\">Systemic Lupus Erythematosus with Nephritis </a></div> </div> <div class=\"col-sm-3 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">BiTE<sup>\u00ae</sup> Molecule</a></div> </div> <div class=\"col-sm-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH2 \">2</span> </a>  </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-sm-8\"> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> Blinatumomab is an anti-CD19 x anti-CD3 BiTE (bispecific T cell engager) molecule. It is being investigated as a treatment for patients with systemic lupus erythematosus with nephritis. </p><label class=\"innerContentTitle\">ADDITIONAL INFORMATION</label> <ul class=\"customBreadcrumb\"> <li><a href=\"http://pi.amgen.com/united_states/blincyto/blincyto_pi_hcp_english.pdf\" target=\"_blank\" data-click-type=\"outbound\" data-click-text=\"Prescribing Information \">Prescribing Information <img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/arrow-long.png\"></a></li> </ul> </div> <div class=\"col-sm-4 pronunce-content\"> </div> </div> <p></p> </div> <div class=\"wrapper row\">  <div class=\"col-sm-4 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"><h4 class=\"panel-title\"><a href=\"javascript:void(0)\" data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span><span class=\"tarea-text\">Inflammation</span> </a> </h4> </div> </div>  </div>  <div class=\"col-sm-4 second-column\"> <div class=\"card card-block\"> <a href=\"javascript:void(0)\">Refractory Rheumatoid Arthritis </a></div> </div> <div class=\"col-sm-3 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">BiTE<sup>\u00ae</sup> Molecule</a></div> </div> <div class=\"col-sm-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH2 \">2</span> </a>  </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-sm-8\"> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> Blinatumomab is an anti-CD19 x anti-CD3 BiTE (bispecific T cell engager) molecule. It is being investigated as a treatment for patients with refractory rheumatoid arthritis. </p><label class=\"innerContentTitle\">ADDITIONAL INFORMATION</label> <ul class=\"customBreadcrumb\"> <li><a href=\"http://pi.amgen.com/united_states/blincyto/blincyto_pi_hcp_english.pdf\" target=\"_blank\" data-click-type=\"outbound\" data-click-text=\"Prescribing Information \">Prescribing Information <img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/arrow-long.png\"></a></li> </ul> </div> <div class=\"col-sm-4 pronunce-content\"> </div> </div> <p></p> </div> </div> </div><div class=\"row collapsibleContent\"><div class=\"col-sm-3 border-right\" style=\"padding:0px !important\"><div class=\"textContent\"><p>DAZODALIBEP<br> <span></span></p> </div> </div> <div class=\"col-sm-9\" style=\"padding:0px !important\"> <div class=\"wrapper row\">  <div class=\"col-sm-4 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"><h4 class=\"panel-title\"><a href=\"javascript:void(0)\" data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span><span class=\"tarea-text\">Rare Disease</span> </a> </h4> </div> </div>  </div>  <div class=\"col-sm-4 second-column\"> <div class=\"card card-block\"> <a href=\"javascript:void(0)\">Sj\u00f6gren\u2019s Disease </a></div> </div> <div class=\"col-sm-3 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Fusion Protein</a></div> </div> <div class=\"col-sm-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH3 \">3</span> </a>  </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-sm-8\"> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> Dazodalibep is a fusion protein binding CD40L on T cells, blocking their interaction with CD40-expressing B cells. It is being investigated for the treatment of Sj\u00f6gren\u2019s disease. </p>  </div> <div class=\"col-sm-4 pronunce-content\"> </div> </div> <p></p> </div> </div> </div><div class=\"row collapsibleContent\"><div class=\"col-sm-3 border-right\" style=\"padding:0px !important\"><div class=\"textContent\"><p>EVENITY<sup>\u00ae</sup>\n\n<br> <span>(romosozumab-aqqg)</span></p> </div> </div> <div class=\"col-sm-9\" style=\"padding:0px !important\"> <div class=\"wrapper row\">  <div class=\"col-sm-4 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"><h4 class=\"panel-title\"><a href=\"javascript:void(0)\" data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span><span class=\"tarea-text\">Bone</span> </a> </h4> </div> </div>  </div>  <div class=\"col-sm-4 second-column\"> <div class=\"card card-block\"> <a href=\"javascript:void(0)\">Pediatric Osteogenesis Imperfecta </a></div> </div> <div class=\"col-sm-3 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Monoclonal Antibody</a></div> </div> <div class=\"col-sm-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH3 \">3</span> </a>  </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-sm-8\"> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> EVENITY is a monoclonal antibody that inhibits the action of sclerostin. It is being investigated for the treatment of osteogenesis imperfecta in pediatric patients. </p> <label class=\"innerContentTitle\">ADDITIONAL INFORMATION</label> <p class=\"innterContentText\">EVENITY is being developed in collaboration with UCB.</p> <ul class=\"customBreadcrumb\"> <li><a href=\"https://pi.amgen.com/united_states/evenity/evenity_pi_hcp_english.pdf\" target=\"_blank\" data-click-type=\"outbound\" data-click-text=\"Prescribing Information\">Prescribing Information<img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/arrow-long.png\"></a></li> </ul> </div> <div class=\"col-sm-4 pronunce-content\"> </div> </div> <p></p> </div> </div> </div><div class=\"row collapsibleContent\"><div class=\"col-sm-3 border-right\" style=\"padding:0px !important\"><div class=\"textContent\"><p>IMDELLTRA<sup>\u00ae</sup><br><span style=\"text-transform: lowercase !important;\">(tarlatamab-dlle)</span><br> <span></span></p> </div> </div> <div class=\"col-sm-9\" style=\"padding:0px !important\"> <div class=\"wrapper row\">  <div class=\"col-sm-4 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"><h4 class=\"panel-title\"><a href=\"javascript:void(0)\" data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span><span class=\"tarea-text\">Hematology / Oncology</span> </a> </h4> </div> </div>  </div>  <div class=\"col-sm-4 second-column\"> <div class=\"card card-block\"> <a href=\"javascript:void(0)\">Small Cell Lung Cancer </a></div> </div> <div class=\"col-sm-3 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">BiTE<sup>\u00ae</sup> Molecule</a></div> </div> <div class=\"col-sm-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH3 \">3</span> </a>  </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-sm-8\"> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> IMDELLTRA is an anti-delta-like ligand 3 (DLL3) x anti-CD3 bispecific T cell engager (BiTE) molecule. It is being investigated for the treatment of small cell lung cancer in limited-stage and extensive-stage settings.\n\n\n</p><p class=\"innerContentTitle\"><strong>ADDITIONAL CLINICAL STUDIES</strong></p>\n\n<p class=\"innterContentText\">IMDELLTRA is also being investigated in combination with other therapies. Tarlatamab is also being investigated in Phase 1 for subcutaneous administration and in Phase 2 for alternate dosing regimens for the treatment of small cell lung cancer.</p> <p></p><label class=\"innerContentTitle\">ADDITIONAL INFORMATION</label> <ul class=\"customBreadcrumb\"> <li><a href=\"https://www.pi.amgen.com/united_states/Imdelltra/Imdelltra_fpi.pdf\" target=\"_blank\" data-click-type=\"outbound\" data-click-text=\"Prescribing Information\">Prescribing Information<img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/arrow-long.png\"></a></li> </ul> </div> <div class=\"col-sm-4 pronunce-content\"> </div> </div> <p></p> </div> <div class=\"wrapper row\">  <div class=\"col-sm-4 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"><h4 class=\"panel-title\"><a href=\"javascript:void(0)\" data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span><span class=\"tarea-text\">Hematology / Oncology</span> </a> </h4> </div> </div>  </div>  <div class=\"col-sm-4 second-column\"> <div class=\"card card-block\"> <a href=\"javascript:void(0)\">Neuroendocrine Prostate Cancer </a></div> </div> <div class=\"col-sm-3 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">BiTE<sup>\u00ae</sup> Molecule</a></div> </div> <div class=\"col-sm-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH1 \">1</span> </a>  </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-sm-8\"> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> IMDELLTRA is an anti-delta-like ligand 3 (DLL3) x anti-CD3 bispecific T cell engager (BiTE) molecule. It is being investigated for the treatment of DLL3+ neuroendocrine prostate cancer. </p><label class=\"innerContentTitle\">ADDITIONAL INFORMATION</label> <ul class=\"customBreadcrumb\"> <li><a href=\"https://www.pi.amgen.com/united_states/Imdelltra/Imdelltra_fpi.pdf\" target=\"_blank\" data-click-type=\"outbound\" data-click-text=\"Prescribing Information\">Prescribing Information<img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/arrow-long.png\"></a></li> </ul> </div> <div class=\"col-sm-4 pronunce-content\"> </div> </div> <p></p> </div> </div> </div><div class=\"row collapsibleContent\"><div class=\"col-sm-3 border-right\" style=\"padding:0px !important\"><div class=\"textContent\"><p>LUMAKRAS<sup>\u00ae</sup><br><span style=\"text-transform: lowercase !important;\">(sotorasib)</span><br> <span></span></p> </div> </div> <div class=\"col-sm-9\" style=\"padding:0px !important\"> <div class=\"wrapper row\">  <div class=\"col-sm-4 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"><h4 class=\"panel-title\"><a href=\"javascript:void(0)\" data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span><span class=\"tarea-text\">Hematology / Oncology</span> </a> </h4> </div> </div>  </div>  <div class=\"col-sm-4 second-column\"> <div class=\"card card-block\"> <a href=\"javascript:void(0)\">Advanced Colorectal Cancer </a></div> </div> <div class=\"col-sm-3 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Small Molecule</a></div> </div> <div class=\"col-sm-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH3 \">3</span> </a>  </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-sm-8\"> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> LUMAKRAS is a KRAS G12C small molecule inhibitor under investigation for the treatment of previously treated advanced KRAS G12C-mutated colorectal cancer in combination with another therapy.\n\n</p><p class=\"innerContentTitle\"><strong>ADDITIONAL CLINICAL STUDIES</strong></p>\n\n<p class=\"innterContentText\">LUMAKRAS is also being investigated in newly diagnosed advanced KRAS G12C-mutated CRC in combination with other therapies.</p> <p></p> <label class=\"innerContentTitle\">ADDITIONAL INFORMATION</label> <p class=\"innterContentText\">\n\n</p> <ul class=\"customBreadcrumb\"> <li><a href=\"https://pi.amgen.com/united_states/lumakras/lumakras_pi_hcp_english.pdf\" target=\"_blank\" data-click-type=\"outbound\" data-click-text=\"Prescribing Information \">Prescribing Information <img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/arrow-long.png\"></a></li> </ul> </div> <div class=\"col-sm-4 pronunce-content\"> </div> </div> <p></p> </div> <div class=\"wrapper row\">  <div class=\"col-sm-4 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"><h4 class=\"panel-title\"><a href=\"javascript:void(0)\" data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span><span class=\"tarea-text\">Hematology / Oncology</span> </a> </h4> </div> </div>  </div>  <div class=\"col-sm-4 second-column\"> <div class=\"card card-block\"> <a href=\"javascript:void(0)\">Non-Small Cell Lung Cancer </a></div> </div> <div class=\"col-sm-3 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Small Molecule</a></div> </div> <div class=\"col-sm-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH3 \">3</span> </a>  </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-sm-8\"> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> LUMAKRAS is a KRAS G12C  small molecule inhibitor under investigation for the treatment of previously treated advanced KRAS G12C-mutated non-small cell lung cancer.\n\n</p><p class=\"innerContentTitle\"><strong>ADDITIONAL CLINICAL STUDIES</strong></p>\n<p class=\"innterContentText\">LUMAKRAS is also being investigated in newly diagnosed advanced KRAS G12C-mutated NSCLC in combination with other therapies.</p> <p></p> <label class=\"innerContentTitle\">ADDITIONAL INFORMATION</label> <p class=\"innterContentText\">\n\n\n</p> <ul class=\"customBreadcrumb\"> <li><a href=\"https://pi.amgen.com/united_states/lumakras/lumakras_pi_hcp_english.pdf\" target=\"_blank\" data-click-type=\"outbound\" data-click-text=\"Prescribing Information \">Prescribing Information <img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/arrow-long.png\"></a></li> </ul> </div> <div class=\"col-sm-4 pronunce-content\"> </div> </div> <p></p> </div> </div> </div><div class=\"row collapsibleContent\"><div class=\"col-sm-3 border-right\" style=\"padding:0px !important\"><div class=\"textContent\"><p>MARIDEBART CAFRAGLUTIDE<br><span style=\"text-transform: uppercase !important;\">(M</span><span style=\"text-transform: lowercase !important;\">ari</span><span style=\"text-transform: uppercase !important;\">T</span><span style=\"text-transform: lowercase !important;\">ide, formerly </span><span style=\"text-transform: uppercase !important;\">AMG 133</span><span style=\"text-transform: lowercase !important;\">)</span><br> <span></span></p> </div> </div> <div class=\"col-sm-9\" style=\"padding:0px !important\"> <div class=\"wrapper row\">  <div class=\"col-sm-4 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"><h4 class=\"panel-title\"><a href=\"javascript:void(0)\" data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span><span class=\"tarea-text\">Cardiometabolic</span> </a> </h4> </div> </div>  </div>  <div class=\"col-sm-4 second-column\"> <div class=\"card card-block\"> <a href=\"javascript:void(0)\">Obesity </a></div> </div> <div class=\"col-sm-3 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Peptide-Antibody Conjugate</a></div> </div> <div class=\"col-sm-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH3 \">3</span> </a>  </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-sm-8\"> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> Maridebart cafraglutide (MariTide, formerly AMG 133) is a peptide-antibody conjugate that activates the glucagon-like peptide 1 (GLP-1) receptor and antagonizes the glucose-dependent insulinotropic polypeptide receptor (GIPR). It is being investigated for the treatment of obesity. </p>  </div> <div class=\"col-sm-4 pronunce-content\"> </div> </div> <p></p> </div> <div class=\"wrapper row\">  <div class=\"col-sm-4 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"><h4 class=\"panel-title\"><a href=\"javascript:void(0)\" data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span><span class=\"tarea-text\">Cardiometabolic</span> </a> </h4> </div> </div>  </div>  <div class=\"col-sm-4 second-column\"> <div class=\"card card-block\"> <a href=\"javascript:void(0)\">Cardiovascular Disease </a></div> </div> <div class=\"col-sm-3 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Peptide-Antibody Conjugate</a></div> </div> <div class=\"col-sm-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH3 \">3</span> </a>  </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-sm-8\"> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> Maridebart cafraglutide (MariTide, formerly AMG 133) is a peptide-antibody conjugate that activates the glucagon-like peptide 1 (GLP-1) receptor and antagonizes the glucose-dependent insulinotropic polypeptide receptor (GIPR). It is being investigated as a treatment for the reduction in cardiovascular risk in adults with established atherosclerotic cardiovascular disease and obesity or overweight. </p>  </div> <div class=\"col-sm-4 pronunce-content\"> </div> </div> <p></p> </div> <div class=\"wrapper row\">  <div class=\"col-sm-4 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"><h4 class=\"panel-title\"><a href=\"javascript:void(0)\" data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span><span class=\"tarea-text\">Cardiometabolic</span> </a> </h4> </div> </div>  </div>  <div class=\"col-sm-4 second-column\"> <div class=\"card card-block\"> <a href=\"javascript:void(0)\">Heart Failure </a></div> </div> <div class=\"col-sm-3 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Peptide-Antibody Conjugate</a></div> </div> <div class=\"col-sm-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH3 \">3</span> </a>  </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-sm-8\"> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> Maridebart cafraglutide (MariTide, formerly AMG 133) is a peptide-antibody conjugate that activates the glucagon-like peptide 1 (GLP-1) receptor and antagonizes the glucose-dependent insulinotropic polypeptide receptor (GIPR). It is being investigated as a treatment for the reduction of heart failure events and cardiovascular risk in adults with heart failure with preserved or mildly reduced ejection fraction and obesity. </p>  </div> <div class=\"col-sm-4 pronunce-content\"> </div> </div> <p></p> </div> <div class=\"wrapper row\">  <div class=\"col-sm-4 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"><h4 class=\"panel-title\"><a href=\"javascript:void(0)\" data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span><span class=\"tarea-text\">Diabetes</span> </a> </h4> </div> </div>  </div>  <div class=\"col-sm-4 second-column\"> <div class=\"card card-block\"> <a href=\"javascript:void(0)\">Type 2 Diabetes </a></div> </div> <div class=\"col-sm-3 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Peptide-Antibody Conjugate</a></div> </div> <div class=\"col-sm-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH2 \">2</span> </a>  </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-sm-8\"> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> Maridebart cafraglutide (MariTide, formerly AMG 133) is a peptide-antibody conjugate that activates the glucagon-like peptide 1 (GLP-1) receptor and antagonizes the glucose-dependent insulinotropic polypeptide receptor (GIPR). It is being investigated for the treatment of Type 2 diabetes. </p>  </div> <div class=\"col-sm-4 pronunce-content\"> </div> </div> <p></p> </div> </div> </div><div class=\"row collapsibleContent\"><div class=\"col-sm-3 border-right\" style=\"padding:0px !important\"><div class=\"textContent\"><p>Nplate<sup>\u00ae</sup><br> <span>(romiplostim)</span></p> </div> </div> <div class=\"col-sm-9\" style=\"padding:0px !important\"> <div class=\"wrapper row\">  <div class=\"col-sm-4 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"><h4 class=\"panel-title\"><a href=\"javascript:void(0)\" data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span><span class=\"tarea-text\">Hematology / Oncology</span> </a> </h4> </div> </div>  </div>  <div class=\"col-sm-4 second-column\"> <div class=\"card card-block\"> <a href=\"javascript:void(0)\">Chemotherapy-Induced Thrombocytopenia </a></div> </div> <div class=\"col-sm-3 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Peptibody</a></div> </div> <div class=\"col-sm-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH3 \">3</span> </a>  </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-sm-8\"> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> Nplate<sup>&nbsp;</sup>is a thrombopoietin receptor agonist (TPO-RA).  It is being investigated for the treatment of chemotherapy-induced thrombocytopenia (CIT). </p><label class=\"innerContentTitle\">ADDITIONAL INFORMATION</label> <ul class=\"customBreadcrumb\"> <li><a href=\"http://pi.amgen.com/united_states/nplate/nplate_pi_hcp_english.pdf\" target=\"_blank\" data-click-type=\"outbound\" data-click-text=\"Prescribing Information\">Prescribing Information<img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/arrow-long.png\"></a></li> </ul> </div> <div class=\"col-sm-4 pronunce-content\"> </div> </div> <p></p> </div> </div> </div><div class=\"row collapsibleContent\"><div class=\"col-sm-3 border-right\" style=\"padding:0px !important\"><div class=\"textContent\"><p>OLPASIRAN<br>\n<span style=\"text-transform: lowercase !important;\">(formerly <span style=\"text-transform: uppercase !important;\">AMG</span> 890)</span><br> <span></span></p> </div> </div> <div class=\"col-sm-9\" style=\"padding:0px !important\"> <div class=\"wrapper row\">  <div class=\"col-sm-4 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"><h4 class=\"panel-title\"><a href=\"javascript:void(0)\" data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span><span class=\"tarea-text\">Cardiometabolic</span> </a> </h4> </div> </div>  </div>  <div class=\"col-sm-4 second-column\"> <div class=\"card card-block\"> <a href=\"javascript:void(0)\">Cardiovascular Disease </a></div> </div> <div class=\"col-sm-3 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">siRNA</a></div> </div> <div class=\"col-sm-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH3 \">3</span> </a>  </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-sm-8\"> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> Olpasiran (formerly AMG 890)  is a small interfering RNA (siRNA) that lowers lipoprotein(a), also known as Lp(a). It is being investigated for the treatment of atherosclerotic cardiovascular disease. </p>  </div> <div class=\"col-sm-4 pronunce-content\"> </div> </div> <p></p> </div> </div> </div><div class=\"row collapsibleContent\"><div class=\"col-sm-3 border-right\" style=\"padding:0px !important\"><div class=\"textContent\"><p>Otezla<sup>\u00ae</sup><br> <span>(apremilast)</span></p> </div> </div> <div class=\"col-sm-9\" style=\"padding:0px !important\"> <div class=\"wrapper row\">  <div class=\"col-sm-4 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"><h4 class=\"panel-title\"><a href=\"javascript:void(0)\" data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span><span class=\"tarea-text\">Inflammation</span> </a> </h4> </div> </div>  </div>  <div class=\"col-sm-4 second-column\"> <div class=\"card card-block\"> <a href=\"javascript:void(0)\">Juvenile Psoriatic Arthritis </a></div> </div> <div class=\"col-sm-3 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Small Molecule</a></div> </div> <div class=\"col-sm-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH3 \">3</span> </a>  </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-sm-8\"> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> Otezla is a small molecule that inhibits phosphodiesterase 4 (PDE4). It is being investigated for the treatment of juvenile psoriatic arthritis in pediatric patients. </p><label class=\"innerContentTitle\">ADDITIONAL INFORMATION</label> <ul class=\"customBreadcrumb\"> <li><a href=\"https://www.pi.amgen.com/united_states/otezla/otezla_pi_english.pdf\" target=\"_blank\" data-click-type=\"outbound\" data-click-text=\"Prescribing Information\">Prescribing Information<img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/arrow-long.png\"></a></li> </ul> </div> <div class=\"col-sm-4 pronunce-content\"> </div> </div> <p></p> </div> <div class=\"wrapper row\">  <div class=\"col-sm-4 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"><h4 class=\"panel-title\"><a href=\"javascript:void(0)\" data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span><span class=\"tarea-text\">Inflammation</span> </a> </h4> </div> </div>  </div>  <div class=\"col-sm-4 second-column\"> <div class=\"card card-block\"> <a href=\"javascript:void(0)\">Pediatric Behcet\u2019s Disease </a></div> </div> <div class=\"col-sm-3 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Small Molecule</a></div> </div> <div class=\"col-sm-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH3 \">3</span> </a>  </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-sm-8\"> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> Otezla is a small molecule that inhibits phosphodiesterase 4 (PDE4). It is being investigated for the treatment of Behcet\u2019s disease in pediatric patients. </p><label class=\"innerContentTitle\">ADDITIONAL INFORMATION</label> <ul class=\"customBreadcrumb\"> <li><a href=\"https://www.pi.amgen.com/united_states/otezla/otezla_pi_english.pdf\" target=\"_blank\" data-click-type=\"outbound\" data-click-text=\"Prescribing Information\">Prescribing Information<img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/arrow-long.png\"></a></li> </ul> </div> <div class=\"col-sm-4 pronunce-content\"> </div> </div> <p></p> </div> </div> </div><div class=\"row collapsibleContent\"><div class=\"col-sm-3 border-right\" style=\"padding:0px !important\"><div class=\"textContent\"><p>Parsabiv<sup>\u00ae</sup><br> <span>(etelcalcetide)</span></p> </div> </div> <div class=\"col-sm-9\" style=\"padding:0px !important\"> <div class=\"wrapper row\">  <div class=\"col-sm-4 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"><h4 class=\"panel-title\"><a href=\"javascript:void(0)\" data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span><span class=\"tarea-text\">Nephrology</span> </a> </h4> </div> </div>  </div>  <div class=\"col-sm-4 second-column\"> <div class=\"card card-block\"> <a href=\"javascript:void(0)\">Pediatric Secondary Hyperparathyroidism </a></div> </div> <div class=\"col-sm-3 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Peptide</a></div> </div> <div class=\"col-sm-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH3 \">3</span> </a>  </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-sm-8\"> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> Parsabiv is a calcium-sensing receptor agonist.  It is being investigated for the treatment of secondary hyperparathyroidism (HPT) in pediatric patients with chronic kidney disease (CKD) receiving hemodialysis. </p><label class=\"innerContentTitle\">ADDITIONAL INFORMATION</label> <ul class=\"customBreadcrumb\"> <li><a href=\"http://pi.amgen.com/united_states/parsabiv/parsabiv_pi.pdf\" target=\"_blank\" data-click-type=\"outbound\" data-click-text=\"Prescribing Information\">Prescribing Information<img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/arrow-long.png\"></a></li> </ul> </div> <div class=\"col-sm-4 pronunce-content\"> </div> </div> <p></p> </div> </div> </div><div class=\"row collapsibleContent\"><div class=\"col-sm-3 border-right\" style=\"padding:0px !important\"><div class=\"textContent\"><p>Repatha<sup>\u00ae</sup><br> <span>(evolocumab)</span></p> </div> </div> <div class=\"col-sm-9\" style=\"padding:0px !important\"> <div class=\"wrapper row\">  <div class=\"col-sm-4 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"><h4 class=\"panel-title\"><a href=\"javascript:void(0)\" data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span><span class=\"tarea-text\">Cardiometabolic</span> </a> </h4> </div> </div>  </div>  <div class=\"col-sm-4 second-column\"> <div class=\"card card-block\"> <a href=\"javascript:void(0)\">Hypercholesterolemia </a></div> </div> <div class=\"col-sm-3 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Monoclonal Antibody</a></div> </div> <div class=\"col-sm-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH3 \">3</span> </a>  </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-sm-8\"> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> Repatha is a monoclonal antibody that inhibits proprotein convertase subtilisin/kexin type 9 (PCSK9). It is being investigated in patients at high cardiovascular risk without a prior myocardial infarction or stroke. </p><label class=\"innerContentTitle\">ADDITIONAL INFORMATION</label> <ul class=\"customBreadcrumb\"> <li><a href=\"http://pi.amgen.com/united_states/repatha/repatha_pi_hcp_english.pdf\" target=\"_blank\" data-click-type=\"outbound\" data-click-text=\"Prescribing Information\">Prescribing Information<img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/arrow-long.png\"></a></li> </ul> </div> <div class=\"col-sm-4 pronunce-content\"> </div> </div> <p></p> </div> </div> </div><div class=\"row collapsibleContent\"><div class=\"col-sm-3 border-right\" style=\"padding:0px !important\"><div class=\"textContent\"><p>Rocatinlimab<br><span style=\"text-transform: lowercase !important;\">(formerly <span style=\"text-transform: uppercase !important;\">AMG 451 / KHK4083</span>)</span><br> <span></span></p> </div> </div> <div class=\"col-sm-9\" style=\"padding:0px !important\"> <div class=\"wrapper row\">  <div class=\"col-sm-4 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"><h4 class=\"panel-title\"><a href=\"javascript:void(0)\" data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span><span class=\"tarea-text\">Inflammation</span> </a> </h4> </div> </div>  </div>  <div class=\"col-sm-4 second-column\"> <div class=\"card card-block\"> <a href=\"javascript:void(0)\">Atopic Dermatitis </a></div> </div> <div class=\"col-sm-3 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Monoclonal Antibody</a></div> </div> <div class=\"col-sm-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH3 \">3</span> </a>  </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-sm-8\"> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> Rocatinlimab (formerly AMG 451 / KHK4083) is a T-cell rebalancing monoclonal antibody that inhibits and reduces pathogenic T-cells by targeting the OX40 receptor. It is being investigated for the treatment of moderate-to-severe atopic dermatitis. </p> <label class=\"innerContentTitle\">ADDITIONAL INFORMATION</label> <p class=\"innterContentText\">Rocatinlimab is being developed in collaboration with Kyowa Kirin Co., Ltd.</p>  </div> <div class=\"col-sm-4 pronunce-content\"> </div> </div> <p></p> </div> <div class=\"wrapper row\">  <div class=\"col-sm-4 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"><h4 class=\"panel-title\"><a href=\"javascript:void(0)\" data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span><span class=\"tarea-text\">Inflammation</span> </a> </h4> </div> </div>  </div>  <div class=\"col-sm-4 second-column\"> <div class=\"card card-block\"> <a href=\"javascript:void(0)\">Prurigo Nodularis </a></div> </div> <div class=\"col-sm-3 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Monoclonal Antibody</a></div> </div> <div class=\"col-sm-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH3 \">3</span> </a>  </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-sm-8\"> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> Rocatinlimab (formerly AMG 451 / KHK4083) is a T-cell rebalancing monoclonal antibody that inhibits and reduces pathogenic T-cells by targeting the OX40 receptor. It is being investigated for the treatment of prurigo nodularis. </p> <label class=\"innerContentTitle\">ADDITIONAL INFORMATION</label> <p class=\"innterContentText\">Rocatinlimab is being developed in collaboration with Kyowa Kirin Co., Ltd.</p>  </div> <div class=\"col-sm-4 pronunce-content\"> </div> </div> <p></p> </div> <div class=\"wrapper row\">  <div class=\"col-sm-4 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"><h4 class=\"panel-title\"><a href=\"javascript:void(0)\" data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span><span class=\"tarea-text\">Inflammation</span> </a> </h4> </div> </div>  </div>  <div class=\"col-sm-4 second-column\"> <div class=\"card card-block\"> <a href=\"javascript:void(0)\">Asthma </a></div> </div> <div class=\"col-sm-3 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Monoclonal Antibody</a></div> </div> <div class=\"col-sm-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH2 \">2</span> </a>  </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-sm-8\"> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> Rocatinlimab (formerly AMG 451 / KHK4083) is a T-cell rebalancing monoclonal antibody that inhibits and reduces pathogenic T-cells by targeting the OX40 receptor. It is being investigated for the treatment of moderate-to-severe asthma. </p> <label class=\"innerContentTitle\">ADDITIONAL INFORMATION</label> <p class=\"innterContentText\">Rocatinlimab is being developed in collaboration with Kyowa Kirin Co., Ltd.</p>  </div> <div class=\"col-sm-4 pronunce-content\"> </div> </div> <p></p> </div> </div> </div><div class=\"row collapsibleContent\"><div class=\"col-sm-3 border-right\" style=\"padding:0px !important\"><div class=\"textContent\"><p>TAVNEOS<sup>\u00ae</sup> <br><span style=\"text-transform: lowercase !important;\">(avacopan)</span><br> <span></span></p> </div> </div> <div class=\"col-sm-9\" style=\"padding:0px !important\"> <div class=\"wrapper row\">  <div class=\"col-sm-4 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"><h4 class=\"panel-title\"><a href=\"javascript:void(0)\" data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span><span class=\"tarea-text\">Rare Disease</span> </a> </h4> </div> </div>  </div>  <div class=\"col-sm-4 second-column\"> <div class=\"card card-block\"> <a href=\"javascript:void(0)\">Pediatric Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis </a></div> </div> <div class=\"col-sm-3 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Small Molecule</a></div> </div> <div class=\"col-sm-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH3 \">3</span> </a>  </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-sm-8\"> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> TAVNEOS is a complement 5a receptor 1 (C5aR1) antagonist that inhibits the effects of C5a.  It is being investigated for the treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA)) in pediatric patients.\n </p><label class=\"innerContentTitle\">ADDITIONAL INFORMATION</label> <ul class=\"customBreadcrumb\"> <li><a href=\"https://www.pi.amgen.com/-/media/Project/Amgen/Repository/pi-amgen-com/Tavneos/tavneos_fpi_english.pdf\" target=\"_blank\" data-click-type=\"outbound\" data-click-text=\"Prescribing Information\">Prescribing Information<img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/arrow-long.png\"></a></li> </ul> </div> <div class=\"col-sm-4 pronunce-content\"> </div> </div> <p></p> </div> </div> </div><div class=\"row collapsibleContent\"><div class=\"col-sm-3 border-right\" style=\"padding:0px !important\"><div class=\"textContent\"><p>TEPEZZA<sup>\u00ae</sup><br><span style=\"text-transform: lowercase !important;\">(teprotumumab-trbw)</span><br> <span></span></p> </div> </div> <div class=\"col-sm-9\" style=\"padding:0px !important\"> <div class=\"wrapper row\">  <div class=\"col-sm-4 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"><h4 class=\"panel-title\"><a href=\"javascript:void(0)\" data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span><span class=\"tarea-text\">Rare Disease</span> </a> </h4> </div> </div>  </div>  <div class=\"col-sm-4 second-column\"> <div class=\"card card-block\"> <a href=\"javascript:void(0)\">Thyroid Eye Disease </a></div> </div> <div class=\"col-sm-3 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Monoclonal Antibody</a></div> </div> <div class=\"col-sm-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH3 \">3</span> </a>  </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-sm-8\"> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> Teprotumumab is a monoclonal antibody against insulin-like growth factor-1 receptor (IGF-1R). It is being investigated for subcutaneous administration for the treatment of thyroid eye disease. </p><label class=\"innerContentTitle\">ADDITIONAL INFORMATION</label> <ul class=\"customBreadcrumb\"> <li><a href=\"https://www.hzndocs.com/TEPEZZA-Prescribing-Information.pdf\" target=\"_blank\" data-click-type=\"outbound\" data-click-text=\"Prescribing Information\">Prescribing Information<img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/arrow-long.png\"></a></li> </ul> </div> <div class=\"col-sm-4 pronunce-content\"> </div> </div> <p></p> </div> </div> </div><div class=\"row collapsibleContent\"><div class=\"col-sm-3 border-right\" style=\"padding:0px !important\"><div class=\"textContent\"><p>TEZSPIRE<sup>\u00ae</sup> <br><span style=\"text-transform: lowercase !important;\">(tezepelumab-ekko)</span><br> <span></span></p> </div> </div> <div class=\"col-sm-9\" style=\"padding:0px !important\"> <div class=\"wrapper row\">  <div class=\"col-sm-4 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"><h4 class=\"panel-title\"><a href=\"javascript:void(0)\" data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span><span class=\"tarea-text\">Inflammation</span> </a> </h4> </div> </div>  </div>  <div class=\"col-sm-4 second-column\"> <div class=\"card card-block\"> <a href=\"javascript:void(0)\">Chronic Obstructive Pulmonary Disease </a></div> </div> <div class=\"col-sm-3 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Monoclonal Antibody</a></div> </div> <div class=\"col-sm-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH3 \">3</span> </a>  </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-sm-8\"> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> TEZSPIRE is a monoclonal antibody that inhibits the action of the thymic stromal lymphopoietin (TSLP). It is being investigated for the treatment of chronic obstructive pulmonary disease (COPD). </p> <label class=\"innerContentTitle\">ADDITIONAL INFORMATION</label> <p class=\"innterContentText\">TEZSPIRE is being developed in collaboration with AstraZeneca plc.<br>\nIn July 2024, Amgen announced that the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy Designation to TEZSPIRE.</p> <ul class=\"customBreadcrumb\"> <li><a href=\"https://www.pi.amgen.com/united_states/tezspire/tezspire_pi_hcp_english.pdf\" target=\"_blank\" data-click-type=\"outbound\" data-click-text=\"Prescribing Information \">Prescribing Information <img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/arrow-long.png\"></a></li> </ul> </div> <div class=\"col-sm-4 pronunce-content\"> </div> </div> <p></p> </div> <div class=\"wrapper row\">  <div class=\"col-sm-4 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"><h4 class=\"panel-title\"><a href=\"javascript:void(0)\" data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span><span class=\"tarea-text\">Inflammation</span> </a> </h4> </div> </div>  </div>  <div class=\"col-sm-4 second-column\"> <div class=\"card card-block\"> <a href=\"javascript:void(0)\">Chronic Rhinosinusitis with Nasal Polyps </a></div> </div> <div class=\"col-sm-3 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Monoclonal Antibody</a></div> </div> <div class=\"col-sm-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH3 \">3</span> </a>  </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-sm-8\"> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> TEZSPIRE is a monoclonal antibody that inhibits the action of the thymic stromal lymphopoietin (TSLP). It is being investigated for the treatment of chronic rhinosinusitis with nasal polyps (CRSwNP). </p> <label class=\"innerContentTitle\">ADDITIONAL INFORMATION</label> <p class=\"innterContentText\">TEZSPIRE is being developed in collaboration with AstraZeneca plc.</p> <ul class=\"customBreadcrumb\"> <li><a href=\"https://www.pi.amgen.com/united_states/tezspire/tezspire_pi_hcp_english.pdf\" target=\"_blank\" data-click-type=\"outbound\" data-click-text=\"Prescribing Information \">Prescribing Information <img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/arrow-long.png\"></a></li> </ul> </div> <div class=\"col-sm-4 pronunce-content\"> </div> </div> <p></p> </div> <div class=\"wrapper row\">  <div class=\"col-sm-4 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"><h4 class=\"panel-title\"><a href=\"javascript:void(0)\" data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span><span class=\"tarea-text\">Inflammation</span> </a> </h4> </div> </div>  </div>  <div class=\"col-sm-4 second-column\"> <div class=\"card card-block\"> <a href=\"javascript:void(0)\">Eosinophilic Esophagitis </a></div> </div> <div class=\"col-sm-3 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Monoclonal Antibody</a></div> </div> <div class=\"col-sm-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH3 \">3</span> </a>  </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-sm-8\"> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> TEZSPIRE is a monoclonal antibody that inhibits the action of the thymic stromal lymphopoietin (TSLP). It is being investigated for the treatment of eosinophilic esophagitis (EoE). </p> <label class=\"innerContentTitle\">ADDITIONAL INFORMATION</label> <p class=\"innterContentText\">TEZSPIRE is being developed in collaboration with AstraZeneca plc.\n</p> <ul class=\"customBreadcrumb\"> <li><a href=\"https://www.pi.amgen.com/united_states/tezspire/tezspire_pi_hcp_english.pdf\" target=\"_blank\" data-click-type=\"outbound\" data-click-text=\"Prescribing Information \">Prescribing Information <img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/arrow-long.png\"></a></li> </ul> </div> <div class=\"col-sm-4 pronunce-content\"> </div> </div> <p></p> </div> </div> </div><div class=\"row collapsibleContent\"><div class=\"col-sm-3 border-right\" style=\"padding:0px !important\"><div class=\"textContent\"><p>UPLIZNA<sup>\u00ae</sup> <br><span style=\"text-transform: lowercase !important;\">(inebilizumab-cdon)</span><br> <span></span></p> </div> </div> <div class=\"col-sm-9\" style=\"padding:0px !important\"> <div class=\"wrapper row\">  <div class=\"col-sm-4 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"><h4 class=\"panel-title\"><a href=\"javascript:void(0)\" data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span><span class=\"tarea-text\">Rare Disease</span> </a> </h4> </div> </div>  </div>  <div class=\"col-sm-4 second-column\"> <div class=\"card card-block\"> <a href=\"javascript:void(0)\">IgG4-Related Disease </a></div> </div> <div class=\"col-sm-3 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Monoclonal Antibody</a></div> </div> <div class=\"col-sm-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH3 \">3</span> </a>  </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-sm-8\"> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> UPLIZNA is a humanized, affinity-optimized, afucosylated IgG1 kappa (IgG1\u03ba) monoclonal antibody that binds to the B cell-specific surface antigen CD19. It is being investigated for the prevention of flares in patients with IgG4-related disease. </p> <label class=\"innerContentTitle\">ADDITIONAL INFORMATION</label> <p class=\"innterContentText\">In September 2024, Amgen announced that the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy Designation to UPLIZNA in the treatment of IgG4-related disease.</p> <ul class=\"customBreadcrumb\"> <li><a href=\"https://www.hzndocs.com/Uplizna-Prescribing-Information.pdf\" target=\"_blank\" data-click-type=\"outbound\" data-click-text=\"Prescription Information\">Prescription Information<img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/arrow-long.png\"></a></li> </ul> </div> <div class=\"col-sm-4 pronunce-content\"> </div> </div> <p></p> </div> <div class=\"wrapper row\">  <div class=\"col-sm-4 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"><h4 class=\"panel-title\"><a href=\"javascript:void(0)\" data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span><span class=\"tarea-text\">Rare Disease</span> </a> </h4> </div> </div>  </div>  <div class=\"col-sm-4 second-column\"> <div class=\"card card-block\"> <a href=\"javascript:void(0)\">Generalized Myasthenia Gravis </a></div> </div> <div class=\"col-sm-3 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Monoclonal Antibody</a></div> </div> <div class=\"col-sm-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH3 \">3</span> </a>  </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-sm-8\"> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> UPLIZNA is a humanized, affinity-optimized, afucosylated IgG1 kappa (IgG1\u03ba) monoclonal antibody that binds to the B cell-specific surface antigen CD19. It is being investigated for improving outcomes in patients with generalized myasthenia gravis. </p><label class=\"innerContentTitle\">ADDITIONAL INFORMATION</label> <ul class=\"customBreadcrumb\"> <li><a href=\"https://www.hzndocs.com/Uplizna-Prescribing-Information.pdf\" target=\"_blank\" data-click-type=\"outbound\" data-click-text=\"Prescribing Information\">Prescribing Information<img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/arrow-long.png\"></a></li> </ul> </div> <div class=\"col-sm-4 pronunce-content\"> </div> </div> <p></p> </div> <div class=\"wrapper row\">  <div class=\"col-sm-4 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"><h4 class=\"panel-title\"><a href=\"javascript:void(0)\" data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span><span class=\"tarea-text\">Inflammation</span> </a> </h4> </div> </div>  </div>  <div class=\"col-sm-4 second-column\"> <div class=\"card card-block\"> <a href=\"javascript:void(0)\">Systemic Lupus Erythematosus with Nephritis </a></div> </div> <div class=\"col-sm-3 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Monoclonal Antibody</a></div> </div> <div class=\"col-sm-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH2 \">2</span> </a>  </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-sm-8\"> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> Inebilizumab is a humanized, affinity-optimized, afucosylated IgG1 kappa (IgG1\u03ba) monoclonal antibody that binds to the B cell-specific surface antigen CD19. It is being investigated as a treatment for patients with systemic lupus erythematosus with nephritis. </p><label class=\"innerContentTitle\">ADDITIONAL INFORMATION</label> <ul class=\"customBreadcrumb\"> <li><a href=\"https://www.hzndocs.com/Uplizna-Prescribing-Information.pdf\" target=\"_blank\" data-click-type=\"outbound\" data-click-text=\"Prescribing Information\">Prescribing Information<img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/arrow-long.png\"></a></li> </ul> </div> <div class=\"col-sm-4 pronunce-content\"> </div> </div> <p></p> </div> </div> </div><div class=\"row collapsibleContent\"><div class=\"col-sm-3 border-right\" style=\"padding:0px !important\"><div class=\"textContent\"><p>XALURITAMIG <br><span style=\"text-transform: lowercase !important;\">(formerly <span style=\"text-transform: uppercase !important;\">AMG</span> 509)</span><br> <span></span></p> </div> </div> <div class=\"col-sm-9\" style=\"padding:0px !important\"> <div class=\"wrapper row\">  <div class=\"col-sm-4 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"><h4 class=\"panel-title\"><a href=\"javascript:void(0)\" data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span><span class=\"tarea-text\">Hematology / Oncology</span> </a> </h4> </div> </div>  </div>  <div class=\"col-sm-4 second-column\"> <div class=\"card card-block\"> <a href=\"javascript:void(0)\">Prostate Cancer </a></div> </div> <div class=\"col-sm-3 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">XmAb<sup>\u00ae</sup> Antibody</a></div> </div> <div class=\"col-sm-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH3 \">3</span> </a>  </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-sm-8\"> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> Xaluritamig is an anti-six transmembrane epithelial antigen of the prostate 1 (STEAP1) x anti-CD3 XmAb<sup>\u00ae</sup> bispecific T cell engager molecule. It is being investigated for the treatment of prostate cancer.\n\n</p><p class=\"innerContentTitle\"><strong>ADDITIONAL CLINICAL STUDIES</strong></p>\n\n<p class=\"innterContentText\">Xaluritamig is also being investigated in combination with other therapies.</p>\n <p></p> <label class=\"innerContentTitle\">ADDITIONAL INFORMATION</label> <p class=\"innterContentText\">XmAb is a registered trademark of Xencor, Inc.</p>  </div> <div class=\"col-sm-4 pronunce-content\"> </div> </div> <p></p> </div> </div> </div><div class=\"row collapsibleContent\"><div class=\"col-sm-3 border-right\" style=\"padding:0px !important\"><div class=\"textContent\"><p>ABP 206<br> <span><span style=\"text-transform: none\">(Investigational biosimilar to OPDIVO<sup>\u00ae</sup> (nivolumab))</span></span></p> </div> </div> <div class=\"col-sm-9\" style=\"padding:0px !important\"> <div class=\"wrapper row\">  <div class=\"col-sm-4 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"><h4 class=\"panel-title\"><a href=\"javascript:void(0)\" data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span><span class=\"tarea-text\">Hematology / Oncology</span> </a> </h4> </div> </div>  </div>  <div class=\"col-sm-4 second-column\"> <div class=\"card card-block\"> <a href=\"javascript:void(0)\">Investigational Biosimilar </a></div> </div> <div class=\"col-sm-3 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Monoclonal Antibody</a></div> </div> <div class=\"col-sm-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH3 \">3</span> </a>  </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-sm-8\"> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> ABP 206 is an investigational biosimilar to OPDIVO (nivolumab), which is a monoclonal antibody that binds to the receptor protein called programmed death protein 1 (PD-1). </p> <label class=\"innerContentTitle\">ADDITIONAL INFORMATION</label> <p class=\"innterContentText\">OPDIVO is a registered trademark of Bristol-Myers Squibb Company.</p>  </div> <div class=\"col-sm-4 pronunce-content\"> </div> </div> <p></p> </div> </div> </div><div class=\"row collapsibleContent\"><div class=\"col-sm-3 border-right\" style=\"padding:0px !important\"><div class=\"textContent\"><p>ABP 234<br> <span><span style=\"text-transform: none\">(Investigational biosimilar to KEYTRUDA\u00ae (pembrolizumab))</span></span></p> </div> </div> <div class=\"col-sm-9\" style=\"padding:0px !important\"> <div class=\"wrapper row\">  <div class=\"col-sm-4 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"><h4 class=\"panel-title\"><a href=\"javascript:void(0)\" data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span><span class=\"tarea-text\">Hematology / Oncology</span> </a> </h4> </div> </div>  </div>  <div class=\"col-sm-4 second-column\"> <div class=\"card card-block\"> <a href=\"javascript:void(0)\">Investigational Biosimilar </a></div> </div> <div class=\"col-sm-3 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Monoclonal Antibody</a></div> </div> <div class=\"col-sm-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH3 \">3</span> </a>  </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-sm-8\"> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> ABP 234 is an investigational biosimilar to KEYTRUDA (pembrolizumab), which is a monoclonal antibody that binds to the receptor protein called programmed death protein 1 (PD-1). </p> <label class=\"innerContentTitle\">ADDITIONAL INFORMATION</label> <p class=\"innterContentText\">KEYTRUDA is a registered trademark of Merck &amp; Co.</p>  </div> <div class=\"col-sm-4 pronunce-content\"> </div> </div> <p></p> </div> </div> </div><div class=\"row collapsibleContent\"><div class=\"col-sm-3 border-right\" style=\"padding:0px !important\"><div class=\"textContent\"><p>ABP 692<br> <span><span style=\"text-transform: none\">(Investigational biosimilar to OCREVUS\u00ae (ocrelizumab))</span></span></p> </div> </div> <div class=\"col-sm-9\" style=\"padding:0px !important\"> <div class=\"wrapper row\">  <div class=\"col-sm-4 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"><h4 class=\"panel-title\"><a href=\"javascript:void(0)\" data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span><span class=\"tarea-text\">Inflammation</span> </a> </h4> </div> </div>  </div>  <div class=\"col-sm-4 second-column\"> <div class=\"card card-block\"> <a href=\"javascript:void(0)\">Investigational Biosimilar </a></div> </div> <div class=\"col-sm-3 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Monoclonal Antibody</a></div> </div> <div class=\"col-sm-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH3 \">3</span> </a>  </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-sm-8\"> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> ABP 692 is an investigational biosimilar to OCREVUS (ocrelizumab), which is a monoclonal antibody that binds to CD20, which is a protein found on the surface of B-cells. </p> <label class=\"innerContentTitle\">ADDITIONAL INFORMATION</label> <p class=\"innterContentText\">OCREVUS is a registered trademark of Genentech.</p>  </div> <div class=\"col-sm-4 pronunce-content\"> </div> </div> <p></p> </div> </div> </div><div class=\"row collapsibleContent\"><div class=\"col-sm-3 border-right\" style=\"padding:0px !important\"><div class=\"textContent\"><p>DAXDILIMAB<br> <span></span></p> </div> </div> <div class=\"col-sm-9\" style=\"padding:0px !important\"> <div class=\"wrapper row\">  <div class=\"col-sm-4 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"><h4 class=\"panel-title\"><a href=\"javascript:void(0)\" data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span><span class=\"tarea-text\">Rare Disease</span> </a> </h4> </div> </div>  </div>  <div class=\"col-sm-4 second-column\"> <div class=\"card card-block\"> <a href=\"javascript:void(0)\">Dermatomyositis and Anti-Synthetase Inflammatory Myositis </a></div> </div> <div class=\"col-sm-3 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Monoclonal Antibody</a></div> </div> <div class=\"col-sm-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH2 \">2</span> </a>  </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-sm-8\"> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> Daxdilimab is a fully human monoclonal antibody against ILT7 that depletes certain dendritic cells. It is being investigated for the treatment of dermatomyositis and anti-synthetase inflammatory myositis. </p>  </div> <div class=\"col-sm-4 pronunce-content\"> </div> </div> <p></p> </div> <div class=\"wrapper row\">  <div class=\"col-sm-4 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"><h4 class=\"panel-title\"><a href=\"javascript:void(0)\" data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span><span class=\"tarea-text\">Rare Disease</span> </a> </h4> </div> </div>  </div>  <div class=\"col-sm-4 second-column\"> <div class=\"card card-block\"> <a href=\"javascript:void(0)\">Discoid Lupus Erythematosus </a></div> </div> <div class=\"col-sm-3 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Monoclonal Antibody</a></div> </div> <div class=\"col-sm-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH2 \">2</span> </a>  </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-sm-8\"> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> Daxdilimab is a fully human monoclonal antibody against ILT7 that depletes certain dendritic cells. It is being investigated for the treatment of discoid lupus erythematosus. </p>  </div> <div class=\"col-sm-4 pronunce-content\"> </div> </div> <p></p> </div> </div> </div><div class=\"row collapsibleContent\"><div class=\"col-sm-3 border-right\" style=\"padding:0px !important\"><div class=\"textContent\"><p>KYPROLIS<sup>\u00ae</sup><br> <span>(carfilzomib)</span></p> </div> </div> <div class=\"col-sm-9\" style=\"padding:0px !important\"> <div class=\"wrapper row\">  <div class=\"col-sm-4 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"><h4 class=\"panel-title\"><a href=\"javascript:void(0)\" data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span><span class=\"tarea-text\">Hematology / Oncology</span> </a> </h4> </div> </div>  </div>  <div class=\"col-sm-4 second-column\"> <div class=\"card card-block\"> <a href=\"javascript:void(0)\">Pediatric Acute Lymphoblastic Leukemia </a></div> </div> <div class=\"col-sm-3 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Small Molecule</a></div> </div> <div class=\"col-sm-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH2 \">2</span> </a>  </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-sm-8\"> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> KYPROLIS is a small molecule proteasome inhibitor (PI). It is being investigated for the treatment of acute lymphoblastic leukemia (ALL) in pediatric patients. </p><label class=\"innerContentTitle\">ADDITIONAL INFORMATION</label> <ul class=\"customBreadcrumb\"> <li><a href=\"https://www.pi.amgen.com/~/media/amgen/repositorysites/pi-amgen-com/kyprolis/kyprolis_pi.pdf\" target=\"_blank\" data-click-type=\"outbound\" data-click-text=\"Prescribing Information\">Prescribing Information<img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/arrow-long.png\"></a></li> </ul> </div> <div class=\"col-sm-4 pronunce-content\"><label class=\"innerContentTitle\">PRONUNCIATION</label> <p> /car fil' zoe mib /<audio id=\"myAudio\"><source src=\"-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/pronunciation/kyprolis-carfilzomib.mp3\" type=\"audio/mpeg\"></audio><span class=\"audioIcon\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/audio.svg\"></span></p> </div> </div> <p></p> </div> </div> </div><div class=\"row collapsibleContent\"><div class=\"col-sm-3 border-right\" style=\"padding:0px !important\"><div class=\"textContent\"><p>ORDESEKIMAB**<br><span style=\"text-transform: lowercase !important;\">(formerly <span style=\"text-transform: uppercase !important;\">AMG 714 / PRV-015</span>)</span>\n<br> <span></span></p> </div> </div> <div class=\"col-sm-9\" style=\"padding:0px !important\"> <div class=\"wrapper row\">  <div class=\"col-sm-4 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"><h4 class=\"panel-title\"><a href=\"javascript:void(0)\" data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span><span class=\"tarea-text\">Inflammation</span> </a> </h4> </div> </div>  </div>  <div class=\"col-sm-4 second-column\"> <div class=\"card card-block\"> <a href=\"javascript:void(0)\">Celiac Disease </a></div> </div> <div class=\"col-sm-3 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Monoclonal Antibody</a></div> </div> <div class=\"col-sm-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH2 \">2</span> </a>  </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-sm-8\"> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> Ordesekimab (formerly AMG 714/PRV-015) is a monoclonal antibody that inhibits the action of Interleukin-15 (IL-15). It is being investigated for the treatment of non-responsive celiac disease as an adjunct to a gluten free diet. </p> <label class=\"innerContentTitle\">ADDITIONAL INFORMATION</label> <p class=\"innterContentText\">Ordesekimab is being developed in collaboration with Provention Bio, a Sanofi company.</p>  </div> <div class=\"col-sm-4 pronunce-content\"> </div> </div> <p></p> </div> </div> </div><div class=\"row collapsibleContent\"><div class=\"col-sm-3 border-right\" style=\"padding:0px !important\"><div class=\"textContent\"><p>AMG 104<br> <span></span></p> </div> </div> <div class=\"col-sm-9\" style=\"padding:0px !important\"> <div class=\"wrapper row\">  <div class=\"col-sm-4 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"><h4 class=\"panel-title\"><a href=\"javascript:void(0)\" data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span><span class=\"tarea-text\">Inflammation</span> </a> </h4> </div> </div>  </div>  <div class=\"col-sm-4 second-column\"> <div class=\"card card-block\"> <a href=\"javascript:void(0)\">Asthma </a></div> </div> <div class=\"col-sm-3 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Monoclonal Antibody</a></div> </div> <div class=\"col-sm-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH2 \">2</span> </a>  </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-sm-8\"> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> AMG 104 is a human anti-TSLP Fab. It is being investigated for the treatment of asthma. </p> <label class=\"innerContentTitle\">ADDITIONAL INFORMATION</label> <p class=\"innterContentText\">AMG 104 is being developed in collaboration with AstraZeneca plc.</p>  </div> <div class=\"col-sm-4 pronunce-content\"> </div> </div> <p></p> </div> </div> </div><div class=\"row collapsibleContent\"><div class=\"col-sm-3 border-right\" style=\"padding:0px !important\"><div class=\"textContent\"><p>AMG 193<br> <span></span></p> </div> </div> <div class=\"col-sm-9\" style=\"padding:0px !important\"> <div class=\"wrapper row\">  <div class=\"col-sm-4 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"><h4 class=\"panel-title\"><a href=\"javascript:void(0)\" data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span><span class=\"tarea-text\">Hematology / Oncology</span> </a> </h4> </div> </div>  </div>  <div class=\"col-sm-4 second-column\"> <div class=\"card card-block\"> <a href=\"javascript:void(0)\">Non-Small Cell Lung Cancer </a></div> </div> <div class=\"col-sm-3 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Small Molecule</a></div> </div> <div class=\"col-sm-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH2 \">2</span> </a>  </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-sm-8\"> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> AMG 193 is a small molecule methylthioadenosine (MTA) cooperative protein arginine methyltransferase 5 (PRMT5) inhibitor. It is being investigated for the treatment of non-small cell lung cancer.\n\n</p><p class=\"innerContentTitle\"><strong>ADDITIONAL CLINICAL STUDIES</strong></p>\n\n<p class=\"innterContentText\">AMG 193 is also in Phase 1 development for the treatment of non-small cell lung cancer in combination with other  therapies.</p> <p></p>  </div> <div class=\"col-sm-4 pronunce-content\"> </div> </div> <p></p> </div> <div class=\"wrapper row\">  <div class=\"col-sm-4 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"><h4 class=\"panel-title\"><a href=\"javascript:void(0)\" data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span><span class=\"tarea-text\">Hematology / Oncology</span> </a> </h4> </div> </div>  </div>  <div class=\"col-sm-4 second-column\"> <div class=\"card card-block\"> <a href=\"javascript:void(0)\">Other Tumors </a></div> </div> <div class=\"col-sm-3 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Small Molecule</a></div> </div> <div class=\"col-sm-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH1 \">1</span> </a>  </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-sm-8\"> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> AMG 193 is a small molecule methylthioadenosine (MTA) cooperative protein arginine methyltransferase 5 (PRMT5) inhibitor. It is being investigated for the treatment of solid tumors other than non-small cell lung cancer.\n\n</p><p class=\"innerContentTitle\"><strong>ADDITIONAL INFORMATION</strong></p>\n\n<p class=\"innterContentText\">AMG 193 is also in Phase 1 development for the treatment of solid tumors in combination with other therapies.</p> <p></p>  </div> <div class=\"col-sm-4 pronunce-content\"> </div> </div> <p></p> </div> </div> </div><div class=\"row collapsibleContent\"><div class=\"col-sm-3 border-right\" style=\"padding:0px !important\"><div class=\"textContent\"><p>AMG 329<br><span style=\"text-transform: lowercase !important;\">(formerly <span style=\"text-transform: uppercase !important;\">HZN-1116</span>)</span><br> <span></span></p> </div> </div> <div class=\"col-sm-9\" style=\"padding:0px !important\"> <div class=\"wrapper row\">  <div class=\"col-sm-4 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"><h4 class=\"panel-title\"><a href=\"javascript:void(0)\" data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span><span class=\"tarea-text\">Rare Disease</span> </a> </h4> </div> </div>  </div>  <div class=\"col-sm-4 second-column\"> <div class=\"card card-block\"> <a href=\"javascript:void(0)\">Sj\u00f6gren\u2019s Disease </a></div> </div> <div class=\"col-sm-3 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Monoclonal Antibody</a></div> </div> <div class=\"col-sm-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH2 \">2</span> </a>  </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-sm-8\"> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> AMG 329 is a fully human monoclonal antibody that binds and neutralizes the function of the FLT3-ligand, thereby reducing both conventional and plasmacytoid dendritic cells. It is being investigated for the treatment of Sj\u00f6gren's disease. </p>  </div> <div class=\"col-sm-4 pronunce-content\"> </div> </div> <p></p> </div> </div> </div><div class=\"row collapsibleContent\"><div class=\"col-sm-3 border-right\" style=\"padding:0px !important\"><div class=\"textContent\"><p>AMG 732<br><span style=\"text-transform: lowercase !important;\">(formerly <span style=\"text-transform: uppercase !important;\">HZN-280</span>)</span><br> <span></span></p> </div> </div> <div class=\"col-sm-9\" style=\"padding:0px !important\"> <div class=\"wrapper row\">  <div class=\"col-sm-4 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"><h4 class=\"panel-title\"><a href=\"javascript:void(0)\" data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span><span class=\"tarea-text\">Rare Disease</span> </a> </h4> </div> </div>  </div>  <div class=\"col-sm-4 second-column\"> <div class=\"card card-block\"> <a href=\"javascript:void(0)\">Thyroid Eye Disease </a></div> </div> <div class=\"col-sm-3 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Monoclonal Antibody</a></div> </div> <div class=\"col-sm-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH2 \">2</span> </a>  </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-sm-8\"> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> AMG 732 is a monoclonal antibody against insulin-like growth factor-1 receptor (IGF-1R). It is being investigated for the treatment of thyroid eye disease. </p>  </div> <div class=\"col-sm-4 pronunce-content\"> </div> </div> <p></p> </div> </div> </div><div class=\"row collapsibleContent\"><div class=\"col-sm-3 border-right\" style=\"padding:0px !important\"><div class=\"textContent\"><p>AMG 305<br> <span></span></p> </div> </div> <div class=\"col-sm-9\" style=\"padding:0px !important\"> <div class=\"wrapper row\">  <div class=\"col-sm-4 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"><h4 class=\"panel-title\"><a href=\"javascript:void(0)\" data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span><span class=\"tarea-text\">Hematology / Oncology</span> </a> </h4> </div> </div>  </div>  <div class=\"col-sm-4 second-column\"> <div class=\"card card-block\"> <a href=\"javascript:void(0)\">Solid Tumors </a></div> </div> <div class=\"col-sm-3 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">BiTE<sup>\u00ae</sup> Molecule</a></div> </div> <div class=\"col-sm-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH1 \">1</span> </a>  </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-sm-8\"> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> AMG 305 is a dual-targeting bispecific T cell engager (BiTE) molecule against P-cadherin (CDH3), mesothelin (MSLN) and CD3. It is being investigated for the treatment of solid tumors. </p>  </div> <div class=\"col-sm-4 pronunce-content\"> </div> </div> <p></p> </div> </div> </div><div class=\"row collapsibleContent\"><div class=\"col-sm-3 border-right\" style=\"padding:0px !important\"><div class=\"textContent\"><p>AMG 355<br> <span></span></p> </div> </div> <div class=\"col-sm-9\" style=\"padding:0px !important\"> <div class=\"wrapper row\">  <div class=\"col-sm-4 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"><h4 class=\"panel-title\"><a href=\"javascript:void(0)\" data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span><span class=\"tarea-text\">Hematology / Oncology</span> </a> </h4> </div> </div>  </div>  <div class=\"col-sm-4 second-column\"> <div class=\"card card-block\"> <a href=\"javascript:void(0)\">Solid Tumors </a></div> </div> <div class=\"col-sm-3 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Monoclonal Antibody</a></div> </div> <div class=\"col-sm-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH1 \">1</span> </a>  </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-sm-8\"> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> AMG 355 is an anti-CCR8 monoclonal antibody. It is being investigated for the treatment of advanced solid tumor malignancies. </p>  </div> <div class=\"col-sm-4 pronunce-content\"> </div> </div> <p></p> </div> </div> </div><div class=\"row collapsibleContent\"><div class=\"col-sm-3 border-right\" style=\"padding:0px !important\"><div class=\"textContent\"><p>AMG 378<br> <span></span></p> </div> </div> <div class=\"col-sm-9\" style=\"padding:0px !important\"> <div class=\"wrapper row\">  <div class=\"col-sm-4 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"><h4 class=\"panel-title\"><a href=\"javascript:void(0)\" data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span><span class=\"tarea-text\">Inflammation</span> </a> </h4> </div> </div>  </div>  <div class=\"col-sm-4 second-column\"> <div class=\"card card-block\"> <a href=\"javascript:void(0)\">Ulcerative Colitis </a></div> </div> <div class=\"col-sm-3 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Small Molecule</a></div> </div> <div class=\"col-sm-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH1 \">1</span> </a>  </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-sm-8\"> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> AMG 378 is a small molecule being investigated for the treatment of ulcerative colitis. </p>  </div> <div class=\"col-sm-4 pronunce-content\"> </div> </div> <p></p> </div> </div> </div><div class=\"row collapsibleContent\"><div class=\"col-sm-3 border-right\" style=\"padding:0px !important\"><div class=\"textContent\"><p>AMG 410<br> <span></span></p> </div> </div> <div class=\"col-sm-9\" style=\"padding:0px !important\"> <div class=\"wrapper row\">  <div class=\"col-sm-4 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"><h4 class=\"panel-title\"><a href=\"javascript:void(0)\" data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span><span class=\"tarea-text\">Hematology / Oncology</span> </a> </h4> </div> </div>  </div>  <div class=\"col-sm-4 second-column\"> <div class=\"card card-block\"> <a href=\"javascript:void(0)\">Solid Tumors </a></div> </div> <div class=\"col-sm-3 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Small Molecule</a></div> </div> <div class=\"col-sm-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH1 \">1</span> </a>  </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-sm-8\"> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> AMG 410 is a small molecule being investigated for the treatment of solid tumors. </p>  </div> <div class=\"col-sm-4 pronunce-content\"> </div> </div> <p></p> </div> </div> </div><div class=\"row collapsibleContent\"><div class=\"col-sm-3 border-right\" style=\"padding:0px !important\"><div class=\"textContent\"><p>AMG 513<br> <span></span></p> </div> </div> <div class=\"col-sm-9\" style=\"padding:0px !important\"> <div class=\"wrapper row\">  <div class=\"col-sm-4 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"><h4 class=\"panel-title\"><a href=\"javascript:void(0)\" data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span><span class=\"tarea-text\">Cardiometabolic</span> </a> </h4> </div> </div>  </div>  <div class=\"col-sm-4 second-column\"> <div class=\"card card-block\"> <a href=\"javascript:void(0)\">Obesity </a></div> </div> <div class=\"col-sm-3 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\"></a></div> </div> <div class=\"col-sm-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH1 \">1</span> </a>  </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-sm-8\"> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> AMG 513 is a molecule being investigated for the treatment of obesity. </p>  </div> <div class=\"col-sm-4 pronunce-content\"> </div> </div> <p></p> </div> </div> </div><div class=\"row collapsibleContent\"><div class=\"col-sm-3 border-right\" style=\"padding:0px !important\"><div class=\"textContent\"><p>AMG 691<br> <span></span></p> </div> </div> <div class=\"col-sm-9\" style=\"padding:0px !important\"> <div class=\"wrapper row\">  <div class=\"col-sm-4 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"><h4 class=\"panel-title\"><a href=\"javascript:void(0)\" data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span><span class=\"tarea-text\">Inflammation</span> </a> </h4> </div> </div>  </div>  <div class=\"col-sm-4 second-column\"> <div class=\"card card-block\"> <a href=\"javascript:void(0)\">Asthma </a></div> </div> <div class=\"col-sm-3 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Monoclonal Antibody</a></div> </div> <div class=\"col-sm-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH1 \">1</span> </a>  </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-sm-8\"> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> AMG 691 is a monoclonal antibody being investigated for the treatment of asthma. </p>  </div> <div class=\"col-sm-4 pronunce-content\"> </div> </div> <p></p> </div> </div> </div></div>\n            <div class=\"molecule-list-container mobile-view\"> <div class=\"row collapsibleContent\"> <div class=\"col-12 border-bottom\"> <div class=\"textContent\"> <p>Aimovig<sup>\u00ae</sup><br> <span>(erenumab-aooe)</span></p></div>  </div> <div class=\"col-12\"> <div class=\"wrapper row\">  <div class=\"col-1 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"> <h4 class=\"panel-title\"><a data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span> </a> </h4> </div> </div>  </div>  <div class=\"col-5 second-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Investigational Indication</a></div> </div> <div class=\"col-5 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Pediatric Migraine</a></div> </div> <div class=\"col-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH3 \">3</span></a> </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-12\"> <label class=\"innerContentTitle\">THERAPEUTIC AREA</label> <p class=\"innterContentText\"> Neuroscience </p> <label class=\"innerContentTitle\">MODALITY</label> <p class=\"innterContentText\"> Monoclonal Antibody </p> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> Aimovig is a monoclonal antibody that inhibits the calcitonin gene-related peptide receptor (CGRP-R). It is being investigated for the prevention of chronic and episodic migraine in pediatric patients.\n </p> <label class=\"innerContentTitle\">ADDITIONAL INFORMATION</label> <p class=\"innterContentText\">Aimovig is developed in collaboration with Novartis.</p> <ul class=\"customBreadcrumb\"> <li><a href=\"https://pi.amgen.com/united_states/Aimovig/Aimovig_pi_hcp_english.pdf\" target=\"_blank\" data-click-type=\"outbound\" data-click-text=\"Prescribing Information \">Prescribing Information <img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/arrow-long.png\"></a></li> </ul> </div> </div> <p></p> </div> </div> </div> <div class=\"row collapsibleContent\"> <div class=\"col-12 border-bottom\"> <div class=\"textContent\"> <p>BEMARITUZUMAB<br> <span></span></p></div>  </div> <div class=\"col-12\"> <div class=\"wrapper row\">  <div class=\"col-1 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"> <h4 class=\"panel-title\"><a data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span> </a> </h4> </div> </div>  </div>  <div class=\"col-5 second-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Investigational Indication</a></div> </div> <div class=\"col-5 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Gastric and Gastroesophageal Junction (GEJ) Cancers</a></div> </div> <div class=\"col-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH3 \">3</span></a> </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-12\"> <label class=\"innerContentTitle\">THERAPEUTIC AREA</label> <p class=\"innterContentText\"> Hematology / Oncology </p> <label class=\"innerContentTitle\">MODALITY</label> <p class=\"innterContentText\"> Monoclonal Antibody </p> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> Bemarituzumab is a monoclonal antibody that inhibits fibroblast growth factor receptor 2b (FGFR2b). It is being investigated for the treatment of advanced Gastric and Gastroesophageal Junction (GEJ) Cancers. </p> <label class=\"innerContentTitle\">ADDITIONAL INFORMATION</label> <p class=\"innterContentText\">In April 2021, Amgen announced that the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy Designation for bemarituzumab.\n\n\n</p><p class=\"innerContentTitle\"><strong>ADDITIONAL CLINICAL STUDIES</strong></p>\n\n<p class=\"innterContentText\">Bemarituzumab is also in Phase 1 and Phase 2 development for the treatment of advanced Gastric and Gastroesophageal cancers in combination with other therapies.</p><p></p>  </div> </div> <p></p> </div> <div class=\"wrapper row\">  <div class=\"col-1 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"> <h4 class=\"panel-title\"><a data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span> </a> </h4> </div> </div>  </div>  <div class=\"col-5 second-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Investigational Indication</a></div> </div> <div class=\"col-5 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Other Tumors</a></div> </div> <div class=\"col-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH2 \">2</span></a> </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-12\"> <label class=\"innerContentTitle\">THERAPEUTIC AREA</label> <p class=\"innterContentText\"> Hematology / Oncology </p> <label class=\"innerContentTitle\">MODALITY</label> <p class=\"innterContentText\"> Monoclonal Antibody </p> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> Bemarituzumab is a monoclonal antibody that inhibits fibroblast growth factor receptor 2b (FGFR2b). It is being investigated for the treatment of advanced solid tumors other than advanced squamous non-small cell lung cancer. </p>  </div> </div> <p></p> </div> </div> </div> <div class=\"row collapsibleContent\"> <div class=\"col-12 border-bottom\"> <div class=\"textContent\"> <p>BLINCYTO<sup>\u00ae</sup><br> <span>(blinatumomab)</span></p></div>  </div> <div class=\"col-12\"> <div class=\"wrapper row\">  <div class=\"col-1 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"> <h4 class=\"panel-title\"><a data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span> </a> </h4> </div> </div>  </div>  <div class=\"col-5 second-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Investigational Indication</a></div> </div> <div class=\"col-5 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Acute Lymphoblastic Leukemia</a></div> </div> <div class=\"col-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH3 \">3</span></a> </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-12\"> <label class=\"innerContentTitle\">THERAPEUTIC AREA</label> <p class=\"innterContentText\"> Hematology / Oncology </p> <label class=\"innerContentTitle\">MODALITY</label> <p class=\"innterContentText\"> BiTE<sup>\u00ae</sup> Molecule </p> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> BLINCYTO is an anti-CD19 x anti-CD3 BiTE (bispecific T cell engager) molecule. It is being investigated for the treatment of newly diagnosed adults and pediatric patients with B-Cell precursor Acute Lymphoblastic Leukemia (ALL).\n\n</p><p class=\"innerContentTitle\"><strong>ADDITIONAL CLINICAL STUDIES</strong></p>\n\n<p class=\"innterContentText\">Blinatumomab is also in Phase 1 development being investigated for subcutaneous administration for the treatment of adults with relapsed/refractory Acute Lymphoblastic Leukemia (ALL).</p> <p></p><label class=\"innerContentTitle\">ADDITIONAL INFORMATION</label> <ul class=\"customBreadcrumb\"> <li><a href=\"http://pi.amgen.com/united_states/blincyto/blincyto_pi_hcp_english.pdf\" target=\"_blank\" data-click-type=\"outbound\" data-click-text=\"Prescribing Information \">Prescribing Information <img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/arrow-long.png\"></a></li> </ul> </div> </div> <p></p> </div> <div class=\"wrapper row\">  <div class=\"col-1 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"> <h4 class=\"panel-title\"><a data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span> </a> </h4> </div> </div>  </div>  <div class=\"col-5 second-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Investigational Indication</a></div> </div> <div class=\"col-5 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Systemic Lupus Erythematosus with Nephritis</a></div> </div> <div class=\"col-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH2 \">2</span></a> </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-12\"> <label class=\"innerContentTitle\">THERAPEUTIC AREA</label> <p class=\"innterContentText\"> Inflammation </p> <label class=\"innerContentTitle\">MODALITY</label> <p class=\"innterContentText\"> BiTE<sup>\u00ae</sup> Molecule </p> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> Blinatumomab is an anti-CD19 x anti-CD3 BiTE (bispecific T cell engager) molecule. It is being investigated as a treatment for patients with systemic lupus erythematosus with nephritis. </p><label class=\"innerContentTitle\">ADDITIONAL INFORMATION</label> <ul class=\"customBreadcrumb\"> <li><a href=\"http://pi.amgen.com/united_states/blincyto/blincyto_pi_hcp_english.pdf\" target=\"_blank\" data-click-type=\"outbound\" data-click-text=\"Prescribing Information \">Prescribing Information <img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/arrow-long.png\"></a></li> </ul> </div> </div> <p></p> </div> <div class=\"wrapper row\">  <div class=\"col-1 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"> <h4 class=\"panel-title\"><a data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span> </a> </h4> </div> </div>  </div>  <div class=\"col-5 second-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Investigational Indication</a></div> </div> <div class=\"col-5 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Refractory Rheumatoid Arthritis</a></div> </div> <div class=\"col-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH2 \">2</span></a> </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-12\"> <label class=\"innerContentTitle\">THERAPEUTIC AREA</label> <p class=\"innterContentText\"> Inflammation </p> <label class=\"innerContentTitle\">MODALITY</label> <p class=\"innterContentText\"> BiTE<sup>\u00ae</sup> Molecule </p> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> Blinatumomab is an anti-CD19 x anti-CD3 BiTE (bispecific T cell engager) molecule. It is being investigated as a treatment for patients with refractory rheumatoid arthritis. </p><label class=\"innerContentTitle\">ADDITIONAL INFORMATION</label> <ul class=\"customBreadcrumb\"> <li><a href=\"http://pi.amgen.com/united_states/blincyto/blincyto_pi_hcp_english.pdf\" target=\"_blank\" data-click-type=\"outbound\" data-click-text=\"Prescribing Information \">Prescribing Information <img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/arrow-long.png\"></a></li> </ul> </div> </div> <p></p> </div> </div> </div> <div class=\"row collapsibleContent\"> <div class=\"col-12 border-bottom\"> <div class=\"textContent\"> <p>DAZODALIBEP<br> <span></span></p></div>  </div> <div class=\"col-12\"> <div class=\"wrapper row\">  <div class=\"col-1 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"> <h4 class=\"panel-title\"><a data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span> </a> </h4> </div> </div>  </div>  <div class=\"col-5 second-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Investigational Indication</a></div> </div> <div class=\"col-5 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Sj\u00f6gren\u2019s Disease</a></div> </div> <div class=\"col-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH3 \">3</span></a> </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-12\"> <label class=\"innerContentTitle\">THERAPEUTIC AREA</label> <p class=\"innterContentText\"> Rare Disease </p> <label class=\"innerContentTitle\">MODALITY</label> <p class=\"innterContentText\"> Fusion Protein </p> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> Dazodalibep is a fusion protein binding CD40L on T cells, blocking their interaction with CD40-expressing B cells. It is being investigated for the treatment of Sj\u00f6gren\u2019s disease. </p>  </div> </div> <p></p> </div> </div> </div> <div class=\"row collapsibleContent\"> <div class=\"col-12 border-bottom\"> <div class=\"textContent\"> <p>EVENITY<sup>\u00ae</sup>\n\n<br> <span>(romosozumab-aqqg)</span></p></div>  </div> <div class=\"col-12\"> <div class=\"wrapper row\">  <div class=\"col-1 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"> <h4 class=\"panel-title\"><a data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span> </a> </h4> </div> </div>  </div>  <div class=\"col-5 second-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Investigational Indication</a></div> </div> <div class=\"col-5 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Pediatric Osteogenesis Imperfecta</a></div> </div> <div class=\"col-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH3 \">3</span></a> </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-12\"> <label class=\"innerContentTitle\">THERAPEUTIC AREA</label> <p class=\"innterContentText\"> Bone </p> <label class=\"innerContentTitle\">MODALITY</label> <p class=\"innterContentText\"> Monoclonal Antibody </p> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> EVENITY is a monoclonal antibody that inhibits the action of sclerostin. It is being investigated for the treatment of osteogenesis imperfecta in pediatric patients. </p> <label class=\"innerContentTitle\">ADDITIONAL INFORMATION</label> <p class=\"innterContentText\">EVENITY is being developed in collaboration with UCB.</p> <ul class=\"customBreadcrumb\"> <li><a href=\"https://pi.amgen.com/united_states/evenity/evenity_pi_hcp_english.pdf\" target=\"_blank\" data-click-type=\"outbound\" data-click-text=\"Prescribing Information\">Prescribing Information<img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/arrow-long.png\"></a></li> </ul> </div> </div> <p></p> </div> </div> </div> <div class=\"row collapsibleContent\"> <div class=\"col-12 border-bottom\"> <div class=\"textContent\"> <p>IMDELLTRA<sup>\u00ae</sup><br><span style=\"text-transform: lowercase !important;\">(tarlatamab-dlle)</span><br> <span></span></p></div>  </div> <div class=\"col-12\"> <div class=\"wrapper row\">  <div class=\"col-1 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"> <h4 class=\"panel-title\"><a data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span> </a> </h4> </div> </div>  </div>  <div class=\"col-5 second-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Investigational Indication</a></div> </div> <div class=\"col-5 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Small Cell Lung Cancer</a></div> </div> <div class=\"col-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH3 \">3</span></a> </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-12\"> <label class=\"innerContentTitle\">THERAPEUTIC AREA</label> <p class=\"innterContentText\"> Hematology / Oncology </p> <label class=\"innerContentTitle\">MODALITY</label> <p class=\"innterContentText\"> BiTE<sup>\u00ae</sup> Molecule </p> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> IMDELLTRA is an anti-delta-like ligand 3 (DLL3) x anti-CD3 bispecific T cell engager (BiTE) molecule. It is being investigated for the treatment of small cell lung cancer in limited-stage and extensive-stage settings.\n\n\n</p><p class=\"innerContentTitle\"><strong>ADDITIONAL CLINICAL STUDIES</strong></p>\n\n<p class=\"innterContentText\">IMDELLTRA is also being investigated in combination with other therapies. Tarlatamab is also being investigated in Phase 1 for subcutaneous administration and in Phase 2 for alternate dosing regimens for the treatment of small cell lung cancer.</p> <p></p><label class=\"innerContentTitle\">ADDITIONAL INFORMATION</label> <ul class=\"customBreadcrumb\"> <li><a href=\"https://www.pi.amgen.com/united_states/Imdelltra/Imdelltra_fpi.pdf\" target=\"_blank\" data-click-type=\"outbound\" data-click-text=\"Prescribing Information\">Prescribing Information<img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/arrow-long.png\"></a></li> </ul> </div> </div> <p></p> </div> <div class=\"wrapper row\">  <div class=\"col-1 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"> <h4 class=\"panel-title\"><a data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span> </a> </h4> </div> </div>  </div>  <div class=\"col-5 second-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Investigational Indication</a></div> </div> <div class=\"col-5 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Neuroendocrine Prostate Cancer</a></div> </div> <div class=\"col-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH1 \">1</span></a> </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-12\"> <label class=\"innerContentTitle\">THERAPEUTIC AREA</label> <p class=\"innterContentText\"> Hematology / Oncology </p> <label class=\"innerContentTitle\">MODALITY</label> <p class=\"innterContentText\"> BiTE<sup>\u00ae</sup> Molecule </p> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> IMDELLTRA is an anti-delta-like ligand 3 (DLL3) x anti-CD3 bispecific T cell engager (BiTE) molecule. It is being investigated for the treatment of DLL3+ neuroendocrine prostate cancer. </p><label class=\"innerContentTitle\">ADDITIONAL INFORMATION</label> <ul class=\"customBreadcrumb\"> <li><a href=\"https://www.pi.amgen.com/united_states/Imdelltra/Imdelltra_fpi.pdf\" target=\"_blank\" data-click-type=\"outbound\" data-click-text=\"Prescribing Information\">Prescribing Information<img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/arrow-long.png\"></a></li> </ul> </div> </div> <p></p> </div> </div> </div> <div class=\"row collapsibleContent\"> <div class=\"col-12 border-bottom\"> <div class=\"textContent\"> <p>LUMAKRAS<sup>\u00ae</sup><br><span style=\"text-transform: lowercase !important;\">(sotorasib)</span><br> <span></span></p></div>  </div> <div class=\"col-12\"> <div class=\"wrapper row\">  <div class=\"col-1 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"> <h4 class=\"panel-title\"><a data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span> </a> </h4> </div> </div>  </div>  <div class=\"col-5 second-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Investigational Indication</a></div> </div> <div class=\"col-5 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Advanced Colorectal Cancer</a></div> </div> <div class=\"col-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH3 \">3</span></a> </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-12\"> <label class=\"innerContentTitle\">THERAPEUTIC AREA</label> <p class=\"innterContentText\"> Hematology / Oncology </p> <label class=\"innerContentTitle\">MODALITY</label> <p class=\"innterContentText\"> Small Molecule </p> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> LUMAKRAS is a KRAS G12C small molecule inhibitor under investigation for the treatment of previously treated advanced KRAS G12C-mutated colorectal cancer in combination with another therapy.\n\n</p><p class=\"innerContentTitle\"><strong>ADDITIONAL CLINICAL STUDIES</strong></p>\n\n<p class=\"innterContentText\">LUMAKRAS is also being investigated in newly diagnosed advanced KRAS G12C-mutated CRC in combination with other therapies.</p> <p></p> <label class=\"innerContentTitle\">ADDITIONAL INFORMATION</label> <p class=\"innterContentText\">\n\n</p> <ul class=\"customBreadcrumb\"> <li><a href=\"https://pi.amgen.com/united_states/lumakras/lumakras_pi_hcp_english.pdf\" target=\"_blank\" data-click-type=\"outbound\" data-click-text=\"Prescribing Information \">Prescribing Information <img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/arrow-long.png\"></a></li> </ul> </div> </div> <p></p> </div> <div class=\"wrapper row\">  <div class=\"col-1 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"> <h4 class=\"panel-title\"><a data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span> </a> </h4> </div> </div>  </div>  <div class=\"col-5 second-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Investigational Indication</a></div> </div> <div class=\"col-5 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Non-Small Cell Lung Cancer</a></div> </div> <div class=\"col-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH3 \">3</span></a> </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-12\"> <label class=\"innerContentTitle\">THERAPEUTIC AREA</label> <p class=\"innterContentText\"> Hematology / Oncology </p> <label class=\"innerContentTitle\">MODALITY</label> <p class=\"innterContentText\"> Small Molecule </p> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> LUMAKRAS is a KRAS G12C  small molecule inhibitor under investigation for the treatment of previously treated advanced KRAS G12C-mutated non-small cell lung cancer.\n\n</p><p class=\"innerContentTitle\"><strong>ADDITIONAL CLINICAL STUDIES</strong></p>\n<p class=\"innterContentText\">LUMAKRAS is also being investigated in newly diagnosed advanced KRAS G12C-mutated NSCLC in combination with other therapies.</p> <p></p> <label class=\"innerContentTitle\">ADDITIONAL INFORMATION</label> <p class=\"innterContentText\">\n\n\n</p> <ul class=\"customBreadcrumb\"> <li><a href=\"https://pi.amgen.com/united_states/lumakras/lumakras_pi_hcp_english.pdf\" target=\"_blank\" data-click-type=\"outbound\" data-click-text=\"Prescribing Information \">Prescribing Information <img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/arrow-long.png\"></a></li> </ul> </div> </div> <p></p> </div> </div> </div> <div class=\"row collapsibleContent\"> <div class=\"col-12 border-bottom\"> <div class=\"textContent\"> <p>MARIDEBART CAFRAGLUTIDE<br><span style=\"text-transform: uppercase !important;\">(M</span><span style=\"text-transform: lowercase !important;\">ari</span><span style=\"text-transform: uppercase !important;\">T</span><span style=\"text-transform: lowercase !important;\">ide, formerly </span><span style=\"text-transform: uppercase !important;\">AMG 133</span><span style=\"text-transform: lowercase !important;\">)</span><br> <span></span></p></div>  </div> <div class=\"col-12\"> <div class=\"wrapper row\">  <div class=\"col-1 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"> <h4 class=\"panel-title\"><a data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span> </a> </h4> </div> </div>  </div>  <div class=\"col-5 second-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Investigational Indication</a></div> </div> <div class=\"col-5 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Obesity</a></div> </div> <div class=\"col-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH3 \">3</span></a> </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-12\"> <label class=\"innerContentTitle\">THERAPEUTIC AREA</label> <p class=\"innterContentText\"> Cardiometabolic </p> <label class=\"innerContentTitle\">MODALITY</label> <p class=\"innterContentText\"> Peptide-Antibody Conjugate </p> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> Maridebart cafraglutide (MariTide, formerly AMG 133) is a peptide-antibody conjugate that activates the glucagon-like peptide 1 (GLP-1) receptor and antagonizes the glucose-dependent insulinotropic polypeptide receptor (GIPR). It is being investigated for the treatment of obesity. </p>  </div> </div> <p></p> </div> <div class=\"wrapper row\">  <div class=\"col-1 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"> <h4 class=\"panel-title\"><a data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span> </a> </h4> </div> </div>  </div>  <div class=\"col-5 second-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Investigational Indication</a></div> </div> <div class=\"col-5 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Cardiovascular Disease</a></div> </div> <div class=\"col-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH3 \">3</span></a> </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-12\"> <label class=\"innerContentTitle\">THERAPEUTIC AREA</label> <p class=\"innterContentText\"> Cardiometabolic </p> <label class=\"innerContentTitle\">MODALITY</label> <p class=\"innterContentText\"> Peptide-Antibody Conjugate </p> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> Maridebart cafraglutide (MariTide, formerly AMG 133) is a peptide-antibody conjugate that activates the glucagon-like peptide 1 (GLP-1) receptor and antagonizes the glucose-dependent insulinotropic polypeptide receptor (GIPR). It is being investigated as a treatment for the reduction in cardiovascular risk in adults with established atherosclerotic cardiovascular disease and obesity or overweight. </p>  </div> </div> <p></p> </div> <div class=\"wrapper row\">  <div class=\"col-1 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"> <h4 class=\"panel-title\"><a data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span> </a> </h4> </div> </div>  </div>  <div class=\"col-5 second-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Investigational Indication</a></div> </div> <div class=\"col-5 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Heart Failure</a></div> </div> <div class=\"col-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH3 \">3</span></a> </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-12\"> <label class=\"innerContentTitle\">THERAPEUTIC AREA</label> <p class=\"innterContentText\"> Cardiometabolic </p> <label class=\"innerContentTitle\">MODALITY</label> <p class=\"innterContentText\"> Peptide-Antibody Conjugate </p> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> Maridebart cafraglutide (MariTide, formerly AMG 133) is a peptide-antibody conjugate that activates the glucagon-like peptide 1 (GLP-1) receptor and antagonizes the glucose-dependent insulinotropic polypeptide receptor (GIPR). It is being investigated as a treatment for the reduction of heart failure events and cardiovascular risk in adults with heart failure with preserved or mildly reduced ejection fraction and obesity. </p>  </div> </div> <p></p> </div> <div class=\"wrapper row\">  <div class=\"col-1 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"> <h4 class=\"panel-title\"><a data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span> </a> </h4> </div> </div>  </div>  <div class=\"col-5 second-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Investigational Indication</a></div> </div> <div class=\"col-5 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Type 2 Diabetes</a></div> </div> <div class=\"col-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH2 \">2</span></a> </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-12\"> <label class=\"innerContentTitle\">THERAPEUTIC AREA</label> <p class=\"innterContentText\"> Diabetes </p> <label class=\"innerContentTitle\">MODALITY</label> <p class=\"innterContentText\"> Peptide-Antibody Conjugate </p> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> Maridebart cafraglutide (MariTide, formerly AMG 133) is a peptide-antibody conjugate that activates the glucagon-like peptide 1 (GLP-1) receptor and antagonizes the glucose-dependent insulinotropic polypeptide receptor (GIPR). It is being investigated for the treatment of Type 2 diabetes. </p>  </div> </div> <p></p> </div> </div> </div> <div class=\"row collapsibleContent\"> <div class=\"col-12 border-bottom\"> <div class=\"textContent\"> <p>Nplate<sup>\u00ae</sup><br> <span>(romiplostim)</span></p></div>  </div> <div class=\"col-12\"> <div class=\"wrapper row\">  <div class=\"col-1 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"> <h4 class=\"panel-title\"><a data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span> </a> </h4> </div> </div>  </div>  <div class=\"col-5 second-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Investigational Indication</a></div> </div> <div class=\"col-5 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Chemotherapy-Induced Thrombocytopenia</a></div> </div> <div class=\"col-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH3 \">3</span></a> </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-12\"> <label class=\"innerContentTitle\">THERAPEUTIC AREA</label> <p class=\"innterContentText\"> Hematology / Oncology </p> <label class=\"innerContentTitle\">MODALITY</label> <p class=\"innterContentText\"> Peptibody </p> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> Nplate<sup>&nbsp;</sup>is a thrombopoietin receptor agonist (TPO-RA).  It is being investigated for the treatment of chemotherapy-induced thrombocytopenia (CIT). </p><label class=\"innerContentTitle\">ADDITIONAL INFORMATION</label> <ul class=\"customBreadcrumb\"> <li><a href=\"http://pi.amgen.com/united_states/nplate/nplate_pi_hcp_english.pdf\" target=\"_blank\" data-click-type=\"outbound\" data-click-text=\"Prescribing Information\">Prescribing Information<img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/arrow-long.png\"></a></li> </ul> </div> </div> <p></p> </div> </div> </div> <div class=\"row collapsibleContent\"> <div class=\"col-12 border-bottom\"> <div class=\"textContent\"> <p>OLPASIRAN<br>\n<span style=\"text-transform: lowercase !important;\">(formerly <span style=\"text-transform: uppercase !important;\">AMG</span> 890)</span><br> <span></span></p></div>  </div> <div class=\"col-12\"> <div class=\"wrapper row\">  <div class=\"col-1 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"> <h4 class=\"panel-title\"><a data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span> </a> </h4> </div> </div>  </div>  <div class=\"col-5 second-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Investigational Indication</a></div> </div> <div class=\"col-5 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Cardiovascular Disease</a></div> </div> <div class=\"col-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH3 \">3</span></a> </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-12\"> <label class=\"innerContentTitle\">THERAPEUTIC AREA</label> <p class=\"innterContentText\"> Cardiometabolic </p> <label class=\"innerContentTitle\">MODALITY</label> <p class=\"innterContentText\"> siRNA </p> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> Olpasiran (formerly AMG 890)  is a small interfering RNA (siRNA) that lowers lipoprotein(a), also known as Lp(a). It is being investigated for the treatment of atherosclerotic cardiovascular disease. </p>  </div> </div> <p></p> </div> </div> </div> <div class=\"row collapsibleContent\"> <div class=\"col-12 border-bottom\"> <div class=\"textContent\"> <p>Otezla<sup>\u00ae</sup><br> <span>(apremilast)</span></p></div>  </div> <div class=\"col-12\"> <div class=\"wrapper row\">  <div class=\"col-1 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"> <h4 class=\"panel-title\"><a data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span> </a> </h4> </div> </div>  </div>  <div class=\"col-5 second-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Investigational Indication</a></div> </div> <div class=\"col-5 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Juvenile Psoriatic Arthritis</a></div> </div> <div class=\"col-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH3 \">3</span></a> </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-12\"> <label class=\"innerContentTitle\">THERAPEUTIC AREA</label> <p class=\"innterContentText\"> Inflammation </p> <label class=\"innerContentTitle\">MODALITY</label> <p class=\"innterContentText\"> Small Molecule </p> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> Otezla is a small molecule that inhibits phosphodiesterase 4 (PDE4). It is being investigated for the treatment of juvenile psoriatic arthritis in pediatric patients. </p><label class=\"innerContentTitle\">ADDITIONAL INFORMATION</label> <ul class=\"customBreadcrumb\"> <li><a href=\"https://www.pi.amgen.com/united_states/otezla/otezla_pi_english.pdf\" target=\"_blank\" data-click-type=\"outbound\" data-click-text=\"Prescribing Information\">Prescribing Information<img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/arrow-long.png\"></a></li> </ul> </div> </div> <p></p> </div> <div class=\"wrapper row\">  <div class=\"col-1 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"> <h4 class=\"panel-title\"><a data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span> </a> </h4> </div> </div>  </div>  <div class=\"col-5 second-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Investigational Indication</a></div> </div> <div class=\"col-5 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Pediatric Behcet\u2019s Disease</a></div> </div> <div class=\"col-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH3 \">3</span></a> </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-12\"> <label class=\"innerContentTitle\">THERAPEUTIC AREA</label> <p class=\"innterContentText\"> Inflammation </p> <label class=\"innerContentTitle\">MODALITY</label> <p class=\"innterContentText\"> Small Molecule </p> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> Otezla is a small molecule that inhibits phosphodiesterase 4 (PDE4). It is being investigated for the treatment of Behcet\u2019s disease in pediatric patients. </p><label class=\"innerContentTitle\">ADDITIONAL INFORMATION</label> <ul class=\"customBreadcrumb\"> <li><a href=\"https://www.pi.amgen.com/united_states/otezla/otezla_pi_english.pdf\" target=\"_blank\" data-click-type=\"outbound\" data-click-text=\"Prescribing Information\">Prescribing Information<img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/arrow-long.png\"></a></li> </ul> </div> </div> <p></p> </div> </div> </div> <div class=\"row collapsibleContent\"> <div class=\"col-12 border-bottom\"> <div class=\"textContent\"> <p>Parsabiv<sup>\u00ae</sup><br> <span>(etelcalcetide)</span></p></div>  </div> <div class=\"col-12\"> <div class=\"wrapper row\">  <div class=\"col-1 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"> <h4 class=\"panel-title\"><a data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span> </a> </h4> </div> </div>  </div>  <div class=\"col-5 second-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Investigational Indication</a></div> </div> <div class=\"col-5 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Pediatric Secondary Hyperparathyroidism</a></div> </div> <div class=\"col-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH3 \">3</span></a> </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-12\"> <label class=\"innerContentTitle\">THERAPEUTIC AREA</label> <p class=\"innterContentText\"> Nephrology </p> <label class=\"innerContentTitle\">MODALITY</label> <p class=\"innterContentText\"> Peptide </p> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> Parsabiv is a calcium-sensing receptor agonist.  It is being investigated for the treatment of secondary hyperparathyroidism (HPT) in pediatric patients with chronic kidney disease (CKD) receiving hemodialysis. </p><label class=\"innerContentTitle\">ADDITIONAL INFORMATION</label> <ul class=\"customBreadcrumb\"> <li><a href=\"http://pi.amgen.com/united_states/parsabiv/parsabiv_pi.pdf\" target=\"_blank\" data-click-type=\"outbound\" data-click-text=\"Prescribing Information\">Prescribing Information<img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/arrow-long.png\"></a></li> </ul> </div> </div> <p></p> </div> </div> </div> <div class=\"row collapsibleContent\"> <div class=\"col-12 border-bottom\"> <div class=\"textContent\"> <p>Repatha<sup>\u00ae</sup><br> <span>(evolocumab)</span></p></div>  </div> <div class=\"col-12\"> <div class=\"wrapper row\">  <div class=\"col-1 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"> <h4 class=\"panel-title\"><a data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span> </a> </h4> </div> </div>  </div>  <div class=\"col-5 second-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Investigational Indication</a></div> </div> <div class=\"col-5 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Hypercholesterolemia</a></div> </div> <div class=\"col-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH3 \">3</span></a> </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-12\"> <label class=\"innerContentTitle\">THERAPEUTIC AREA</label> <p class=\"innterContentText\"> Cardiometabolic </p> <label class=\"innerContentTitle\">MODALITY</label> <p class=\"innterContentText\"> Monoclonal Antibody </p> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> Repatha is a monoclonal antibody that inhibits proprotein convertase subtilisin/kexin type 9 (PCSK9). It is being investigated in patients at high cardiovascular risk without a prior myocardial infarction or stroke. </p><label class=\"innerContentTitle\">ADDITIONAL INFORMATION</label> <ul class=\"customBreadcrumb\"> <li><a href=\"http://pi.amgen.com/united_states/repatha/repatha_pi_hcp_english.pdf\" target=\"_blank\" data-click-type=\"outbound\" data-click-text=\"Prescribing Information\">Prescribing Information<img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/arrow-long.png\"></a></li> </ul> </div> </div> <p></p> </div> </div> </div> <div class=\"row collapsibleContent\"> <div class=\"col-12 border-bottom\"> <div class=\"textContent\"> <p>Rocatinlimab<br><span style=\"text-transform: lowercase !important;\">(formerly <span style=\"text-transform: uppercase !important;\">AMG 451 / KHK4083</span>)</span><br> <span></span></p></div>  </div> <div class=\"col-12\"> <div class=\"wrapper row\">  <div class=\"col-1 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"> <h4 class=\"panel-title\"><a data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span> </a> </h4> </div> </div>  </div>  <div class=\"col-5 second-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Investigational Indication</a></div> </div> <div class=\"col-5 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Atopic Dermatitis</a></div> </div> <div class=\"col-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH3 \">3</span></a> </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-12\"> <label class=\"innerContentTitle\">THERAPEUTIC AREA</label> <p class=\"innterContentText\"> Inflammation </p> <label class=\"innerContentTitle\">MODALITY</label> <p class=\"innterContentText\"> Monoclonal Antibody </p> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> Rocatinlimab (formerly AMG 451 / KHK4083) is a T-cell rebalancing monoclonal antibody that inhibits and reduces pathogenic T-cells by targeting the OX40 receptor. It is being investigated for the treatment of moderate-to-severe atopic dermatitis. </p> <label class=\"innerContentTitle\">ADDITIONAL INFORMATION</label> <p class=\"innterContentText\">Rocatinlimab is being developed in collaboration with Kyowa Kirin Co., Ltd.</p>  </div> </div> <p></p> </div> <div class=\"wrapper row\">  <div class=\"col-1 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"> <h4 class=\"panel-title\"><a data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span> </a> </h4> </div> </div>  </div>  <div class=\"col-5 second-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Investigational Indication</a></div> </div> <div class=\"col-5 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Prurigo Nodularis</a></div> </div> <div class=\"col-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH3 \">3</span></a> </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-12\"> <label class=\"innerContentTitle\">THERAPEUTIC AREA</label> <p class=\"innterContentText\"> Inflammation </p> <label class=\"innerContentTitle\">MODALITY</label> <p class=\"innterContentText\"> Monoclonal Antibody </p> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> Rocatinlimab (formerly AMG 451 / KHK4083) is a T-cell rebalancing monoclonal antibody that inhibits and reduces pathogenic T-cells by targeting the OX40 receptor. It is being investigated for the treatment of prurigo nodularis. </p> <label class=\"innerContentTitle\">ADDITIONAL INFORMATION</label> <p class=\"innterContentText\">Rocatinlimab is being developed in collaboration with Kyowa Kirin Co., Ltd.</p>  </div> </div> <p></p> </div> <div class=\"wrapper row\">  <div class=\"col-1 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"> <h4 class=\"panel-title\"><a data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span> </a> </h4> </div> </div>  </div>  <div class=\"col-5 second-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Investigational Indication</a></div> </div> <div class=\"col-5 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Asthma</a></div> </div> <div class=\"col-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH2 \">2</span></a> </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-12\"> <label class=\"innerContentTitle\">THERAPEUTIC AREA</label> <p class=\"innterContentText\"> Inflammation </p> <label class=\"innerContentTitle\">MODALITY</label> <p class=\"innterContentText\"> Monoclonal Antibody </p> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> Rocatinlimab (formerly AMG 451 / KHK4083) is a T-cell rebalancing monoclonal antibody that inhibits and reduces pathogenic T-cells by targeting the OX40 receptor. It is being investigated for the treatment of moderate-to-severe asthma. </p> <label class=\"innerContentTitle\">ADDITIONAL INFORMATION</label> <p class=\"innterContentText\">Rocatinlimab is being developed in collaboration with Kyowa Kirin Co., Ltd.</p>  </div> </div> <p></p> </div> </div> </div> <div class=\"row collapsibleContent\"> <div class=\"col-12 border-bottom\"> <div class=\"textContent\"> <p>TAVNEOS<sup>\u00ae</sup> <br><span style=\"text-transform: lowercase !important;\">(avacopan)</span><br> <span></span></p></div>  </div> <div class=\"col-12\"> <div class=\"wrapper row\">  <div class=\"col-1 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"> <h4 class=\"panel-title\"><a data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span> </a> </h4> </div> </div>  </div>  <div class=\"col-5 second-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Investigational Indication</a></div> </div> <div class=\"col-5 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Pediatric Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis</a></div> </div> <div class=\"col-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH3 \">3</span></a> </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-12\"> <label class=\"innerContentTitle\">THERAPEUTIC AREA</label> <p class=\"innterContentText\"> Rare Disease </p> <label class=\"innerContentTitle\">MODALITY</label> <p class=\"innterContentText\"> Small Molecule </p> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> TAVNEOS is a complement 5a receptor 1 (C5aR1) antagonist that inhibits the effects of C5a.  It is being investigated for the treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA)) in pediatric patients.\n </p><label class=\"innerContentTitle\">ADDITIONAL INFORMATION</label> <ul class=\"customBreadcrumb\"> <li><a href=\"https://www.pi.amgen.com/-/media/Project/Amgen/Repository/pi-amgen-com/Tavneos/tavneos_fpi_english.pdf\" target=\"_blank\" data-click-type=\"outbound\" data-click-text=\"Prescribing Information\">Prescribing Information<img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/arrow-long.png\"></a></li> </ul> </div> </div> <p></p> </div> </div> </div> <div class=\"row collapsibleContent\"> <div class=\"col-12 border-bottom\"> <div class=\"textContent\"> <p>TEPEZZA<sup>\u00ae</sup><br><span style=\"text-transform: lowercase !important;\">(teprotumumab-trbw)</span><br> <span></span></p></div>  </div> <div class=\"col-12\"> <div class=\"wrapper row\">  <div class=\"col-1 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"> <h4 class=\"panel-title\"><a data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span> </a> </h4> </div> </div>  </div>  <div class=\"col-5 second-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Investigational Indication</a></div> </div> <div class=\"col-5 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Thyroid Eye Disease</a></div> </div> <div class=\"col-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH3 \">3</span></a> </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-12\"> <label class=\"innerContentTitle\">THERAPEUTIC AREA</label> <p class=\"innterContentText\"> Rare Disease </p> <label class=\"innerContentTitle\">MODALITY</label> <p class=\"innterContentText\"> Monoclonal Antibody </p> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> Teprotumumab is a monoclonal antibody against insulin-like growth factor-1 receptor (IGF-1R). It is being investigated for subcutaneous administration for the treatment of thyroid eye disease. </p><label class=\"innerContentTitle\">ADDITIONAL INFORMATION</label> <ul class=\"customBreadcrumb\"> <li><a href=\"https://www.hzndocs.com/TEPEZZA-Prescribing-Information.pdf\" target=\"_blank\" data-click-type=\"outbound\" data-click-text=\"Prescribing Information\">Prescribing Information<img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/arrow-long.png\"></a></li> </ul> </div> </div> <p></p> </div> </div> </div> <div class=\"row collapsibleContent\"> <div class=\"col-12 border-bottom\"> <div class=\"textContent\"> <p>TEZSPIRE<sup>\u00ae</sup> <br><span style=\"text-transform: lowercase !important;\">(tezepelumab-ekko)</span><br> <span></span></p></div>  </div> <div class=\"col-12\"> <div class=\"wrapper row\">  <div class=\"col-1 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"> <h4 class=\"panel-title\"><a data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span> </a> </h4> </div> </div>  </div>  <div class=\"col-5 second-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Investigational Indication</a></div> </div> <div class=\"col-5 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Chronic Obstructive Pulmonary Disease</a></div> </div> <div class=\"col-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH3 \">3</span></a> </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-12\"> <label class=\"innerContentTitle\">THERAPEUTIC AREA</label> <p class=\"innterContentText\"> Inflammation </p> <label class=\"innerContentTitle\">MODALITY</label> <p class=\"innterContentText\"> Monoclonal Antibody </p> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> TEZSPIRE is a monoclonal antibody that inhibits the action of the thymic stromal lymphopoietin (TSLP). It is being investigated for the treatment of chronic obstructive pulmonary disease (COPD). </p> <label class=\"innerContentTitle\">ADDITIONAL INFORMATION</label> <p class=\"innterContentText\">TEZSPIRE is being developed in collaboration with AstraZeneca plc.<br>\nIn July 2024, Amgen announced that the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy Designation to TEZSPIRE.</p> <ul class=\"customBreadcrumb\"> <li><a href=\"https://www.pi.amgen.com/united_states/tezspire/tezspire_pi_hcp_english.pdf\" target=\"_blank\" data-click-type=\"outbound\" data-click-text=\"Prescribing Information \">Prescribing Information <img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/arrow-long.png\"></a></li> </ul> </div> </div> <p></p> </div> <div class=\"wrapper row\">  <div class=\"col-1 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"> <h4 class=\"panel-title\"><a data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span> </a> </h4> </div> </div>  </div>  <div class=\"col-5 second-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Investigational Indication</a></div> </div> <div class=\"col-5 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Chronic Rhinosinusitis with Nasal Polyps</a></div> </div> <div class=\"col-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH3 \">3</span></a> </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-12\"> <label class=\"innerContentTitle\">THERAPEUTIC AREA</label> <p class=\"innterContentText\"> Inflammation </p> <label class=\"innerContentTitle\">MODALITY</label> <p class=\"innterContentText\"> Monoclonal Antibody </p> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> TEZSPIRE is a monoclonal antibody that inhibits the action of the thymic stromal lymphopoietin (TSLP). It is being investigated for the treatment of chronic rhinosinusitis with nasal polyps (CRSwNP). </p> <label class=\"innerContentTitle\">ADDITIONAL INFORMATION</label> <p class=\"innterContentText\">TEZSPIRE is being developed in collaboration with AstraZeneca plc.</p> <ul class=\"customBreadcrumb\"> <li><a href=\"https://www.pi.amgen.com/united_states/tezspire/tezspire_pi_hcp_english.pdf\" target=\"_blank\" data-click-type=\"outbound\" data-click-text=\"Prescribing Information \">Prescribing Information <img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/arrow-long.png\"></a></li> </ul> </div> </div> <p></p> </div> <div class=\"wrapper row\">  <div class=\"col-1 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"> <h4 class=\"panel-title\"><a data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span> </a> </h4> </div> </div>  </div>  <div class=\"col-5 second-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Investigational Indication</a></div> </div> <div class=\"col-5 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Eosinophilic Esophagitis</a></div> </div> <div class=\"col-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH3 \">3</span></a> </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-12\"> <label class=\"innerContentTitle\">THERAPEUTIC AREA</label> <p class=\"innterContentText\"> Inflammation </p> <label class=\"innerContentTitle\">MODALITY</label> <p class=\"innterContentText\"> Monoclonal Antibody </p> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> TEZSPIRE is a monoclonal antibody that inhibits the action of the thymic stromal lymphopoietin (TSLP). It is being investigated for the treatment of eosinophilic esophagitis (EoE). </p> <label class=\"innerContentTitle\">ADDITIONAL INFORMATION</label> <p class=\"innterContentText\">TEZSPIRE is being developed in collaboration with AstraZeneca plc.\n</p> <ul class=\"customBreadcrumb\"> <li><a href=\"https://www.pi.amgen.com/united_states/tezspire/tezspire_pi_hcp_english.pdf\" target=\"_blank\" data-click-type=\"outbound\" data-click-text=\"Prescribing Information \">Prescribing Information <img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/arrow-long.png\"></a></li> </ul> </div> </div> <p></p> </div> </div> </div> <div class=\"row collapsibleContent\"> <div class=\"col-12 border-bottom\"> <div class=\"textContent\"> <p>UPLIZNA<sup>\u00ae</sup> <br><span style=\"text-transform: lowercase !important;\">(inebilizumab-cdon)</span><br> <span></span></p></div>  </div> <div class=\"col-12\"> <div class=\"wrapper row\">  <div class=\"col-1 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"> <h4 class=\"panel-title\"><a data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span> </a> </h4> </div> </div>  </div>  <div class=\"col-5 second-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Investigational Indication</a></div> </div> <div class=\"col-5 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">IgG4-Related Disease</a></div> </div> <div class=\"col-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH3 \">3</span></a> </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-12\"> <label class=\"innerContentTitle\">THERAPEUTIC AREA</label> <p class=\"innterContentText\"> Rare Disease </p> <label class=\"innerContentTitle\">MODALITY</label> <p class=\"innterContentText\"> Monoclonal Antibody </p> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> UPLIZNA is a humanized, affinity-optimized, afucosylated IgG1 kappa (IgG1\u03ba) monoclonal antibody that binds to the B cell-specific surface antigen CD19. It is being investigated for the prevention of flares in patients with IgG4-related disease. </p> <label class=\"innerContentTitle\">ADDITIONAL INFORMATION</label> <p class=\"innterContentText\">In September 2024, Amgen announced that the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy Designation to UPLIZNA in the treatment of IgG4-related disease.</p> <ul class=\"customBreadcrumb\"> <li><a href=\"https://www.hzndocs.com/Uplizna-Prescribing-Information.pdf\" target=\"_blank\" data-click-type=\"outbound\" data-click-text=\"Prescription Information\">Prescription Information<img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/arrow-long.png\"></a></li> </ul> </div> </div> <p></p> </div> <div class=\"wrapper row\">  <div class=\"col-1 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"> <h4 class=\"panel-title\"><a data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span> </a> </h4> </div> </div>  </div>  <div class=\"col-5 second-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Investigational Indication</a></div> </div> <div class=\"col-5 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Generalized Myasthenia Gravis</a></div> </div> <div class=\"col-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH3 \">3</span></a> </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-12\"> <label class=\"innerContentTitle\">THERAPEUTIC AREA</label> <p class=\"innterContentText\"> Rare Disease </p> <label class=\"innerContentTitle\">MODALITY</label> <p class=\"innterContentText\"> Monoclonal Antibody </p> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> UPLIZNA is a humanized, affinity-optimized, afucosylated IgG1 kappa (IgG1\u03ba) monoclonal antibody that binds to the B cell-specific surface antigen CD19. It is being investigated for improving outcomes in patients with generalized myasthenia gravis. </p><label class=\"innerContentTitle\">ADDITIONAL INFORMATION</label> <ul class=\"customBreadcrumb\"> <li><a href=\"https://www.hzndocs.com/Uplizna-Prescribing-Information.pdf\" target=\"_blank\" data-click-type=\"outbound\" data-click-text=\"Prescribing Information\">Prescribing Information<img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/arrow-long.png\"></a></li> </ul> </div> </div> <p></p> </div> <div class=\"wrapper row\">  <div class=\"col-1 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"> <h4 class=\"panel-title\"><a data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span> </a> </h4> </div> </div>  </div>  <div class=\"col-5 second-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Investigational Indication</a></div> </div> <div class=\"col-5 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Systemic Lupus Erythematosus with Nephritis</a></div> </div> <div class=\"col-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH2 \">2</span></a> </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-12\"> <label class=\"innerContentTitle\">THERAPEUTIC AREA</label> <p class=\"innterContentText\"> Inflammation </p> <label class=\"innerContentTitle\">MODALITY</label> <p class=\"innterContentText\"> Monoclonal Antibody </p> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> Inebilizumab is a humanized, affinity-optimized, afucosylated IgG1 kappa (IgG1\u03ba) monoclonal antibody that binds to the B cell-specific surface antigen CD19. It is being investigated as a treatment for patients with systemic lupus erythematosus with nephritis. </p><label class=\"innerContentTitle\">ADDITIONAL INFORMATION</label> <ul class=\"customBreadcrumb\"> <li><a href=\"https://www.hzndocs.com/Uplizna-Prescribing-Information.pdf\" target=\"_blank\" data-click-type=\"outbound\" data-click-text=\"Prescribing Information\">Prescribing Information<img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/arrow-long.png\"></a></li> </ul> </div> </div> <p></p> </div> </div> </div> <div class=\"row collapsibleContent\"> <div class=\"col-12 border-bottom\"> <div class=\"textContent\"> <p>XALURITAMIG <br><span style=\"text-transform: lowercase !important;\">(formerly <span style=\"text-transform: uppercase !important;\">AMG</span> 509)</span><br> <span></span></p></div>  </div> <div class=\"col-12\"> <div class=\"wrapper row\">  <div class=\"col-1 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"> <h4 class=\"panel-title\"><a data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span> </a> </h4> </div> </div>  </div>  <div class=\"col-5 second-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Investigational Indication</a></div> </div> <div class=\"col-5 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Prostate Cancer</a></div> </div> <div class=\"col-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH3 \">3</span></a> </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-12\"> <label class=\"innerContentTitle\">THERAPEUTIC AREA</label> <p class=\"innterContentText\"> Hematology / Oncology </p> <label class=\"innerContentTitle\">MODALITY</label> <p class=\"innterContentText\"> XmAb<sup>\u00ae</sup> Antibody </p> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> Xaluritamig is an anti-six transmembrane epithelial antigen of the prostate 1 (STEAP1) x anti-CD3 XmAb<sup>\u00ae</sup> bispecific T cell engager molecule. It is being investigated for the treatment of prostate cancer.\n\n</p><p class=\"innerContentTitle\"><strong>ADDITIONAL CLINICAL STUDIES</strong></p>\n\n<p class=\"innterContentText\">Xaluritamig is also being investigated in combination with other therapies.</p>\n <p></p> <label class=\"innerContentTitle\">ADDITIONAL INFORMATION</label> <p class=\"innterContentText\">XmAb is a registered trademark of Xencor, Inc.</p>  </div> </div> <p></p> </div> </div> </div> <div class=\"row collapsibleContent\"> <div class=\"col-12 border-bottom\"> <div class=\"textContent\"> <p>ABP 206<br> <span><span style=\"text-transform: none\">(Investigational biosimilar to OPDIVO<sup>\u00ae</sup> (nivolumab))</span></span></p></div>  </div> <div class=\"col-12\"> <div class=\"wrapper row\">  <div class=\"col-1 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"> <h4 class=\"panel-title\"><a data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span> </a> </h4> </div> </div>  </div>  <div class=\"col-5 second-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Investigational Indication</a></div> </div> <div class=\"col-5 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Investigational Biosimilar</a></div> </div> <div class=\"col-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH3 \">3</span></a> </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-12\"> <label class=\"innerContentTitle\">THERAPEUTIC AREA</label> <p class=\"innterContentText\"> Hematology / Oncology </p> <label class=\"innerContentTitle\">MODALITY</label> <p class=\"innterContentText\"> Monoclonal Antibody </p> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> ABP 206 is an investigational biosimilar to OPDIVO (nivolumab), which is a monoclonal antibody that binds to the receptor protein called programmed death protein 1 (PD-1). </p> <label class=\"innerContentTitle\">ADDITIONAL INFORMATION</label> <p class=\"innterContentText\">OPDIVO is a registered trademark of Bristol-Myers Squibb Company.</p>  </div> </div> <p></p> </div> </div> </div> <div class=\"row collapsibleContent\"> <div class=\"col-12 border-bottom\"> <div class=\"textContent\"> <p>ABP 234<br> <span><span style=\"text-transform: none\">(Investigational biosimilar to KEYTRUDA\u00ae (pembrolizumab))</span></span></p></div>  </div> <div class=\"col-12\"> <div class=\"wrapper row\">  <div class=\"col-1 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"> <h4 class=\"panel-title\"><a data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span> </a> </h4> </div> </div>  </div>  <div class=\"col-5 second-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Investigational Indication</a></div> </div> <div class=\"col-5 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Investigational Biosimilar</a></div> </div> <div class=\"col-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH3 \">3</span></a> </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-12\"> <label class=\"innerContentTitle\">THERAPEUTIC AREA</label> <p class=\"innterContentText\"> Hematology / Oncology </p> <label class=\"innerContentTitle\">MODALITY</label> <p class=\"innterContentText\"> Monoclonal Antibody </p> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> ABP 234 is an investigational biosimilar to KEYTRUDA (pembrolizumab), which is a monoclonal antibody that binds to the receptor protein called programmed death protein 1 (PD-1). </p> <label class=\"innerContentTitle\">ADDITIONAL INFORMATION</label> <p class=\"innterContentText\">KEYTRUDA is a registered trademark of Merck &amp; Co.</p>  </div> </div> <p></p> </div> </div> </div> <div class=\"row collapsibleContent\"> <div class=\"col-12 border-bottom\"> <div class=\"textContent\"> <p>ABP 692<br> <span><span style=\"text-transform: none\">(Investigational biosimilar to OCREVUS\u00ae (ocrelizumab))</span></span></p></div>  </div> <div class=\"col-12\"> <div class=\"wrapper row\">  <div class=\"col-1 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"> <h4 class=\"panel-title\"><a data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span> </a> </h4> </div> </div>  </div>  <div class=\"col-5 second-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Investigational Indication</a></div> </div> <div class=\"col-5 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Investigational Biosimilar</a></div> </div> <div class=\"col-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH3 \">3</span></a> </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-12\"> <label class=\"innerContentTitle\">THERAPEUTIC AREA</label> <p class=\"innterContentText\"> Inflammation </p> <label class=\"innerContentTitle\">MODALITY</label> <p class=\"innterContentText\"> Monoclonal Antibody </p> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> ABP 692 is an investigational biosimilar to OCREVUS (ocrelizumab), which is a monoclonal antibody that binds to CD20, which is a protein found on the surface of B-cells. </p> <label class=\"innerContentTitle\">ADDITIONAL INFORMATION</label> <p class=\"innterContentText\">OCREVUS is a registered trademark of Genentech.</p>  </div> </div> <p></p> </div> </div> </div> <div class=\"row collapsibleContent\"> <div class=\"col-12 border-bottom\"> <div class=\"textContent\"> <p>DAXDILIMAB<br> <span></span></p></div>  </div> <div class=\"col-12\"> <div class=\"wrapper row\">  <div class=\"col-1 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"> <h4 class=\"panel-title\"><a data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span> </a> </h4> </div> </div>  </div>  <div class=\"col-5 second-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Investigational Indication</a></div> </div> <div class=\"col-5 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Dermatomyositis and Anti-Synthetase Inflammatory Myositis</a></div> </div> <div class=\"col-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH2 \">2</span></a> </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-12\"> <label class=\"innerContentTitle\">THERAPEUTIC AREA</label> <p class=\"innterContentText\"> Rare Disease </p> <label class=\"innerContentTitle\">MODALITY</label> <p class=\"innterContentText\"> Monoclonal Antibody </p> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> Daxdilimab is a fully human monoclonal antibody against ILT7 that depletes certain dendritic cells. It is being investigated for the treatment of dermatomyositis and anti-synthetase inflammatory myositis. </p>  </div> </div> <p></p> </div> <div class=\"wrapper row\">  <div class=\"col-1 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"> <h4 class=\"panel-title\"><a data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span> </a> </h4> </div> </div>  </div>  <div class=\"col-5 second-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Investigational Indication</a></div> </div> <div class=\"col-5 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Discoid Lupus Erythematosus</a></div> </div> <div class=\"col-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH2 \">2</span></a> </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-12\"> <label class=\"innerContentTitle\">THERAPEUTIC AREA</label> <p class=\"innterContentText\"> Rare Disease </p> <label class=\"innerContentTitle\">MODALITY</label> <p class=\"innterContentText\"> Monoclonal Antibody </p> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> Daxdilimab is a fully human monoclonal antibody against ILT7 that depletes certain dendritic cells. It is being investigated for the treatment of discoid lupus erythematosus. </p>  </div> </div> <p></p> </div> </div> </div> <div class=\"row collapsibleContent\"> <div class=\"col-12 border-bottom\"> <div class=\"textContent\"> <p>KYPROLIS<sup>\u00ae</sup><br> <span>(carfilzomib)</span></p></div>  </div> <div class=\"col-12\"> <div class=\"wrapper row\">  <div class=\"col-1 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"> <h4 class=\"panel-title\"><a data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span> </a> </h4> </div> </div>  </div>  <div class=\"col-5 second-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Investigational Indication</a></div> </div> <div class=\"col-5 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Pediatric Acute Lymphoblastic Leukemia</a></div> </div> <div class=\"col-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH2 \">2</span></a> </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-12\"> <label class=\"innerContentTitle\">THERAPEUTIC AREA</label> <p class=\"innterContentText\"> Hematology / Oncology </p> <label class=\"innerContentTitle\">MODALITY</label> <p class=\"innterContentText\"> Small Molecule </p> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> KYPROLIS is a small molecule proteasome inhibitor (PI). It is being investigated for the treatment of acute lymphoblastic leukemia (ALL) in pediatric patients. </p><label class=\"innerContentTitle\">PRONUNCIATION</label> <p> /car fil' zoe mib /<audio id=\"myAudio\"><source src=\"-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/pronunciation/kyprolis-carfilzomib.mp3\" type=\"audio/mpeg\"></audio><span class=\"audioIcon\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/audio.svg\"></span></p><label class=\"innerContentTitle\">ADDITIONAL INFORMATION</label> <ul class=\"customBreadcrumb\"> <li><a href=\"https://www.pi.amgen.com/~/media/amgen/repositorysites/pi-amgen-com/kyprolis/kyprolis_pi.pdf\" target=\"_blank\" data-click-type=\"outbound\" data-click-text=\"Prescribing Information\">Prescribing Information<img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/arrow-long.png\"></a></li> </ul> </div> </div> <p></p> </div> </div> </div> <div class=\"row collapsibleContent\"> <div class=\"col-12 border-bottom\"> <div class=\"textContent\"> <p>ORDESEKIMAB**<br><span style=\"text-transform: lowercase !important;\">(formerly <span style=\"text-transform: uppercase !important;\">AMG 714 / PRV-015</span>)</span>\n<br> <span></span></p></div>  </div> <div class=\"col-12\"> <div class=\"wrapper row\">  <div class=\"col-1 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"> <h4 class=\"panel-title\"><a data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span> </a> </h4> </div> </div>  </div>  <div class=\"col-5 second-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Investigational Indication</a></div> </div> <div class=\"col-5 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Celiac Disease</a></div> </div> <div class=\"col-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH2 \">2</span></a> </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-12\"> <label class=\"innerContentTitle\">THERAPEUTIC AREA</label> <p class=\"innterContentText\"> Inflammation </p> <label class=\"innerContentTitle\">MODALITY</label> <p class=\"innterContentText\"> Monoclonal Antibody </p> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> Ordesekimab (formerly AMG 714/PRV-015) is a monoclonal antibody that inhibits the action of Interleukin-15 (IL-15). It is being investigated for the treatment of non-responsive celiac disease as an adjunct to a gluten free diet. </p> <label class=\"innerContentTitle\">ADDITIONAL INFORMATION</label> <p class=\"innterContentText\">Ordesekimab is being developed in collaboration with Provention Bio, a Sanofi company.</p>  </div> </div> <p></p> </div> </div> </div> <div class=\"row collapsibleContent\"> <div class=\"col-12 border-bottom\"> <div class=\"textContent\"> <p>AMG 104<br> <span></span></p></div>  </div> <div class=\"col-12\"> <div class=\"wrapper row\">  <div class=\"col-1 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"> <h4 class=\"panel-title\"><a data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span> </a> </h4> </div> </div>  </div>  <div class=\"col-5 second-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Investigational Indication</a></div> </div> <div class=\"col-5 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Asthma</a></div> </div> <div class=\"col-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH2 \">2</span></a> </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-12\"> <label class=\"innerContentTitle\">THERAPEUTIC AREA</label> <p class=\"innterContentText\"> Inflammation </p> <label class=\"innerContentTitle\">MODALITY</label> <p class=\"innterContentText\"> Monoclonal Antibody </p> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> AMG 104 is a human anti-TSLP Fab. It is being investigated for the treatment of asthma. </p> <label class=\"innerContentTitle\">ADDITIONAL INFORMATION</label> <p class=\"innterContentText\">AMG 104 is being developed in collaboration with AstraZeneca plc.</p>  </div> </div> <p></p> </div> </div> </div> <div class=\"row collapsibleContent\"> <div class=\"col-12 border-bottom\"> <div class=\"textContent\"> <p>AMG 193<br> <span></span></p></div>  </div> <div class=\"col-12\"> <div class=\"wrapper row\">  <div class=\"col-1 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"> <h4 class=\"panel-title\"><a data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span> </a> </h4> </div> </div>  </div>  <div class=\"col-5 second-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Investigational Indication</a></div> </div> <div class=\"col-5 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Non-Small Cell Lung Cancer</a></div> </div> <div class=\"col-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH2 \">2</span></a> </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-12\"> <label class=\"innerContentTitle\">THERAPEUTIC AREA</label> <p class=\"innterContentText\"> Hematology / Oncology </p> <label class=\"innerContentTitle\">MODALITY</label> <p class=\"innterContentText\"> Small Molecule </p> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> AMG 193 is a small molecule methylthioadenosine (MTA) cooperative protein arginine methyltransferase 5 (PRMT5) inhibitor. It is being investigated for the treatment of non-small cell lung cancer.\n\n</p><p class=\"innerContentTitle\"><strong>ADDITIONAL CLINICAL STUDIES</strong></p>\n\n<p class=\"innterContentText\">AMG 193 is also in Phase 1 development for the treatment of non-small cell lung cancer in combination with other  therapies.</p> <p></p>  </div> </div> <p></p> </div> <div class=\"wrapper row\">  <div class=\"col-1 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"> <h4 class=\"panel-title\"><a data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span> </a> </h4> </div> </div>  </div>  <div class=\"col-5 second-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Investigational Indication</a></div> </div> <div class=\"col-5 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Other Tumors</a></div> </div> <div class=\"col-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH1 \">1</span></a> </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-12\"> <label class=\"innerContentTitle\">THERAPEUTIC AREA</label> <p class=\"innterContentText\"> Hematology / Oncology </p> <label class=\"innerContentTitle\">MODALITY</label> <p class=\"innterContentText\"> Small Molecule </p> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> AMG 193 is a small molecule methylthioadenosine (MTA) cooperative protein arginine methyltransferase 5 (PRMT5) inhibitor. It is being investigated for the treatment of solid tumors other than non-small cell lung cancer.\n\n</p><p class=\"innerContentTitle\"><strong>ADDITIONAL INFORMATION</strong></p>\n\n<p class=\"innterContentText\">AMG 193 is also in Phase 1 development for the treatment of solid tumors in combination with other therapies.</p> <p></p>  </div> </div> <p></p> </div> </div> </div> <div class=\"row collapsibleContent\"> <div class=\"col-12 border-bottom\"> <div class=\"textContent\"> <p>AMG 329<br><span style=\"text-transform: lowercase !important;\">(formerly <span style=\"text-transform: uppercase !important;\">HZN-1116</span>)</span><br> <span></span></p></div>  </div> <div class=\"col-12\"> <div class=\"wrapper row\">  <div class=\"col-1 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"> <h4 class=\"panel-title\"><a data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span> </a> </h4> </div> </div>  </div>  <div class=\"col-5 second-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Investigational Indication</a></div> </div> <div class=\"col-5 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Sj\u00f6gren\u2019s Disease</a></div> </div> <div class=\"col-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH2 \">2</span></a> </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-12\"> <label class=\"innerContentTitle\">THERAPEUTIC AREA</label> <p class=\"innterContentText\"> Rare Disease </p> <label class=\"innerContentTitle\">MODALITY</label> <p class=\"innterContentText\"> Monoclonal Antibody </p> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> AMG 329 is a fully human monoclonal antibody that binds and neutralizes the function of the FLT3-ligand, thereby reducing both conventional and plasmacytoid dendritic cells. It is being investigated for the treatment of Sj\u00f6gren's disease. </p>  </div> </div> <p></p> </div> </div> </div> <div class=\"row collapsibleContent\"> <div class=\"col-12 border-bottom\"> <div class=\"textContent\"> <p>AMG 732<br><span style=\"text-transform: lowercase !important;\">(formerly <span style=\"text-transform: uppercase !important;\">HZN-280</span>)</span><br> <span></span></p></div>  </div> <div class=\"col-12\"> <div class=\"wrapper row\">  <div class=\"col-1 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"> <h4 class=\"panel-title\"><a data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span> </a> </h4> </div> </div>  </div>  <div class=\"col-5 second-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Investigational Indication</a></div> </div> <div class=\"col-5 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Thyroid Eye Disease</a></div> </div> <div class=\"col-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH2 \">2</span></a> </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-12\"> <label class=\"innerContentTitle\">THERAPEUTIC AREA</label> <p class=\"innterContentText\"> Rare Disease </p> <label class=\"innerContentTitle\">MODALITY</label> <p class=\"innterContentText\"> Monoclonal Antibody </p> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> AMG 732 is a monoclonal antibody against insulin-like growth factor-1 receptor (IGF-1R). It is being investigated for the treatment of thyroid eye disease. </p>  </div> </div> <p></p> </div> </div> </div> <div class=\"row collapsibleContent\"> <div class=\"col-12 border-bottom\"> <div class=\"textContent\"> <p>AMG 305<br> <span></span></p></div>  </div> <div class=\"col-12\"> <div class=\"wrapper row\">  <div class=\"col-1 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"> <h4 class=\"panel-title\"><a data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span> </a> </h4> </div> </div>  </div>  <div class=\"col-5 second-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Investigational Indication</a></div> </div> <div class=\"col-5 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Solid Tumors</a></div> </div> <div class=\"col-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH1 \">1</span></a> </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-12\"> <label class=\"innerContentTitle\">THERAPEUTIC AREA</label> <p class=\"innterContentText\"> Hematology / Oncology </p> <label class=\"innerContentTitle\">MODALITY</label> <p class=\"innterContentText\"> BiTE<sup>\u00ae</sup> Molecule </p> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> AMG 305 is a dual-targeting bispecific T cell engager (BiTE) molecule against P-cadherin (CDH3), mesothelin (MSLN) and CD3. It is being investigated for the treatment of solid tumors. </p>  </div> </div> <p></p> </div> </div> </div> <div class=\"row collapsibleContent\"> <div class=\"col-12 border-bottom\"> <div class=\"textContent\"> <p>AMG 355<br> <span></span></p></div>  </div> <div class=\"col-12\"> <div class=\"wrapper row\">  <div class=\"col-1 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"> <h4 class=\"panel-title\"><a data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span> </a> </h4> </div> </div>  </div>  <div class=\"col-5 second-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Investigational Indication</a></div> </div> <div class=\"col-5 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Solid Tumors</a></div> </div> <div class=\"col-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH1 \">1</span></a> </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-12\"> <label class=\"innerContentTitle\">THERAPEUTIC AREA</label> <p class=\"innterContentText\"> Hematology / Oncology </p> <label class=\"innerContentTitle\">MODALITY</label> <p class=\"innterContentText\"> Monoclonal Antibody </p> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> AMG 355 is an anti-CCR8 monoclonal antibody. It is being investigated for the treatment of advanced solid tumor malignancies. </p>  </div> </div> <p></p> </div> </div> </div> <div class=\"row collapsibleContent\"> <div class=\"col-12 border-bottom\"> <div class=\"textContent\"> <p>AMG 378<br> <span></span></p></div>  </div> <div class=\"col-12\"> <div class=\"wrapper row\">  <div class=\"col-1 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"> <h4 class=\"panel-title\"><a data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span> </a> </h4> </div> </div>  </div>  <div class=\"col-5 second-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Investigational Indication</a></div> </div> <div class=\"col-5 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Ulcerative Colitis</a></div> </div> <div class=\"col-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH1 \">1</span></a> </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-12\"> <label class=\"innerContentTitle\">THERAPEUTIC AREA</label> <p class=\"innterContentText\"> Inflammation </p> <label class=\"innerContentTitle\">MODALITY</label> <p class=\"innterContentText\"> Small Molecule </p> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> AMG 378 is a small molecule being investigated for the treatment of ulcerative colitis. </p>  </div> </div> <p></p> </div> </div> </div> <div class=\"row collapsibleContent\"> <div class=\"col-12 border-bottom\"> <div class=\"textContent\"> <p>AMG 410<br> <span></span></p></div>  </div> <div class=\"col-12\"> <div class=\"wrapper row\">  <div class=\"col-1 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"> <h4 class=\"panel-title\"><a data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span> </a> </h4> </div> </div>  </div>  <div class=\"col-5 second-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Investigational Indication</a></div> </div> <div class=\"col-5 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Solid Tumors</a></div> </div> <div class=\"col-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH1 \">1</span></a> </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-12\"> <label class=\"innerContentTitle\">THERAPEUTIC AREA</label> <p class=\"innterContentText\"> Hematology / Oncology </p> <label class=\"innerContentTitle\">MODALITY</label> <p class=\"innterContentText\"> Small Molecule </p> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> AMG 410 is a small molecule being investigated for the treatment of solid tumors. </p>  </div> </div> <p></p> </div> </div> </div> <div class=\"row collapsibleContent\"> <div class=\"col-12 border-bottom\"> <div class=\"textContent\"> <p>AMG 513<br> <span></span></p></div>  </div> <div class=\"col-12\"> <div class=\"wrapper row\">  <div class=\"col-1 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"> <h4 class=\"panel-title\"><a data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span> </a> </h4> </div> </div>  </div>  <div class=\"col-5 second-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Investigational Indication</a></div> </div> <div class=\"col-5 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Obesity</a></div> </div> <div class=\"col-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH1 \">1</span></a> </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-12\"> <label class=\"innerContentTitle\">THERAPEUTIC AREA</label> <p class=\"innterContentText\"> Cardiometabolic </p> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> AMG 513 is a molecule being investigated for the treatment of obesity. </p>  </div> </div> <p></p> </div> </div> </div> <div class=\"row collapsibleContent\"> <div class=\"col-12 border-bottom\"> <div class=\"textContent\"> <p>AMG 691<br> <span></span></p></div>  </div> <div class=\"col-12\"> <div class=\"wrapper row\">  <div class=\"col-1 first-column\"> <div class=\"panel panel-default\"> <div class=\"panel-heading active\" role=\"tab\" id=\"headingOne\"> <h4 class=\"panel-title\"><a data-toggle=\"collapse\"><span class=\"arrow\"><img src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/accordian-arrow.png\"></span> </a> </h4> </div> </div>  </div>  <div class=\"col-5 second-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Investigational Indication</a></div> </div> <div class=\"col-5 third-column\"> <div class=\"card card-block\"><a href=\"javascript:void(0)\">Asthma</a></div> </div> <div class=\"col-1 fourth-column\"><a href=\"javascript:void(0)\"> <span class=\"badge phases-PH1 \">1</span></a> </div>  </div>  <div class=\"collapseData\"> <div class=\"row\"> <div class=\"col-12\"> <label class=\"innerContentTitle\">THERAPEUTIC AREA</label> <p class=\"innterContentText\"> Inflammation </p> <label class=\"innerContentTitle\">MODALITY</label> <p class=\"innterContentText\"> Monoclonal Antibody </p> <label class=\"innerContentTitle\">DESCRIPTION</label> <p class=\"innterContentText\"> AMG 691 is a monoclonal antibody being investigated for the treatment of asthma. </p>  </div> </div> <p></p> </div> </div> </div></div>\n        </div>\n        <div class=\"row noMoleculeResultContainer\" style=\"display: none;\">\n            <div class=\"col-md-5 noResult\">\n            <p><img src=\"-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/filter-result-warning-icon.svg\" class=\"result-warning-icon\" alt=\"Warning Icon\">No molecules match your criteria</p>\n        </div>\n        <div class=\"col-md-7 text-left\">\n            <button class=\"btn btnViewAllMolecules\">VIEW ALL MOLECULES</button>\n        </div>\n        </div>\n    </div>\n</div>\n\n    \n    \n\n\n\n\n    <div class=\"quantum-container--primary quantum-back-to-top  quantum-back-to-top--persistent \" id=\"\" style=\"\">\n        <div class=\"quantum-back-to-top__inner\">\n            <a class=\"quantum-back-to-top__target \" href=\"#\">\n\n\n                    <span class=\"quantum-back-to-top__label\">\n                        \n                        <svg class=\"quantum-icon quantum-back-to-top__static-icon\">\n\n                            <use xlink:href=\"-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/arrow_svg.svg#\"></use>\n\n                        </svg>\n                    </span>\n                    <span class=\"quantum-back-to-top__button quantum-button quantum-button--icon-only\" title=\"Back to Top\"><img class=\"btarrow-img\" src=\"-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/arrow_svg.svg\">\n                        <svg class=\"quantum-icon quantum-button__icon\">\n                            <use xlink:href=\"-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/arrow_svg.svg#\"></use>\n\n                        </svg>\n                    </span>\n            </a>\n        </div>\n    </div>\n\n\n\n\n    <footer id=\"footer\">\n        \n\n\n\n\n<div class=\"component container\" id=\"footer-quick-links\">\n    <div class=\"component-content\">\n\n\n\n    <div class=\"component rich-text col-12\">\n        <div class=\"component-content\">\nQuick Links        </div>\n    </div>\n\n<div class=\"quantum-quicklinks \" id=\"\">\n    <div class=\"quantum-quicklinks__inner\">\n\n                <div class=\"quantum-quicklinks__column\">\n\n                    <ul class=\"quantum-list-group quantum-quicklinks__column-list-group quantum-list-group--small\">\n                                <li class=\"quantum-list-group__item \">\n\n\n                                    <a class=\"quantum-list-group__link  \" data-click-type=\"outbound\" data-click-text=\"Investors\" href=\"http://investors.amgen.com/\" target=\"\">Investors</a>\n\n                                </li>\n                                <li class=\"quantum-list-group__item \">\n\n\n                                    <a class=\"quantum-list-group__link  \" data-click-type=\"outbound\" data-click-text=\"Amgen Medical Information\" href=\"https://www.amgenmedinfo.com/\" target=\"\">Amgen Medical Information</a>\n\n                                </li>\n                        \n\n\n                    </ul>\n                </div>\n                <div class=\"quantum-quicklinks__column\">\n\n                    <ul class=\"quantum-list-group quantum-quicklinks__column-list-group quantum-list-group--small\">\n                                <li class=\"quantum-list-group__item \">\n\n\n                                    <a class=\"quantum-list-group__link  \" data-click-type=\"outbound\" data-click-text=\"Amgen Media Relations\" href=\"https://www.amgen.com/media/\" target=\"\">Amgen Media Relations</a>\n\n                                </li>\n                                <li class=\"quantum-list-group__item \">\n\n\n                                    <a class=\"quantum-list-group__link  \" data-click-type=\"outbound\" data-click-text=\"Contact us\" href=\"https://www.amgen.com/contact-us/\" target=\"\">Contact Us</a>\n\n                                </li>\n                        \n\n\n                    </ul>\n                </div>\n                <div class=\"quantum-quicklinks__column\">\n\n                    <ul class=\"quantum-list-group quantum-quicklinks__column-list-group quantum-list-group--small\">\n                                <li class=\"quantum-list-group__item \">\n\n\n                                    <a class=\"quantum-list-group__link  \" data-click-type=\"outbound\" data-click-text=\"Amgen Biosimilars\" href=\"https://www.amgenbiosimilars.com/\" target=\"\">AmgenBiosimilars.com</a>\n\n                                </li>\n                                <li class=\"quantum-list-group__item \">\n\n\n                                    <a class=\"quantum-list-group__link  \" data-click-type=\"outbound\" data-click-text=\"Amgen\" href=\"https://www.amgen.com/\" target=\"\">Amgen.com</a>\n\n                                </li>\n                        \n\n\n                    </ul>\n                </div>\n                <div class=\"quantum-quicklinks__column\">\n\n                    <ul class=\"quantum-list-group quantum-quicklinks__column-list-group quantum-list-group--small\">\n                                <li class=\"quantum-list-group__item \">\n\n\n                                    <a class=\"quantum-list-group__link  \" data-click-type=\"outbound\" data-click-text=\"Amgen Science\" href=\"https://www.amgenscience.com/\" target=\"\">AmgenScience.com</a>\n\n                                </li>\n                                <li class=\"quantum-list-group__item \">\n\n\n                                    <a class=\"quantum-list-group__link  \" data-click-type=\"outbound\" data-click-text=\"Amgen Trails\" href=\"http://www.amgentrials.com/amgen/study.aspx\" target=\"\">Amgentrials.com</a>\n\n                                </li>\n                        \n\n\n                    </ul>\n                </div>\n\n    </div>\n</div>\n\n\n\n    </div>\n</div>\n\n\n\n\n<div class=\"component container\" id=\"disclaimer-info\">\n    <div class=\"component-content\">\n\n\n<div class=\"component row-splitter\">\n        <div class=\"container-fluid\">\n            <div>\n                \n\n\n    <div class=\"component rich-text col-12\">\n        <div class=\"component-content\">\n<p>*&nbsp;&nbsp;Modalities in use across pipeline and marketed products. Modality refers to the structural template of a therapeutic agent.</p>\n<p>**&nbsp;&nbsp;Ordesekimab, formerly AMG 714 and also known as PRV-015, is being developed in collaboration with Provention Bio, a Sanofi company. For the purposes of the collaboration, Provention Bio conducts a clinical trial and leads certain development and regulatory activities for the program.</p>        </div>\n    </div>\n\n            </div>\n        </div>\n        <div class=\"container-fluid\">\n            <div>\n                \n\n\n    <div class=\"component rich-text col-12\">\n        <div class=\"component-content\">\n<p>This pipeline presents a selection of the Company\u2019s product candidates and is designed to demonstrate the range of the Company\u2019s commitment to patients in pursuing therapies to treat serious illnesses. We present a selection of these product candidates in our periodic reports based on their importance to the Company and our Annual Report on Form 10-K also includes an annual summary of activity for those Phase 3 product candidates selected for inclusion in our periodic filings. Unless otherwise noted, we are providing this information as of August 5, 2025, and expressly disclaim any duty to update any of the provided information. Amgen's product pipeline will change over time as molecules move through the drug development process, including progressing through clinical phases to licensure and market, returning to strategic partners, being outlicensed, or failing in clinical trials to demonstrate efficacy, safety or to deliver a commercially viable product, due to the nature of the development process. This description contains forward-looking statements that involve significant risks and uncertainties, including those discussed in Amgen's most recent Form 10-K and in Amgen's periodic reports on Form 10-Q and Form 8-K, and actual results may vary materially. Amgen is providing this information as of the date above and does not undertake any obligation to update any forward-looking statements contained in this table as a result of new information, future events or otherwise. </p>        </div>\n    </div>\n\n            </div>\n        </div>\n</div>    </div>\n</div>\n\n\n    <div class=\"quantum-container--secondary quantum-footer \" id=\"\">\n        <div class=\"quantum-footer__inner\">\n\n            \n\n\n    <div class=\"quantum-footer__logo-social-row\">\n\n\n            <a title=\"Logo\" href=\"/Home\" target=\"\" class=\" quantum-footer__logo-link \">\n                <svg class=\"quantum-icon\">\n                    </svg><img src=\"-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/amgen-logo.svg?la=en&amp;h=36&amp;w=151&amp;hash=01EF16D7756AF458A6C8E51C7C001BDA\" class=\"d-none d-sm-block quantum-footer__quantum-logo lozad\" alt=\"footer logo\">\n                    <img src=\"-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/images/Common/amgen-logo.svg?la=en&amp;h=36&amp;w=151&amp;hash=01EF16D7756AF458A6C8E51C7C001BDA\" class=\"d-block d-sm-none quantum-footer__quantum-logo lozad\" alt=\"footer logo\">\n                \n\n            </a>\n\n\n\n    </div>\n\n\n            \n\n            \n<div class=\"quantum-footer__links-row\">\n\n\n                    <a href=\"https://wwwext.amgen.com/terms-of-use/\" class=\"  gtm-footerCl quantum-link quantum-footer__link\" menu-name=\"terms of use\" menu-type=\"footer\" data-click-type=\"outbound\" data-click-text=\"terms of use\" target=\"\">\n                      Terms of Use\n                    </a>\n                    <a href=\"https://wwwext.amgen.com/privacy-statement/\" class=\"  gtm-footerCl quantum-link quantum-footer__link\" menu-name=\"privacy statement\" menu-type=\"footer\" data-click-type=\"outbound\" data-click-text=\"privacy statement\" target=\"\">\n                      Privacy Statement\n                    </a>\n                    <a href=\"https://www.amgen.com/healthdataprivacypolicy/\" class=\"  gtm-footerCl quantum-link quantum-footer__link\" menu-name=\"consumer health data privacy policy\" menu-type=\"footer\" data-click-type=\"outbound\" data-click-text=\"consumer health data privacy policy\" target=\"_blank\">\n                      Consumer Health Data Privacy Policy\n                    </a>\n                    <a href=\"#\" class=\"cb-renew  gtm-footerCl quantum-link quantum-footer__link\" menu-name=\"Your Cookie Preferences\" menu-type=\"footer\" data-click-type=\"outbound\" data-click-text=\"Your Cookie Preferences\" target=\"\">\n                      Your Cookie Preferences\n                    </a>\n</div>\n            \n            <p class=\"quantum-footer__legal-row\">\n                \u00a9 2024 Amgen Inc. All Rights Reserved.\n            </p>\n\n        </div>\n    </div>\n\n\n\n\n            <script>\n                var doPopup = \"True\";\n            </script>\n    </footer>\n    \n\n<script src=\"/-/media/Base-Themes/NG-Amgen-Google-Tag-Manager/Scripts/AccordinGtmTracking.js\"></script><iframe name=\"__uspapiLocator\" tabindex=\"-1\" role=\"presentation\" aria-hidden=\"true\" title=\"Blank\" style=\"display: none; position: absolute; width: 1px; height: 1px; top: -9999px;\"></iframe><iframe tabindex=\"-1\" role=\"presentation\" aria-hidden=\"true\" title=\"Blank\" src=\"https://consentcdn.cookiebot.com/sdk/bc-v4.min.html\" style=\"position: absolute; width: 1px; height: 1px; top: -9999px;\"></iframe><script src=\"/-/media/Base-Themes/NG-Amgen-Google-Tag-Manager/Scripts/BrightCoverVideoGTMTracking.js\"></script><script src=\"/-/media/Base-Themes/NG-Amgen-Google-Tag-Manager/Scripts/GTMinlineScript.js\"></script><script src=\"/-/media/Base-Themes/NG-Amgen-Google-Tag-Manager/Scripts/GTMinlineScriptCL.js\"></script><script src=\"/-/media/Base-Themes/NG-Amgen-Google-Tag-Manager/Scripts/trackGTM.js\"></script><script src=\"/-/media/Base-Themes/CCPAReadMore/Scripts/readmore.js\"></script><script src=\"/-/media/Base-Themes/Core-Libraries/scripts/ie-origin-fix.js\"></script><script src=\"/-/media/Base-Themes/Core-Libraries/scripts/autocomplete.js\"></script><script src=\"/-/media/Base-Themes/Core-Libraries/scripts/jquery-ui-1133.js\"></script><script src=\"/-/media/Base-Themes/Core-Libraries/scripts/jquery-ui-1133min.js\"></script><script src=\"/-/media/Base-Themes/Core-Libraries/scripts/xaquery.js\"></script><script src=\"/-/media/Base-Themes/Core-Libraries/scripts/moment.js\"></script><script src=\"/-/media/Base-Themes/Core-Libraries/scripts/moment-2301.js\"></script><script src=\"/-/media/Base-Themes/Core-Libraries/scripts/lo-dash.js\"></script><script src=\"/-/media/Base-Themes/Core-Libraries/scripts/modernizr.js\"></script><script src=\"/-/media/Base-Themes/Core-Libraries/scripts/galleria-161.js\"></script><script src=\"/-/media/Base-Themes/Core-Libraries/scripts/fullcalendar.js\"></script><script src=\"/-/media/Base-Themes/Core-Libraries/scripts/gcal.js\"></script><script src=\"/-/media/Base-Themes/Core-Libraries/scripts/backbone-min.js\"></script><script src=\"/-/media/Base-Themes/Core-Libraries/scripts/mediaelement-and-player.js\"></script><script src=\"/-/media/Base-Themes/Core-Libraries/scripts/dailymotion.js\"></script><script src=\"/-/media/Base-Themes/Core-Libraries/scripts/facebook.js\"></script><script src=\"/-/media/Base-Themes/Core-Libraries/scripts/soundcloud.js\"></script><script src=\"/-/media/Base-Themes/Core-Libraries/scripts/twitch.js\"></script><script src=\"/-/media/Base-Themes/Core-Libraries/scripts/vimeo.js\"></script><script src=\"/-/media/Base-Themes/XA-API/Scripts/xa.js\"></script><script src=\"/-/media/Base-Themes/Main-Theme/scripts/observer.js\"></script><script src=\"/-/media/Base-Themes/Main-Theme/scripts/partial-design-highlight.js\"></script><script src=\"/-/media/Base-Themes/NG-Amgen-Query-String-Handler/Scripts/QueryStringProcessor.js\"></script><script src=\"/-/media/Base-Themes/Components-Theme/Scripts/accessibility.js\"></script><script src=\"/-/media/Base-Themes/Components-Theme/Scripts/component-accordions.js\"></script><script src=\"/-/media/Base-Themes/Components-Theme/Scripts/component-archive.js\"></script><script src=\"/-/media/Base-Themes/Components-Theme/Scripts/component-breadcrumb.js\"></script><script src=\"/-/media/Base-Themes/Components-Theme/Scripts/component-carousel.js\"></script><script src=\"/-/media/Base-Themes/Components-Theme/Scripts/component-container.js\"></script><script src=\"/-/media/Base-Themes/Components-Theme/Scripts/component-disqus.js\"></script><script src=\"/-/media/Base-Themes/Components-Theme/Scripts/component-facebook.js\"></script><script src=\"/-/media/Base-Themes/Components-Theme/Scripts/component-flip.js\"></script><script src=\"/-/media/Base-Themes/Components-Theme/Scripts/component-fullcalendar.js\"></script><script src=\"/-/media/Base-Themes/Components-Theme/Scripts/component-galleria.js\"></script><script src=\"/-/media/Base-Themes/Components-Theme/Scripts/component-language-selector.js\"></script><script src=\"/-/media/Base-Themes/Components-Theme/Scripts/component-navigation.js\"></script><script src=\"/-/media/Base-Themes/Components-Theme/Scripts/component-overlay.js\"></script><script src=\"/-/media/Base-Themes/Components-Theme/Scripts/component-snippet.js\"></script><script src=\"/-/media/Base-Themes/Components-Theme/Scripts/component-social.js\"></script><script src=\"/-/media/Base-Themes/Components-Theme/Scripts/component-tabs.js\"></script><script src=\"/-/media/Base-Themes/Components-Theme/Scripts/component-toggle.js\"></script><script src=\"/-/media/Base-Themes/Components-Theme/Scripts/component-video.js\"></script><script src=\"/-/media/Base-Themes/Components-Theme/Scripts/component-video-playlist.js\"></script><script src=\"/-/media/Base-Themes/Components-Theme/Scripts/details-polyfill.js\"></script><script src=\"/-/media/Base-Themes/Components-Theme/Scripts/fixheight.js\"></script><script src=\"/-/media/Base-Themes/Components-Theme/Scripts/search-fixheight.js\"></script><script src=\"/-/media/Base-Themes/Resolve-Conflicts/Scripts/resolveconflicts.js\"></script><script src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/Scripts/Gtm.js\"></script><script src=\"/-/media/Themes/Amgen/amgenpipeline-com/amgenpipeline-com/Scripts/pipeline-custom.js\"></script>\n    \n    \n\n\n\n<img id=\"CookiebotSessionPixel\" src=\"https://imgsct.cookiebot.com/1.gif?dgi=3c04f870-41c9-42bc-965e-776f1eef473a\" alt=\"Cookiebot session tracker icon loaded\" data-cookieconsent=\"ignore\" style=\"display: none;\"></body></html>",
    "actions": [
        {
            "action": "scrollBottom",
            "elapsedTime": 5.004,
            "status": "success"
        },
        {
            "action": "waitForTimeout",
            "elapsedTime": 15,
            "status": "success"
        }
    ]
}